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Abstract 
Essential in biomedical research is the necessity of gathering statistically relevant data about large 
populations of specific biological entities – e.g. organisms, cells or molecules – while preserving 
detailed information about each single entity under investigation. This thesis deals with this need 
and proposes the combination of microfluidics and “micro-arraying” techniques in developing 
technological tools to conceive bio-assays at single molecule/cell/organism resolution.  
First, we propose an on-chip immunoassay technique, through which we demonstrated detection 
of the biomarker tumor necrosis factor α in serum down to concentrations in the attomolar range 
(10-18 M). In particular, we provide a comprehensive predictive model of the assay, which employs 
micro-arrays of superparamagnetic beads. We introduce the concept of “magnetic particle-scan-
ning”, as a method for building immunoassays with extremely low limit of detection, down to the 
single-molecule level. Afterwards, we modified our bead micro-arraying technique, to make it 
suitable for the immobilization of particles and cells of various sizes and properties. Specifically, 
we present a method for the electrostatic self-assembly of dielectric microspheres in well tem-
plates, as a technique for fast and versatile fabrication of microlens arrays. By combining these 
arrays with microfluidics, we created a new tool for single-nanoparticle detection in flowing me-
dia, able to detect moving objects of sub-diffraction size through conventional low-magnification 
microscopes. An analogous micro-arraying method was then developed to seed large populations 
of non-adherent cells in isolated micro-compartments. In combination with an electrowetting-on-
dielectric microfluidic platform, this technique allows implementing high-throughput cytotoxicity 
assays on yeast cells, at single-cell resolution.  
Subsequently, we conceived technological solutions for the automated analysis of Caenorhabditis 
elegans, one of the most employed model organisms in biomedical research. First, we developed 
a microfluidic platform for on-chip nematode culture and creation of synchronized C. elegans em-
bryo micro-arrays. Long-term multi-dimensional imaging in our device allows systematic pheno-
typing studies at single-embryo resolution. We could discriminate embryonic development varia-
tions with unprecedented accuracy and we successfully analyzed the impact of perturbations of 
the mitochondrial functions on the embryogenesis. A “second generation prototype” of the device 
is then presented, enabling long-term automated studies on C. elegans at single-nematode reso-
lution and over the whole organism development, from early embryogenesis to adulthood. Finally, 
we introduce a “third generation prototype”, which features: (i) a new microfluidic design tailored 
for the isolation of larvae at a desired developmental stage and for their successive culture and 
treatment; (ii) a method for reversible immobilization of nematodes, enabling long-term high-res-
olution imaging. We successfully employed this platform to analyze protein aggregation in a C. 
elegans model for human amyotrophic lateral sclerosis (ALS). The device allows precisely localizing 
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protein aggregates within the nematodes’ tissues, as well as monitoring the evolution of single 
aggregates over consecutive days at sub-cellular level.  Keywords 
Microfluidics, micro-array, protein detection, superparamagnetic bead, magnetic particle-scan-
ning, electrostatic self-assembly, lens array, nanoparticle detection, yeast, single-cell, Caenorhab-
ditis elegans, on-chip worm culture, multi-dimensional imaging, C. elegans embryo, reversible 
worm immobilization, long-term high-resolution imaging, neurodegenerative disease, protein ag-
gregation, phenotyping. 
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Résumé 
Dans le domaine de la recherche biomédicale, il est essentiel de pouvoir obtenir des données sta-
tistiques relatives à de larges populations d’entités biologiques – comme des cellules ou des mo-
lécules – tout en préservant les informations détaillées qui concernent les entités individuelles 
considérées. Ce travail de thèse traite de cette thématique en combinant l’utilisation des tech-
niques de microfluidique et de mise en micro-matrice pour la réalisation de tests biologiques au 
niveau d’entités individuelles.  
Nous avons ainsi pu établir un test immunologique sur puce, capable de détecter le facteur de 
nécrose tumorale α dans le sérum à des concentrations de l’ordre de l’attomolaire (10-18 M). Nous 
avons développé un modèle prédictif complet de cette technique basé sur l’exploitation de ma-
trices de microparticules superparamagnétiques. Nous avons par la suite introduit le concept de 
“scansion de particules magnétiques” comme nouvelle méthode afin de créer des tests immuno-
logiques aux limites de détection très basses, atteignant le niveau de la molécule unique. En outre, 
la technique de mise en micro-matrice de particules magnétiques a été adaptée à l’immobilisation 
de particules et cellules de tailles et propriétés différentes. Nous avons en effet développé une 
méthode d'auto-assemblage électrostatique de microsphères diélectriques dans des puits pour la 
production de matrices de microlentilles. En introduisant ces matrices dans un système microflui-
dique, nous avons pu créer un nouvel outil pour la détection de nanoparticules en flux. Ce système 
a permis d’identifier des objets en mouvement de taille inférieure à la limite de diffraction de la 
lumière, tout en utilisant des microscopes conventionnels à faible grossissement. Par la suite, nous 
avons établis une méthode pour distribuer dans des puits séparés des populations de cellules non 
adhérentes. Cette technique a été utilisée avec un dispositif microfluidique « electrowetting sur 
diélectrique » pour réaliser des tests de cytotoxicité sur des cellules de levure au niveau de la 
cellule individuelle.  
Une seconde partie de ce travail de thèse a permis de concevoir des technologies dédiées à l’ana-
lyse automatisée du nématode Caenorhabditis elegans, un organisme modèle très utilisé en re-
cherche biomédicale. Nous avons développé un dispositif microfluidique pour l’élevage de néma-
todes sur puce et la mise en micro-matrice d’embryons de C. elegans. À l’aide d’un processus 
d’imagerie multidimensionnelle, ce dispositif a permis l’analyse systématique de phénotypes chez 
l’embryon individuel, en particulier l’impact des perturbations des fonctions mitochondriales sur 
l’embryogenèse. Nous avons ensuite dessiné un second prototype, conçu pour l’analyse automa-
tisée du développement de nématodes isolés, depuis l’embryogenèse jusqu’au stade adulte. En-
fin, nous avons introduit un troisième prototype, qui se caractérise par: (i) une nouvelle architec-
ture fluidique, conçue pour sélectionner des larves de taille spécifique, les élever et les traiter sur 
puce; (ii) une méthode d’immobilisation réversible des nématodes, permettant de les observer à 
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haute résolution et à long terme. Nous avons utilisé cette plateforme pour analyser l’agrégation 
de protéines chez un modèle C. elegans de sclérose latérale amyotrophique (SLA) humaine. Nous 
avons ainsi pu localiser précisément des agrégats spécifiques dans les nématodes et suivre leur 
évolution à un niveau subcellulaire au cours du temps. Mots-clés  
Microfluidique, micro-matrice, détection de protéines, particule super paramagnétique, scansion 
de particules magnétiques, auto-assemblage électrostatique, matrice de lentilles, détection de 
nanoparticules, levure, cellule unique, Caenorhabditis elegans, élevage de nématodes sur puce, 
imagerie multidimensionnelle, embryon de C. elegans, immobilisation réversible de nématodes, 
observation à long terme à haute résolution, maladie neurodégénérative, agrégation de pro-
téines, phénotypage. 
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Sommario 
Nell’ambito della ricerca biomedica è essenziale poter ottenere dati statistici relativi ad ampie 
popolazioni di entità biologiche specifiche – quali, ad esempio, organismi, cellule o molecole – 
preservando al tempo stesso informazioni dettagliate riguardo le singole entità considerate. 
Questa tesi tratta tale tematica e propone l’uso combinato di microfluidica e tecniche di “micro-
compartimentazione” per lo sviluppo di strumenti tecnologici atti a realizzare test biologici con 
risoluzione a livello del singolo organismo, cellula o molecola.  
Presentiamo innanzitutto un nuovo test immonologico “su microchip”, in grado di individuare la 
presenza del biomarcatore fattore di necrosi tumorale α nel siero, fino a concentrazioni 
dell’ordine dell’attomolare (10-18 M). In particolare, forniamo un modello predittivo completo 
della tecnica, che si basa sull’uso di micro-matrici di particelle superparamagnetiche. 
Introduciamo il concetto di “scansione di particelle magnetiche”, come nuovo metodo per ideare 
test immunologici con limiti di rilevazione bassissimi, fino al livello della singola molecola. In 
seguito, abbiamo modificato la nostra tecnica di micro-compartimentazione di particelle 
magnetiche per adattarla all’immobilizzazione di particelle e cellule di varie dimensioni e 
proprietà. Presentiamo un metodo di auto-assemblaggio elettrostatico di microsfere dielettriche 
in strutture ordinate di pozzetti, per la produzione rapida e versatile di matrici di microlenti. 
Inserendo poi queste matrici in un sistema microfluidico, abbiamo creato un nuovo strumento per 
il rilevamento di singole nanoparticelle all’interno di un flusso, che permette di identificare oggetti 
in movimento di taglia inferiore al limite di diffrazione della luce tramite microscopi convenzionali 
a basso ingrandimento. Abbiamo sviluppato inoltre un altro metodo di micro-compartimentazione 
analogo a quello presentato al fine di distribuire in pozzetti separati ampie popolazioni di cellule 
non-aderenti. Abbiamo usiamo questa tecnica in combinazione con l’uso di un dispositivo 
microfluidico di tipo “elettrowetting su dielettrico” per implementare test di citotossicità su cellule 
di lievito con risoluzione a livello della singola cellula.  
Nella fase successiva del progetto, abbiamo ideato soluzioni tecnologiche per l’analisi 
automatizzata del Caenorhabditis elegans, uno degli organismi modello più utilizzati nella ricerca 
biomedica. Abbiamo dapprima sviluppato un dispositivo microfluidico per l’allevamento di 
nematodi “su microchip” e la micro-compartimentazione di embrioni di C. elegans sincronizzati in 
fase evolutiva. Un processo di imaging multidimensionale permette di condurre, nel nostro 
dispositivo, analisi fenotipiche sistematiche su singoli embrioni. Siamo riusciti a distinguere 
variazioni dello sviluppo embrionale a livelli di risoluzione senza precedenti; abbiamo inoltre 
studiato l’impatto di perturbazioni delle funzioni mitocondriali sull’embriogenesi. Presentiamo poi 
un secondo prototipo del dispositivo, concepito per studi automatizzati di lunga durata su C. 
elegans, con risoluzione a livello del singolo nematode e lungo l’intera durata del suo sviluppo, 
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dall’embriogenesi allo stadio adulto. Infine, introduciamo un terzo prototipo che presenta: (i) una 
nuova architettura microfluidica, progettata per selezionare larve ad un determinato stadio di 
sviluppo e, in seguito, allevarle e trattarle; (ii) un metodo di immobilizzazione reversibile dei 
nematodi, che permette la loro osservazione ad alta risoluzione. Abbiamo utilizzato questa 
piattaforma microfluidica per analizzare il processo di aggregazione proteica in un modello C. 
elegans per la sclerosi laterale amiotrofica (SLA) umana. Il dispositivo permette di localizzare 
precisamente aggregati proteici specifici all’interno dei tessuti dei nematodi e di osservare 
l’evoluzione di singoli aggregati a livello subcellulare per più giorni consecutivi.  Parole chiave 
Microfluidica, micro-matrice, rilevamento di proteine, particella superparamagnetica, scansione 
di particelle magnetiche, auto-assemblaggio elettrostatico, matrice di lenti, rilevamento di 
nanoparticelle, lievito, singola cellula, Caenorhabditis elegans, allevamento di nematodi su 
microchip, imaging multidimensionale, embrione di C. elegans, immobilizzazione reversibile di 
nematodi, osservazione di lunga durata ad alta risoluzione, malattia neurodegenerativa, 
aggregazione proteica, analisi fenotipica.  
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Figure 1.1 | Bead-based surface coverage immunoassays. (a) Schematic representation of the 
assay procedure described by Osterfeld et al. and Gaster et al. (reproduced from [17]). Legend: 
capture Abs = blue; target Ags = yellow; biotinylated detection Abs = orange. Streptavidin-
labeled magnetic nanoparticles are bound to the biotinylated detection Abs and used as 
magnetic tags, since they are detected by the underlying GMR sensor. (b) Schematic description 
of the assay techniques reported by Mulvaney et al. (reproduced from [3]). Magnetic 
microbeads are used as labels for Ag detection, while fluidic force discrimination (FFD) is 
employed to reduce unspecific bead adsorptions. (c) Schematic representation of the assay 
procedure described by Shlyapnikov et al. (reproduced from [33]). Magnetic beads are used to 
label speficic immunocomplexes and detect bacterial toxins by direct bead counting via 
microscope observation. ....................................................................................................................... 3 
Figure 1.2 | Overview of the protein detection method. (a) Schematic representation of the 
time-lapse motion of a large bead exploring the detection area and interacting with the 
functionalized surface on the small beads through magnetic dipole-dipole forces. (b) Large bead 
capture mechanism: (bi) in absence of Ags, large beads are transported by the microfluidic flow 
through the whole detection area and washed away; (bii) if at least one Ag molecule is present 
on the large bead surface, the bead is captured onto the detection area via Ag-Ab binding. (c) 
Assay readout: counting of the captured large beads provides a measure of the number of 
molecules present in the sample under analysis; (d) Scanning electron microscopy (SEM) 
photograph of a part of the detection area after small bead patterning. The image is artificially 
colored to emphasize the small beads and APTES patterns. In zoom, atomic force microscopy 
(AFM) image of a 1.5 μm APTES dot after the photoresist lift-off process. (e) Micrograph of a 
detection chip covered with 600 nm – thick structured photoresist layer, used for depositing the 
APTES dot patterns................................................................................................................................ 6 
Figure 1.3 | Experimental results of protein detection. (a) Optical microscopy photograph of a 
small portion of the detection area using as Ag sample three different concentrations (i.e. three 
different amount of molecules to be detected: 0, 200, and 2·109 molecules, respectively) of 
biotinylated anti-streptavidin in FBS. Color enhancement is applied to the large beads for better 
visualization. (b, c) Experimental data for the detection of (b) biotinylated anti-streptavidin and 
(c) TNF-α in FBS (n= 3-4, the error bars are SD). ................................................................................... 7 
Figure 1.4 | Physical modelling for assay specificity enhancement. (a) Diagram of the main 
directions of the viscous (Fdrag,1 and Fdrag,2) and magnetic dipolar (Fdip,1 and Fdip,2) forces acting on 
two large magnetic beads. Bead 1 is translating just above the small bead pattern and bead 2 
just above bead 1. Also the magnetic force Fmag,ext induced by the permanent magnet and the 
specific inter-bead binding force Fspec due to the formation of the Ab-Ag-Ab sandwich 
immunocomplex (in zoom) are indicated. (b) Side-view of the flow velocity in a microfluidic 
channel above a pattern of 4 small magnetic beads of 1 µm diameter, when applying a flow of 
100 nL/s in a microchannel with section h×w = 60 µm×250 µm. (c) Magnetic induction at a 
position of 1 µm above the bottom of the microchannel when applying an external magnetic 
induction of 27 mT. The small beads locally increase the induction, which is the basis for the 
attractive dipolar force with a large bead. (d) x component of the magnetic dipolar force acting 
on 2 large magnetic beads, as indicated in Figure 1.4b (Fdip,1 and Fdip,2), moving with the flow 
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along the x-direction. The centre position of the pattern of 4 small beads is chosen as x=0 µm. 
The forces are plotted with respect to the x-displacement of the large beads, for an external 
induction of 27 mT at the microchannel bottom. ................................................................................. 8 
Figure 1.5 | Magnetic dipolar force calculations. (a) Schematic representation of the modeled 
geometry: a large bead is flowing on top of a nx × ny pattern of immobilized small beads, under 
the presence of a vertical magnetic induction B = 27 mT. (b) Maximum value of the x-component 
of the attractive magnetic dipolar force acting on bead 1, Fdip,1, max, for rectangular small bead 
patterns consisting of a different number nx × ny of small beads. ...................................................... 10 
Figure 1.6 | Experimental optimization of the assay specificity. Force-flow rate diagram, 
indicating different regimes for the magnetic bead-based immunoassay, with insets of 
representative parts of the small bead pattern array. The x-components of the forces are 
indicated for the 2 types of large beads that were presented in Figure 1.4a. For flow rate Q < ∼50 
nL/s, the maximum intensity of the drag force Fdrag,2 is insufficient to remove the large magnetic 
bead(2) from the surface, leading to formation of bead chains (see inset (i)). For ∼50 nL/s < Q < 
95 nL/s, Fdrag,1 is insufficient to remove the large magnetic bead(1) from the surface, which leads 
to immobilization of single beads (see inset (ii)). For Q > 95 nL/s, drag forces are sufficient to 
remove non-specifically linked large magnetic beads (see inset (iii)), while, if a large bead is 
linked to the small bead pattern via an immunocomplex, it stays attached (see inset (iv)) and its 
presence can be used for Ag quantification. Circles are drawn around the captured large beads 
for better visualization. Scale bars in the insets are 20 µm. ............................................................... 11 
Figure 1.7 | Simulations of the 3D inter-particle interaction. (a) Schematic of a small and a large 
magnetic particle with magnetic moment m1 and m2, respectively, and indicating the angle θ and 
the position vector r1,2. (b) FEM simulation of the field lines for a large and small magnetic 
particle, placed in an external magnetic induction of 30 mT. (c) Contact of the large particle 
sliding over a small particle under influence of the torque τmag,dip as indicated by the arc 
corresponding to the angle δ. ............................................................................................................. 13 
Figure 1.8 | Microfluidic platform for the experimental observation of magnetic particle-
scanning. (a) Schematic representation of the magneto-microfluidic device used for 
investigating the “magnetic particle-scanning” mechanism. (b) Spatial distribution of the 
magnetic induction components (Bx and Bz, according to the axis system defined in text) and the 
total intensity (Bnorm) along the bottom of the microfluidic channel, as simulated via 3D FEM for 
2 different magnet geometries: a ring magnet (I) and a disc magnet (ii), positioned respectively 
10 mm and 9 mm below the channel bottom. In both cases the detection area is centered with 
respect to the magnet top face, at x=0. .............................................................................................. 15 
Figure 1.9 | Experimental observation of magnetic particle-scanning. (a) Schematic motion of 
a large particle in the detection area in the presence of a small particle, as obtained from a 
Matlab simulation, for an external magnetic field B = 30 mT and flow rate Q = 100 nL s-1. A total 
contact time of ~4 ms is estimated between the two particles. (b) Motion of a large particle over 
the detection area, for B = 30 mT, Q = 100 nL s-1, as experimentally observed via a high-speed 
camera. Scale bar = 5 µm. (c) Experimental tracks and velocity profiles for four different large 
particles, for B = 30 mT, Q = 100 nL s-1, extracted from a video taken at 1200 fps. At each 
encounter with an immobilized small particle, a large particle undergoes both in-plane and out-
of plane displacements. Scale bar = 10 µm. ........................................................................................ 16 
Figure 1.10 | Estimation of ligand-receptor encounter probability. (a) Large magnetic particle 
moving in a magnetic field that pins its magnetic moment (top) in absence of immobilized small 
particles, (center) in presence of small particles, but only moving in the symmetry plane (no 
lateral displacements) and (bottom) under our experimental conditions, where lateral 
displacements of the large particle occur as well. In the last case, a different section of the large 
particle surface is explored at each interaction with a small particle dot. (b,c) Simulated large 
particle trajectories on (b) a non-tilted and (c) a 6.5° tilted regular array of 4 small particles per 
pattern, iteratively traced by combining FEM simulations and Matlab analytical calculations. The 
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tilted pattern guarantees more frequent encounters between immobilized small particles and 
flowing large particles. (d) Trajectory of a large particle on a tilted small particle array, under our 
standard experimental conditions (Bext,z=27-30 mT, Q=100 nL/s), as experimentally observed 
using a high-speed camera. Red dots are used to visualize the large particle reorientation events 
(~20 over a 250 µm-long array). (e) Optical microscopy photograph of the particle array used for 
protein detection experiments. (f) Capture efficiency Pcapture calculated for the three situations 
of Figure 1.10a as function of the radii of the large and small particles using Equation (1.7),(1.8) 
and (1.9), taking N=1 and rligand = 2.2 nm. The cases i. and ii. are not easily distinguishable on this 
graph (even though case i. always induces a smaller Pcapture than case ii. by at least two orders of 
magnitude) so that this representation merely emphasizes the increased Pcapture from case iii. ........ 18 
Figure 1.11 | Study of the particle capture efficiency vs. length of the channel. (a) Calculation 
of the fraction of the large particles that have landed on the substrate as a function of the 
distance in the microchannel for our standard experimental conditions. Insert: schematic 
illustration of the “landing” and “sliding” regimes of a large particle. (b) Experimental fraction of 
large particles captured as a function of the channel distance, for different concentrations of 
TNF-α molecules spiked in FBS under our standard experimental conditions. (c) Slopes obtained 
from the experimental curves shown in (b) as a function of the number of Ag molecules. The full 
line shows a fit of the experimental data with the model established in Equation (1.24). ................. 21 
Figure 1.12 | Random walk description of the particle scanning. (a) Schematic representation 
of the random walk modeling approach: the contact point between large and small beads 
describes a random-walk on the surface of the large beads, from the initial contact point to the 
location of a captured ligand molecule. (b) Calculation of the large bead coverage of captured 
ligand molecules, assuming a Langmuir relationship for molecule capture, and different values 
of the parameter α (10-3, 10-6 and 10-9 molecule-1). ............................................................................ 23 
Figure 1.13 | Analysis of the model fitting parameters. Plots of the function describing the assay 
readout (Equation (1.24)), for different values of the fitting parameters (a) α is a parameter, β= 
-0.15, γ =2.6, (b) β is a parameter, α= 1.3x10-12 molecule-1, γ=2.6, and (c) γ is a parameter, β= -
0.15 and α= 1.3x10-12 molecule-1. ........................................................................................................ 25 
Figure 1.14 | Explanation of the assay dose-response curves. Experimental data for the 
detection of (a) biotinylated anti-streptavidin and (b) TNF-α in FBS (n= 3-4, the error bars are 
SD), with the corresponding fitting curves. The solid lines are fit to the experimental values 
following the expression for output(NAg) detailed in Equation (1.24). The R2 values are 0.99 and 
0.86 for the fittings of the biotin/streptavidin and TNF-α datasets, respectively. .............................. 26 
Figure 1.15 | Principle of the “Ag on substrate” magnetic particle-based system. The target Ag 
molecules are bound on the substrate and Ab-functionalized large particles scan the surface for 
detection. Counting of the immobilized particles quantifies the number of ligand-receptor 
bindings and hence the Ag concentration on the surface. .................................................................. 28 
Figure 1.16 | Simulated 3D trajectories of superparamagnetic particles. (a) Magnetophoretic 
trajectories of 9 large particles entering the microfluidic channel at different locations, as 
iteratively traced by employing our 3D particle tracking approach, for our standard experimental 
conditions.  (b) Projection of the large particle trajectories on the channel inlet section. The 
trajectories of particles entering the channel at each possible position are simulated to predict 
their landing location inside the microchannel.   If a homogeneous distribution of particles is 
assumed at the channel inlet, this simulation directly allows estimating the number of particles 
effectively reaching the detection area (Figure 1.11a). ...................................................................... 31 
Figure 2.1 | Microsphere optical properties and micropatterning technique. (a) Schematic 
representation of the use of microlenses for on-chip immunofluorescence amplification, as 
reported by Yang et al. (reproduced from [76]). Fluorescent immonocomplexes are immobilized 
onto APTES microstructures. Dielectric particles are then used as spherical microlenses to 
amplify the fluorescent signals, therefore enhancing the immunoassay sensitivity. (b) Schematic 
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representation of the magnetic bead patterning technique described by Witters et al. 
(reproduced from [77]). Beads are attracted inside a microwell array by an external magnetic 
field, while transported by a DMF actuated microfluidic droplet. ...................................................... 37 
Figure 2.2 | Microfabrication process flow for Parylene C/glass well templates. (i) ITO is 
deposited on the back-side of the glass wafer, followed by the deposition of (ii) Parylene-C and 
(iii) amorphous Si on the front-side of the wafer. (iv) Photoresist is spin-coated on the wafer and 
(v) patterned by standard photolithography processing. (vi) Amorphous Si is etched by a Cl2 
plasma. (vii) The photoresist layer and Parylene-C are etched by an O2 plasma. (viii) The 
amorphous Si hard-mask is etched by a Cl2 plasma and the Parylene-C layer is treated by SF6 
plasma to enhance its hydrophobicity. ............................................................................................... 38 
Figure 2.3 | Characterization of microfabricated array templates. (a) Micrograph of the 
microwell array template after fabrication. Microwells with a diameter of 3 μm are interspaced 
by 20 μm in both x- and y-directions. (b,c) AFM measurement on a 3 μm microwell, showing (b) 
the topography and (c) the profile along the dashed line in (b). ........................................................ 38 
Figure 2.4 | Electrostatic self-assembly of dielectric microsphere arrays. (a) Schematic 
representation of the microsphere patterning process: (i) microfabricated Parylene-C microwell 
array; (ii) a droplet with suspended microspheres is transported over the hydrophilic microwells 
multiple times, during which microspheres get trapped; (iii) due to the geometry and surface 
charge of the microwells, the microspheres stay immobilized in the microwell pattern, also after 
removal of the droplet. (b) Microsphere loading efficiency as function of pH of the droplet. (c) 
Schematic illustration of the microsphere patterning at different pH conditions, indicating the 
electrostatic charges involved in the patterning process. ................................................................... 40 
Figure 2.5 | Analysis of lens patterning and immobilization efficiency. (a) Micrograph of a 
representative microwell array after microsphere patterning at pH = 2. Over an area comprising 
1160 microwells, only 6 microwells do not contain a microsphere after patterning (i.e.: 
patterning efficiency ~99.5 %). (b) Number of microspheres Nsph left within the microwell array 
as a function of well size w after application of optical tweezer forces, at relatively high pH 
conditions (pH>7). At constant pulling force, lower pH values and well size closer to the sphere 
size are beneficial for stronger electrostatic self-assembly forces, so that less microspheres can 
get removed from the microwells. (c) Representative micrographs of portions of 4 µm and 5 μm 
well arrays with patterned microlenses, before and after the application of optical tweezer 
forces on the spheres. ......................................................................................................................... 40 
Figure 2.6 | Light focusing property of the microlens array. (a) Schematic representation of an 
array of microspheres while illuminated through a microscope objective. The light source 
beneath each microsphere is focused in a highly localized and intense spot, also named 
“photonic nanojet”. (b) Microscopic image focused onto the plane of the nanojets emitted from 
the melamine microspheres (the focal plane corresponds to the plane at which the nanojets 
have maximum light intensity). The light intensity along the dashed line in (b) is shown in (c): the 
intensity of a photonic nanojet is typically >3 times higher than the background signal coming 
from the area with no microlenses. .................................................................................................... 42 
Figure 2.7 | Detection of gold NPs in a microfluidic flow. Backscattering intensity from gold NPs 
under white-light illumination. Microscopic images (left column) and intensity profiles along the 
dashed lines in the left panels (right column) for gold NPs sizing (a) 400 nm and (b) 50 nm. 400 
nm gold NPs are still detectable when they are outside a nanojet, and their intensity profile is 
plotted on the corresponding right panel too. .................................................................................... 43 
Figure 2.8 | Detection of fluorescent NPs in a microfluidic flow. Emission at λem=515 nm of 
fluorescent NPs when excited at a wavelength of λex=505 nm. Microscopic images (left column) 
and intensity profiles along the dashed lines in the left panels (right column) for fluorescent NPs 
sizing (a) 460 nm and (b) 20 nm. 460 nm fluorescent NPs are still detectable when they are 
outside a nanojet, and their intensity profile is plotted on the corresponding right panel too. ......... 43 
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Figure 2.9 | Microwell size optimization for single-cell patterning. Micrographs of microwell 
templates upon off-chip cell patterning, with wells sizing (a) 12 µm, (b) 8 µm and (c) 5.3 µm. 
Both 12 µm and 8 µm well sizes result in patterning of multiple cells per well (see zooms of 
picture (a) and (b)). 5.3 µm wells allow instead patterning single cells in every microwell (see 
zoom of picture (c)), with high cell loading efficiency (e.g. ~97% in this case). Picture scale bars = 
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Figure 2.10 | Cytotoxicity assays on the DMF platform. (a) Schematic representation of the DMF 
platform configuration and (b) experimental results of the cytotoxicity assays. ................................ 45 
Figure 3.1| Life cycle of wild-type C. elegans at 22°C, in agar plate culture conditions. 0 min is 
fertilization. Numbers in blue along the arrows indicate the length of time the animal spends at 
a certain stage. First cleavage occurs at about 40 min postfertilization. Eggs are laid outside at 
about 150 min postfertilization and during the gastrula stage. The length of the animal at each 
stage is marked next to the stage name in micrometers (Reprinted from [96]). ................................ 51 
Figure 3.2| Embryo-array technologies for Drosophila and zebrafish studies. (ai) Schematic 
representation of the Drosophila embryo trapping process proposed by Chung et al. (reproduced 
from [115]): an embryo is first guided into the trap and vertically oriented by fluidic forces; the 
trap then contracts for the embryo immobilization and imaging (yellow plane = imaging focal 
plane). (aii) A section of the array with trapped embryos. Scale bar = 500 μm. (b) Picture of the 
mesofluidic device for zebrafish embryo arraying, as proposed by Akagi et al. (reproduced from 
[116]). The right panel depicts a magnified section of the device with a single trap holding an 
immobilized zebrafish embryo. ........................................................................................................... 53 
Figure 3.3 | Overview of the microfluidic device. (a) Picture of the microfluidic device, sizing 25 
mm x 75 mm (standard microscope slide size), including lateral microfluidic connections, which 
make the device compatible for imaging with every upright or inverted microscope. Scale bar = 
10 mm (bi) Schematic representation of the central part of the microfluidic chip, having as main 
constitutive parts: the worm culture chamber, the embryo-incubator array, four inlets (In1 to 
In4) and two outlets (Out1 and Out2). Scale bar = 2 mm (bii) Zoom on the worm culture chamber, 
including a drawing of young adult C. elegans for size comparison. The chamber is delimited by 
specific microfluidic channel arrangements, tailored for different functions: (top) worm 
injection, (bottom) worm synchronization, (left) E. coli / drug delivery and (right) egg transfer. 
Scale bar = 1 mm (biii) Three-dimensional schematic zoom on a portion of the embryo incubator 
array. (c) FEM simulation (Comsol Multiphysics) of the fluid dynamics in the incubator array 
region, showing the principle of passive hydrodynamic arraying of single embryos. Fluidic 
velocity and streamlines are calculated for a flow rate of 100 nL/s at the inlet In3. Scale bar = 50 
μm (d) Micrograph of a single incubator on the SU-8/silicon master mold used for PDMS casting. 
(e) Micrograph of a section of the array with immobilized embryos. Scale bar = 100 μm (f) 
Illustration of the multi-dimensional imaging that is enabled on the array of embryos and spans 
six dimensions: the 3 spatial coordinates, time, exposure type and embryo number in the array.
 ............................................................................................................................................................ 55 
Figure 3.4 | Geometry of the worm culture chamber. Schematic representation of the worm 
culture chamber, with zooms on the surrounding microfluidic channel arrangements and their 
specific dimensions. ............................................................................................................................ 56 
Figure 3.5 | Design of the hydrodynamic trapping micro-array. (a) Schematic representation of 
the design of the hydrodynamic embryo trapping system, with (ai) indication of the flow rates 
Q1 and Q2 through a trap and a bypass channel, respectively, and (aii) definition of the 
geometrical parameters. (b) Optical micrograph of an E. coli suspension flowing through an 
embryo incubator, in which a 30 µm PMMA bead has been trapped to study the hydrodynamic 
trapping mechanism. Flowing E. coli bacteria allow visualizing the flow streamlines and assessing 
the presence of residual flow through the occupied incubator. Dashed white lines trace a few of 
the streamlines, while the solid lines are guides to the eye that indicate the boundary between 
the main flow in the bypass channel and the residual flow in the incubator. (c) Schematic 
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representation of the embryo trapping mechanism, (ci) in absence and (cii) in presence of 
residual flow through an occupied incubator. The residual flow enhances the correct embryo 
orientation and positioning inside the next incubator of the array. ................................................... 57 
Figure 3.6 | Optimization of the embryo incubator geometry. (a) Picture of a PDMS embryo 
incubator, with main geometric features the incubator width (Wi) and length (Li), and drain width 
(Wd) and length (Ld). (b) Schematic representation of the microfluidic device designed and 
fabricated for the experimental characterization of different embryo incubator geometries. (c) 
Representative pictures of 16 different embryo incubator geometries, showing possible issues 
in single embryo trapping, positioning and imaging, such as mechanical stress induced on the 
captured embryo, wrong embryo positioning/orientation, multiple embryo capture, etc.. Scale 
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Figure 3.7 | Angular position of embryos inside the incubators. Pictures of a representative 
array of embryos (E1 to E20), upon complete filling of the incubator array. The hydrodynamic 
trapping mechanism results in stable embryo positioning, with angular deviations within a 5-10° 
solid angle, due to the natural size and shape variability of the embryos themselves. Scale bars 
= 10 μm. .............................................................................................................................................. 60 
Figure 3.8 | Operation of the microfluidic device. (a) First a 10 µL suspension of worms in M9 
buffer is injected into the microfluidic device along the In1-Out1 direction at a flow rate of 500 
nL/s. Symbols used for the in- and outlets: dot and arrow = syringe in use (e.g. In1); dot = syringe 
not in use (e.g. In2); circle = open valve (e.g. Out1); cross and circle = closed valve (e.g. Out2).  
The “worm synchronization filter” is tailored to retain inside the chamber only adult worms, as 
selected by their larger size and their better swimming abilities (see picture in zoom). (b) 
Subsequently worm culture is controlled by periodically injecting E. coli in M9 buffer along the 
In2-Out2 direction, typically at 50 nL/s flow rate. This ensures normal development of the worms 
in the liquid environment and continuous embryo production during their adult life span (see 
picture in zoom). Optionally, drugs or chemicals can be introduced at the In4 inlet for on-chip 
worm treatment. (c)  Injection of M9 buffer at 200 nL/s flow rate along the In3-Out2 direction 
triggers the transfer of all the eggs present in the chamber towards the incubator array, where 
they are captured by passive hydrodynamics, as shown by the superposition of 13 video frames 
in the zoom. (d) The perfusion of E. coli suspension towards both Out1 and Out2 simultaneously 
ensures proper worm feeding inside the culture chamber and stable embryo positioning inside 
the incubators, enabling parallel time-lapse imaging of the embryos at cellular resolution (see 
picture in zoom). ................................................................................................................................. 61 
Figure 3.9 | Study of C. elegans embryogenesis for wild-type worms. (a) Time-lapse of the main 
embryonic stages of development with typical time indications for T= 25°C and wild-type worms. 
(b) Full embryonic development from egg capture in the incubator till hatching, as observed in a 
sequence of brightfield microscopy images (63× oil immersion objective, NA 1.4)  taken from a 
movie (1 frame per minute) at 45 min intervals for a N2 wild-type worm strain at 25°C; the 
hatching time defines t=0. Scale bars = 10 μm (c) Illustration of main embryonic development 
phases –1 cell to bean; bean to 1.5-fold; 1.5-fold to hatching– that are clearly morphologically 
distinguishable. (d) Duration of development phases, as observed for an array of 20 embryos for 
a N2 wild-type worm strain at 25°C; (di) variation of the time duration the embryo spends in an 
incubator, originating from differences in the exact moment of egg laying and trapping of the 
embryo; (dii) average duration of development phases, as obtained from the data in (di). .............. 63 
Figure 3.10 | Study of C. elegans embryogenesis for transgenic, mutant and treated worms. 
(a) Duration of different development phases –bean to 1.5-fold; 1.5-fold to hatching– for the N2 
wild-type strain of worms and a number of transgenic strains and mutants. Bar graphs are 
expressed as mean+SEM, *** p≤0.001.  (b) Pictures of a full array of 20 embryos taken 600 min 
after trapping in the incubators, illustrating the blocked development when the embryos are laid 
by N2 wild-type worms that were exposed in the culture chamber to 2 mM of the anticancer 
drug 5-fluorouracil (5-FU) in M9 buffer. Scale bars = 10 μm. .............................................................. 64 
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Figure 3.11 | Mitochondrial unfolded protein response. (a) Schematic representation of the 
mitochondrial unfolded protein response (UPRmt), as known for the larval and adult stages of 
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Figure 3.12 | Study of mitochondrial biogenesis. (a-c) Merges of optical brightfield and 
fluorescent pictures of the Pmyo-3::mito::gfp embryos and (d-f) the corresponding GFP 
quantification over the whole time-span from embryo capture to hatching (n=4). Pictures are 
grouped in blocks of same experimental observation and image representation conditions 
(exposure time and maximum displayed pixel intensity). (g-i) Merges of optical brightfield and 
fluorescent pictures of the Pges-1::mito::gfp embryos and (j-l) the corresponding GFP 
quantification over the whole time-span from embryo capture to hatching (n=14). Pictures are 
grouped in similar blocks as for the Pmyo-3::mito::gfp embryos. For (d-f) and (j-l), the curves 
correspond to the relative GFP induction compared to the initial time point in (d) and (j), 
respectively, of the experiments. Bar graphs are expressed as mean+SEM, * p≤0.05, points below 
a horizontal line are significantly different from the corresponding control.  Scale bars = 10 μm. .... 67 
Figure 3.13 | Study of mitochondrial unfolded protein response (UPRmt) during 
embryogenesis. (a-c) Representative optical brightfield and corresponding fluorescent pictures 
that show the hsp-6::gfp expression in (a) wild type, (b) isp-1(qm150), and (c) Prab-3::cco-1HP 
strains. (d-f) Quantification of the hsp-6::gfp induction in (d) wild type, (e) isp-1(qm150) and (f) 
Prab-3::cco-1HP strains over the whole time-span from embryo capture to hatching (n=17, 7, 
and 21, respectively). The curves correspond to the relative GFP induction compared to the 
initial time point of each experiment. The blue area in each graph represents the base level 95% 
interval of confidence for each experiment. Bar graphs are expressed as mean+SEM, * p≤0.05, 
points below a horizontal line are significantly different from the corresponding control. (g-h) 
Comparison of the relative wild type hsp-6::gfp induction with the one of the (g) isp-1(qm150) 
and (h) Prab-3::cco-1HP strains. Bar graphs are expressed as mean+SEM, * p≤0.05, *** p≤0.001. 
(i-j) Localization of the hsp-6::gfp expression in the embryonic tissues, as observed in a period 
starting 60 min before hatching, for the (i) isp-1(qm150) and (j) Prab-3::cco-1HP strains. Scale 
bars = 10 μm........................................................................................................................................ 69 
Figure 4.1 | Worm-chips for longitudinal studies at single-worm resolution. (a) Schematic 
representation of (ai) the “lifespan chip” geometry and (aii) the worm handling process 
proposed by Hulme et al. (reproduced from [110]). Worms are loaded into the chip at the L4 
larval stage, cultured towards the adult stage and periodically sucked into a narrowing channel 
for temporary immobilization and imaging. (b) Pictures of the droplet-based system for C. 
elegans assays proposed by Shi et al. (reproduced from [161]): (bi) droplets encapsulated with 
worms and (bii) representative images of worms during an on-chip motility test. (ci-cii) Optical 
micrographs of the worm chamber array device proposed by Chung et al. (reproduced from 
[162]). A “loading channel” associated to each chamber is used for worm injection. (ciii) 
Schematic drawing showing a cross-section of the device, with 2 different PDMS compositions 
to tune the elasticity of the microchannels......................................................................................... 77 
Figure 4.2 | Overview of the microfluidic device. (a) Picture of the microfluidic device. Scale bar 
= 5 mm (b) Schematic representation of the microfluidic chip layout, featuring as main 
constitutive parts: the parents’ culture chamber, the progeny’s culture chamber matrix, five 
inlets (In1 to In5) and two outlets (Out1 and Out2). Scale bar = 2 mm. (c) Zoom on the parents’ 
culture chamber, including a drawing of young adult C. elegans for size comparison. The 
chamber is delimited by specific microfluidic channel arrangements, tailored for different 
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Preface 
Recent advances in science and technology at the micro- and nano-scale are rapidly and constantly 
changing the world, with enormous impact on people’s everyday life. The advent of microelec-
tronics in the late 1950s suddenly enabled engineers to incorporate a tremendous amount of ad-
ditional functionality and flexibility into products than was previously even imaginable. This im-
mediately resulted in the fastest technological revolution ever undertaken by human race, which 
produced, in a few decades only, the world as we see it, i.e. permeated by technological devices, 
machines and gadgets of any kind and – potentially – at everyone’s disposal. From a socio-cultural 
point of view, the main effect of the micro/nano-science revolution is probably represented by 
the “democratization of technology”: information, communication systems and functionalities 
that once were accessible to only a selected minority are now available to everyone. The icons of 
such democratization process are today represented by the Internet and the smartphones, but 
we are now wondering when exactly this revolution will involve another – from many facets, more 
important – aspect of human society: healthcare. Micro/nanoscience allows in fact nowadays 
good control and study of biological materials at the same dimensional scale of the individual en-
tities under investigation, such as micro-organisms, cells or even single molecules – probably in 
vague analogy with what happened for the control of electrons in the early days of microelectron-
ics. Moreover, microfluidics – the technology for manipulating small volumes of fluids – largely 
demonstrated its potential to miniaturize whole complex laboratory protocols onto single micro-
chips, with substantial advantages over standard laboratory procedures. These technological so-
lutions, usually named “lab-on-a-chip” (LOC) devices, moreover benefited from investments – 
from government funding agencies and venture capitalists – aiming at promoting their commer-
cialization. Surprisingly, however, despite this convergence of favorable factors, only a few LOC-
based products have been successfully introduced into the market, while most of them never left 
the research labs and were never made accessible to people.  The limiting factor towards the 
implementation of the emerging technological tools in a novel class of “democratized” healthcare 
devices seems to reside in the commercialization process itself. One of the main bottlenecks pre-
venting the lab-to-market transfer of technology is probably represented by the absence of stand-
ardized, versatile, fully automated solutions. In the last two decades, in fact, research efforts have 
been mainly directed towards the development of individual LOC components, tailored for specific 
applications, while fully functional integrated devices have been only rarely proposed. In the ab-
sence of standardized fabrication techniques and versatile adaptable solutions, even the most 
groundbreaking LOC components proved not to be suitable for commercialization, usually be-
cause of their fundamental mutual incompatibility. In the light of these considerations, I always 
focused my research efforts on the development of versatile, fully automated LOC tools, answer-
ing to this urgent need for future commercial solutions. I typically proved the capabilities of our 
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devices to address specific biomedical questions, but always carefully designed them to be mutu-
ally compatible and easily re-adaptable for manifold applications. A common feature of all the LOC 
devices that will be presented in this thesis is represented by the combination of microfluidics and 
“micro-arraying” approaches, as key elements towards standardization, full automation and easy 
scalability of the LOC technology. By means of the combined microfluidic/micro-array toolkit, to-
gether with my scientific collaborators, I addressed different topics and covered a quite large spec-
trum of applications, which range from the development of integrated immunoassays to the de-
tection of nanobiomaterial, moving then towards the conception of whole organism-based bioas-
says. On the one hand, this research approach allowed me diving into a multitude of research 
domains, sometimes very far from each other, and this positively resulted in a fruitful cross-con-
tamination of ideas among the different fields. On the other hand, however, a very large amount 
of work should now be cited for a comprehensive description of all the different topics which have 
been considered in this work. I believe that such an overview would be quite confusing for the 
reader if condensed in a single chapter of this thesis. For these reasons, I structured this document 
according to the main research themes considered in my work and extensively expanded each 
theme individually. Overall, the common thread of my work is represented by the combination of 
microfluidics and “micro-arraying” concepts, as a key approach for the isolation and accurate anal-
ysis of biological entities of different size and level of complexity – from molecules to nanomateri-
als, from cells to whole small model organisms. 
In chapter 1, I describe a new on-chip immunoassay technique, based on the use of micro-arrays 
of superparamagnetic beads as substrates for enhanced specific protein capture, ideally enabling 
single-molecule detection in a simple microfluidic assay format. In chapter 2, then, I extend the 
concept of magnetic bead arraying by introducing a novel method for rapid self-assembly of large 
arrays of micro-entities of different nature and materials – from dielectric beads to non-adherent 
cells. In collaboration with other researchers at LMIS2 and at the biosensors department at KU-
Leuven, we employed this method for two different applications: fabrication of microlens arrays 
for nanoparticle detection and single-cell analysis on yeast cells, respectively. In chapter 3, I intro-
duce a new type of hydrodynamic micro-array system, designed for the automated isolation, long-
term imaging and phenotyping of Caenorhabditis elegans embryos. I then demonstrate the use of 
this system for the investigation of a specific molecular pathway – i.e. the mitochondrial unfolded 
protein response (UPRmt) – in C. elegans embryos. The concept of whole-organism phenotyping is 
further extended in chapter 4, where a new microfluidic arraying system is proposed, tailored for 
long-term studies on C. elegans nematodes at single-organism resolution and over their whole 
development – from embryogenesis to adulthood. In chapter 5, then, I present a complete micro-
fluidic platform for controlled culture, reversible immobilization and long-term high-resolution 
imaging of nematodes. This final microfluidic design is conceived to maximize versatility and scala-
bility of the platform, towards high-throughput applications and proves to be suitable for time-
resolved monitoring of complex biological processes in C. elegans, such as the evolution of a neu-
rodegenerative disease. At last, chapter 6 concludes this thesis, by providing the reader with an 
overview of the presented results and an outlook on future opportunities in the field. 
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 Superparamagnetic micro-particle arrays towards single-molecule detection 
Abstract A novel protein detection method has been developed, based on magnetic and 
microfluidic manipulation of superparamagnetic beads, through which we recently demonstrated 
detection of tumor necrosis factor-α from spiked serum down to 60 attomolar (60×10-18 M) [1], 
thus attaining a limit of detection (LOD) comparable to PCR-based techniques, orders of magni-
tude more sensitive than conventional methods. Our technique extends the current knowledge 
of force differentiation immunoassays. Unlike previously reported bead-based “flow chamber” 
assays [2, 3], in fact, our method introduces the use of magnetic bead dipole–dipole interactions, 
combined with microfluidic viscous forces, to enhance the selectivity of specific antigen-antibody 
(Ag-Ab) immunocomplex formation and thus attain unprecedented limits of detection for this kind 
of assays. Moreover, by combining Finite Element Method (FEM) simulations with analytical cal-
culations, we built a complete predictive model for our technique [4], to be employed as a guide 
for its further use, optimization and development. We corroborated the simulated results with 
experiments and we characterized the enhanced assay selectivity, both theoretically and experi-
mentally. We eventually worked at a comprehensive theoretical model including considerations 
on the probability of the single immunocomplex formation, allowing investigating the assay kinet-
ics and understanding the peculiar behavior of its dose-response curves [5, 6]. 
This chapter is an adapted version of the following publications: 
o M. Cornaglia, R. Trouillon, H. C. Tekin, T. Lehnert, and M. A. M. Gijs, Dose-response curve of a 
microfluidic magnetic bead-based surface coverage sandwich assay, New Biotechnol 32, 433-
440, doi: 10.1016/j.nbt.2015.03.008 (2015) 
o M. Cornaglia, R. Trouillon, H. C. Tekin, T. Lehnert, and M. A. M. Gijs, Magnetic particle-scan-
ning for ultrasensitive immunodetection on-chip. Anal Chem 86, 8213-8223, 
doi:10.1021/ac501568g (2014) 
o M. Cornaglia, H. C. Tekin, T. Lehnert & M. A. M. Gijs. Fine-tuning of magnetic and microfluidic 
viscous forces for specific magnetic bead-based immunocomplex formation. J Appl Phys 114, 
doi: 10.1063/1.4817663 (2013) 
o H. C. Tekin, M. Cornaglia & M. A. M. Gijs. Attomolar protein detection using a magnetic bead 
surface coverage assay. Lab Chip 13, 1053-1059, doi: 10.1039/C3lc41285g (2013) 
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1.1 Introduction  1.1.1 Immunoassays in clinical diagnostics 
Immunoassays are essential in clinical diagnostics to differentiate between health and disease and 
for therapeutic monitoring. A major goal is disease detection at an early stage to minimize the 
invasiveness of the treatment and maximize the chance of healing [7, 8]. To reach this goal, the 
measurement of extremely low concentrations of proteins in serum is necessary [9-13]. At the 
same time, point-of-care medical diagnostics represents one of today’s main challenges towards 
the promise of tests that can be carried out at the site of patient care [14]. From the immunoassay 
integration perspective, this has been translated in terms of miniaturization of the detection sys-
tems and reduction of the sample and reagent volumes needed for the analysis. The conjunction 
of these factors is dictating the need of a new generation of fast, cheap and minimally-invasive 
diagnostics tools, able to selectively detect dramatically low amounts of proteins – down to the 
limit of a single molecule – in complex media. For instance, clinically relevant concentration values 
of tumor necrosis factor α (TNF-α) or interleukins (e.g. IL-6) for early disease detection are in the 
femtomolar regime or lower (<10-15 M) [15]. A minimally invasive immunoassay should ideally be 
performed starting from a sample volume the size of a blood droplet (typically 5 to 10 µL), thus 
containing at maximum a few thousand target Ags. Recent technological advances, in particular 
those enabled by microfluidics, have therefore been creating novel tools for detecting biomarkers 
at low concentrations and/or sample volumes in complex sample media and with a wide variety 
of assay read-outs [1, 3, 16-22]. Functionalized superparamagnetic particles have been shown to 
be ideally suited for the rapid and efficient capture and isolation of target molecules [23, 24]. 
Many of these magneto-microfluidic assays were based on a protocol, in which magnetic particles 
were immobilized in a flow and exposed to a series of sequential reagent exposure and washing 
steps, as inspired by a batch-type assay [25-27]. Also continuous flow microfluidic assays have 
been proposed, in which magnetic particles were moved through multilaminar reagent/washing 
solution flow streams to implement the assay protocol [28]. Furthermore, droplet-based systems 
have been proposed, which allowed storage of reagent/washing solutions in aqueous droplets 
surrounded by an immiscible oil phase and employed magnetic particles that were moved be-
tween the different droplets to perform the assay protocol [29, 30].   1.1.2 Magnetic bead-based surface-coverage immunoassays 
Among the available immunoassay techniques, magnetic bead-based “surface-coverage” meth-
ods recently emerged for their relative ease of implementation and extremely low limits of detec-
tion. In this class of assays, magnetic particles are used as labels to detect the formation of Ag-Ab 
immunocomplexes on a substrate. Quantification of the surface-bound particles is used to provide 
a measure of the Ag concentration to be analyzed. In this context, S. J. Osterfeld et al. [31] de-
signed a sequential assay in which Ags were first captured on a detection surface and bound to 
biotinylated Abs, on which streptavidin-coated magnetic beads were then incubated (Figure 1.1a). 
During such incubation, the magnetic particles formed streptavidin–biotin bonds and their cap-
ture dynamics could be monitored in real time via giant magnetoresistance (GMR) sensors [32]. 
1.1   Introduction 
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By means of this method, Gaster et al. reached a LOD of 200 fg mL−1 for carcinoembryonic antigen 
(CEA) spiked in 50 μL mouse serum with a total assay time of 2.5 h [17].  
S. V. Mulvaney et al. [3] presented magnetic bead-based surface coverage assays in both a se-
quential and a semihomogenous configuration (Figure 1.1b). In the sequential assay format, tar-
get Ags and detection Abs were incubated in separate steps on an Ab-covered detection surface. 
Ab-coated magnetic beads were then deposited over the detection surface, as labels for the for-
mation of specific immunocomplexes, while a washing step was used to remove unspecifically 
bound beads via “fluidic force discrimination” (FFD). Then, target Ags were quantified by counting 
the number of remaining beads on the detection surface. A LOD of 100 fg mL-1 (3.5 fM) for staph-
ylococcal enterotoxin B (SEB) was achieved in 2 µL PBS. In the semi-homogenous assay format, 
magnetic beads were instead mixed with target Ags before transporting them onto the detection 
surface. This resulted in improved assay sensitivity but much higher sample volume consumption, 
with a LOD of 1 fg mL-1 (35 aM) for SEB spiked in 1 mL PBS and 100 fg/mL (3.5 fM) in 1 mL canine 
serum samples.  
Y. M. Shlyapnikov et al. [33] described a bead-based method for the detection of bacterial toxins 
(Figure 1.1c). Electrophoretic concentration of toxins on an Ab-coated surface was performed dur-
ing a 3 min flow in a microfluidic channel. Afterwards, biotinylated Abs were transported over the 
surface-bound Ags for 2 min. In a third step, a permanent magnet was positioned below the de-
vice, to attract streptavidin-coated beads towards the surface, while they were injected into the 
device. This procedure promoted the specific capture of the beads by formation of Ab-Ag-Ab sand-
 
Figure 1.1 | Bead-based surface coverage immunoassays. (a) Schematic representation of the assay pro-
cedure described by Osterfeld et al. and Gaster et al. (reproduced from [17]). Legend: capture Abs = blue; 
target Ags = yellow; biotinylated detection Abs = orange. Streptavidin-labeled magnetic nanoparticles are 
bound to the biotinylated detection Abs and used as magnetic tags, since they are detected by the under-
lying GMR sensor. (b) Schematic description of the assay techniques reported by Mulvaney et al. (repro-
duced from [3]). Magnetic microbeads are used as labels for Ag detection, while fluidic force discrimination 
(FFD) is employed to reduce unspecific bead adsorptions. (c) Schematic representation of the assay proce-
dure described by Shlyapnikov et al. (reproduced from [33]). Magnetic beads are used to label speficic im-
munocomplexes and detect bacterial toxins by direct bead counting via microscope observation. 
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wich immunocomplexes. The number of surface-tethered beads was then measured by micro-
scope observation of the substrate and subsequent image processing. By using this technique, 
cholera toxin (CT), staphylococcal enterotoxin A (SEA), SEB and toxic shock syndrome toxin (TSST) 
could be detected down to 0.1 pg mL−1, while heat-labile toxin of Escherichia coli (LT) was detected 
down to 1 pg mL−1, in tap water and water from pond and river. Significantly higher LODs (0.1 ng 
mL−1) were achievable without the electrophoretic concentration of toxins. Electrophoretic focus-
ing requires however particular sample conditions: for instance, meat and milk extracts need to 
be desalted before being analyzed with this method. The desalination procedures unfortunately 
resulted in a loss of toxins and increased the LOD of CT, SEA, SEB and TSST to 1 pg mL−1.  1.1.3 Challenges and opportunities for ultra-sensitive protein detection 
When assaying samples having an extremely low analyte concentration, the ratio between the 
amount of target molecules and the amount of particles used for their capture is usually very low. 
As a result, the percentage of particles carrying analyte molecules follows a Poisson distribution 
with very low mean value – i.e. particles generally carry either a single molecule or none. In this 
regime, quantification of the amount of molecule-carrying particles is based on single analyte mol-
ecule detection events [34]. However, the size mismatch between target molecules and particles 
may complicate the detection. For instance, the typical size of molecules of interest being in the 
nanometer range (the Stokes radius of a TNF-α monomer was estimated as 2.2 nm at pH=7.0) 
[35], a captured molecule occupies only ~10-7 of the surface of a 300 nm diameter particle. This 
ratio drops to ~10-9 and ~10-11 for 3 µm and 30 µm particles, respectively. If we intend to capture 
these particles on a substrate aiming to count them for single molecule immunodetection, these 
values are indicative of the – extremely low – probability of encounter between a particle-linked 
Ag and substrate-immobilized Abs. Since in such case both single Ag molecules (ligands) and cap-
ture Abs (receptors) are bound to surfaces, their recognition kinetics is substantially reduced as 
compared to freely diffusing species; therefore the formation of specific immunocomplexes would 
be very slow or probabilistically almost impossible [36]. However, solutions to this problem are 
offered on the nanoscale. A first option could be reducing the particles’ size, ideally down to a few 
tens of nm, to reduce the size-mismatch. Although this would improve ligand-receptor encounter 
probabilities, it would result in much more challenging particle manipulation, capture and detec-
tion. In order to take advantage of the size of micrometer particles, an alternative solution is in-
creasing the rotational diffusion of the Ag-carrying particles to enhance the Ag-Ab encounter prob-
ability. While this concept has been proposed for agglutination immunoassays in solution [36, 37], 
it is rather unexplored in surface-based assays.  
In this chapter, we address this issue and we propose as a solution a novel surface-based immu-
noassay technique, which employs superparamagnetic microparticles in a microfluidic chip to at-
tain ultrasensitive protein detection, down to the single-molecule level. In section 1.2 of this chap-
ter, we present the technique and show its potential, by demonstrating detection of only 200 
molecules of TNF- α in a serum sample volume of 5 μL, corresponding to a concentration of 60 
attomolar or 1 fg mL-1. In section 1.3, then, we identify the main forces governing the immunoas-
say performance and present a combined FEM/analytical model to predict and control these 
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forces, with the aim of maximizing the assay specificity and minimizing its “background noise”. In 
section 1.4, we eventually introduce the concept of “magnetic particle-scanning”, as new key 
mechanism to significantly increase the probability of immunocomplex formation in our assay, 
and, more in general, in other single molecule-based heterogeneous immunoassays.   1.2 A new method for ultrasensitive protein detection in serum 1.2.1 Overview of the technique 
Our protein detection method is based on magnetic and microfluidic manipulation of superpara-
magnetic beads. A complete platform for the integration of this method in a microfluidic format 
was developed in the framework of a previous project [38] and its detailed description is out of 
the scope of this work. Here, a few technical aspects of the microfluidic device will be mentioned, 
while the whole process of development and optimization of the detection method itself will be 
presented in detail. Our technique is based on the following immunoassay protocol. First, “large” 
(2.8 µm) Ab-functionalized magnetic beads are used to specifically capture Ags from a serum ma-
trix under active microfluidic mixing. Subsequently, the large beads are gently exposed to a sur-
face pattern of fixed “small” (1.0 µm) Ab-coated magnetic beads (Figure 1.2a). During the expo-
sure, attractive magnetic bead dipole–dipole interactions improve the contact between the two 
bead types and help the Ag-Ab immunocomplex formation (Figure 1.2bi), while non-specific large 
bead adsorption is limited by exploiting viscous drag forces in the microfluidic channel on the 
small-bead pattern (Figure 1.2bii). After exposure of the large beads to the pattern of small beads, 
the Ag concentration is detected by simply counting the number of surface pattern-bound large 
magnetic beads (Figure 1.2c).  
The whole assay is performed in a microfluidic polydimethylsiloxane (PDMS) chip featuring micro-
fluidic channels, pneumatic valves and a micro-mixing chamber [1]. The chip is connected via flu-
idic ports to syringe pumps for automated fluidic manipulations. Nemesys syringe pumps (Cetoni, 
Korbussen, Germany) were used for automated flow control. Complex microfluidic operations 
(e.g.: mixing, valve actuation, etc.) were handled through an in house-developed Labview (Na-
tional Instruments, Austin TX, USA) software interface. A digital camera (Pixelink PL-P742) was 
mounted with 0.5× TV adapter (Zeiss product no. 456101) on an inverted microscope (Zeiss Axio-
vert S100) equipped with a 32× objective (Zeiss LD-Achroplan), to take optical micrographs of the 
(250 µm – wide and 2500 µm – long) surface pattern of fixed small beads, which we will refer to 
as “detection area”. An electrostatic self-assembly method [39] was used to immobilize the small 
beads onto aminopropyl-trietoxysilane (APTES) dot structures (Figure 1.2d), previously microfab-
ricated on glass substrates via standard lithography techniques [40] (Figure 1.2e). For each assay, 
about 3500 large superparamagnetic beads and a 5 µL sample solution were introduced into the 
micro-mixing chamber through reservoirs integrated in the microfluidic chip. On-chip active mix-
ing was conducted to pre-concentrate Ags on the large bead surfaces. Ag-loaded beads were then 
transported in buffer solution through a (250 µm – wide, 60 µm – high) microfluidic channel to 
the detection area, under the presence of the magnetic field produced by a permanent magnet.  
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It is worth noticing that, in principle, other micromagnetic structures could have been used to 
replace the immobilized small particle “landscape” and micropatterned magnetic structures [41], 
the surface of which can be bio-functionalized. However, a direct immobilization of pre-function-
alized magnetic particles offers a very fast and reliable solution for getting patterning and func-
tionalization done at the same time. Moreover, if particles are superparamagnetic, their magnet-
ization can be accurately modulated by an external magnetic field, therefore offering an additional 
degree of freedom with respect to taking permanent micro- or nanomagnets. The magnetic land-
scape can be therefore accurately tuned by an operation as simple as changing the relative posi-
tion between the immobilized particles and a permanent magnet. 1.2.2 Protein detection results 
First, we used our system for the detection of biotinylated anti-streptavidin, spiked as Ag in fetal 
bovine serum (FBS). Figure 1.3a shows representative images of large bead counting for the anal-
ysis of different concentrations of spiked Ags, corresponding to specific numbers of Ag molecules 
to be detected inside each serum sample. The number of large beads bound to the detection area 
increases with the Ag concentration. Figure 1.3b reports the percentage of specifically captured 
beads, as a function of the total number of Ag molecules to be detected. To produce this graph, 
for each sample concentration, the number of specifically bound beads is calculated, as a differ-
 
Figure 1.2 | Overview of the protein detection method. (a) Schematic representation of the time-lapse 
motion of a large bead exploring the detection area and interacting with the functionalized surface on the 
small beads through magnetic dipole-dipole forces. (b) Large bead capture mechanism: (bi) in absence of 
Ags, large beads are transported by the microfluidic flow through the whole detection area and washed 
away; (bii) if at least one Ag molecule is present on the large bead surface, the bead is captured onto the 
detection area via Ag-Ab binding. (c) Assay readout: counting of the captured large beads provides a meas-
ure of the number of molecules present in the sample under analysis; (d) Scanning electron microscopy 
(SEM) photograph of a part of the detection area after small bead patterning. The image is artificially col-
ored to emphasize the small beads and APTES patterns. In zoom, atomic force microscopy (AFM) image of 
a 1.5 μm APTES dot after the photoresist lift-off process. (e) Micrograph of a detection chip covered with 
600 nm – thick structured photoresist layer, used for depositing the APTES dot patterns. 
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ence between the bead count in the presence of Ags spiked into the sample matrix and the aver-
age bead count with no (0 fg mL-1) Ag (i.e. background signal). The obtained values are then divided 
by the total number of beads used for each assay (i.e.: 3500) and expressed as a percentage of 
this value. Data points represent the mean of 3–4 replicates with error bars = standard deviation 
(SD). Moreover, the LOD signal is taken as three times SD of the background signal [42] and it is 
calculated to be 6.5 attomolar, corresponding to the detection of down to ~200 biotinylated an-
tistreptavidin molecules in the 5 μL serum sample.  
Figure 1.3c shows instead the results of detection of TNF-α, spiked at different concentrations in 
FBS. TNF-α is a cytokine secreted from cells during inflammation [43], while the presence of ex-
cessive amounts of TNF-α molecules in the bloodstream can be linked to an increased risk of can-
cer, as well [44]. With our assay, we achieve a LOD of 1 fg mL-1 (60 attomolar), corresponding to 
the possibility of detectiong the presence of a few hundred TNF-α molecules in 5 μL serum sam-
ples.  1.3 Assay specificity enhancement and background noise reduction 
A good specificity is a prerequisite for a low detection limit of the assay, as it translates directly 
into a low signal for the blank reference experiment and reduces noise caused by unspecific ad-
sorption effects. To unravel the origin of the specificity in our immunoassay technique, we devel-
oped a physical model of the force balance involved in our “dual magnetic bead”-based protein 
detection format. We then validated experimentally our theoretical predictions and employed this 
model as a tool for the optimization of the assay performance.  1.3.1 Physical modeling 
Figure 1.4a summarizes the forces involved at the moment of a single immunocomplex formation. 
Large beads are transported in the microfluidic channel by Poiseuille flow and thus subjected to a 
viscous drag force Fdrag. The presence of an external magnetic field and the magnetized small bead 
pattern generates on the large magnetic beads a force Fmag, ext and Fdip, respectively, as will be 
described further. When a specific immunocomplex is formed, an extra retention force Fspec is 
established due to the presence of the Ag. The goal of the optimized immunoassay is to keep large 
 
Figure 1.3 | Experimental results of protein detection. (a) Optical microscopy photograph of a small portion 
of the detection area using as Ag sample three different concentrations (i.e. three different amount of mol-
ecules to be detected: 0, 200, and 2·109 molecules, respectively) of biotinylated anti-streptavidin in FBS. 
Color enhancement is applied to the large beads for better visualization. (b, c) Experimental data for the 
detection of (b) biotinylated anti-streptavidin and (c) TNF-α in FBS (n= 3-4, the error bars are SD). 
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beads attached to the small bead pattern only if an Ag is present, i.e. minimize non-specific ad-
sorption while maximizing the specific bead capture. 
The microfluidic environment is simulated via FEM using Comsol 4.2a (COMSOL Multiphysics, Zü-
rich, Switzerland), by solving the Navier-Stokes equation for incompressible flow [45]. The pres-
ence of a small bead pattern at the channel bottom influences the flow, as represented in Figure 
1.4b. The simulation allows extracting precise values of the local fluid velocity v for accurate esti-
mation of the drag force acting on a large bead approaching the pattern. A “drag coefficient” fD 
has to be employed to take into account the proximity of the large bead to the microfluidic chan-
nel wall. Therefore, the drag force acting on a large bead is calculated as: 
𝐅𝐅𝐝𝐝𝐝𝐝𝐝𝐝𝐝𝐝 =  6𝜋𝜋𝜋𝜋𝜋𝜋𝐯𝐯𝑓𝑓𝐷𝐷 (1.1) 
where μ = 8.9 × 10-4 Pa s is the viscosity of the buffer solution used, R = 1.4 µm is the bead radius, 
and fD the drag coefficient given by [23]: 
𝑓𝑓𝐷𝐷 = �1 − 916 � 𝜋𝜋𝜋𝜋 + 𝑧𝑧� + 18 � 𝜋𝜋𝜋𝜋 + 𝑧𝑧�3 − 45256 � 𝜋𝜋𝜋𝜋 + 𝑧𝑧�4 − 116 � 𝜋𝜋𝜋𝜋 + 𝑧𝑧�5�−1 (1.2) 
with z the distance between the surface of the large bead and the contour of the small bead pat-
tern that is fixed on the bottom of the microfluidic channel. 
In the presence of a magnetic induction Bext, superparamagnetic particles get magnetized with 
magnetic moment m(Bext), according to a non-linear, non-hysteretic magnetization curve, specific 
 
Figure 1.4 | Physical modelling for assay specificity enhancement. (a) Diagram of the main directions of 
the viscous (Fdrag,1 and Fdrag,2) and magnetic dipolar (Fdip,1 and Fdip,2) forces acting on two large magnetic 
beads. Bead 1 is translating just above the small bead pattern and bead 2 just above bead 1. Also the mag-
netic force Fmag,ext induced by the permanent magnet and the specific inter-bead binding force Fspec due to 
the formation of the Ab-Ag-Ab sandwich immunocomplex (in zoom) are indicated. (b) Side-view of the flow 
velocity in a microfluidic channel above a pattern of 4 small magnetic beads of 1 µm diameter, when apply-
ing a flow of 100 nL/s in a microchannel with section h×w = 60 µm×250 µm. (c) Magnetic induction at a 
position of 1 µm above the bottom of the microchannel when applying an external magnetic induction of 
27 mT. The small beads locally increase the induction, which is the basis for the attractive dipolar force with 
a large bead. (d) x component of the magnetic dipolar force acting on 2 large magnetic beads, as indicated 
in Figure 1.4b (Fdip,1 and Fdip,2), moving with the flow along the x-direction. The centre position of the pattern 
of 4 small beads is chosen as x=0 µm. The forces are plotted with respect to the x-displacement of the large 
beads, for an external induction of 27 mT at the microchannel bottom. 
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for the bead type [46]. The magnetic force Fmag,ext acting on a large bead with magnetic moment 
mL is given by [47]: 
𝐅𝐅𝐦𝐦𝐝𝐝𝐝𝐝,𝐞𝐞𝐞𝐞𝐞𝐞 =  (𝐦𝐦𝐋𝐋 ∙ ∇)𝐁𝐁𝐞𝐞𝐞𝐞𝐞𝐞 (1.3) 
Moreover, a magnetic dipolar force acting on a large bead in proximity of the small bead pattern 
can be calculated as the gradient of the total dipolar interaction energy [27]: 
𝐅𝐅𝐦𝐦𝐝𝐝𝐝𝐝,𝐝𝐝𝐝𝐝𝐝𝐝 =  −∇ � 𝜋𝜋04π|𝐝𝐝𝐝𝐝|3 �𝐦𝐦𝐝𝐝 ∙ 𝐦𝐦𝐋𝐋 − 3|𝐝𝐝𝐝𝐝|2 (𝐝𝐝𝐝𝐝 ∙ 𝐦𝐦𝐝𝐝)(𝐝𝐝𝐝𝐝 ∙ 𝐦𝐦𝐋𝐋)�𝑛𝑛i=1 � (1.4) 
where n is the number of small beads in the pattern, µ0 = 4π × 10-7 TmA-1 is the magnetic perme-
ability, ri is the distance vector between the center of the large bead and of the ith small bead, mL 
and mi are the magnetic moments of the large bead and of the ith small bead, respectively. If the 
derivative is calculated along the direction of the microfluidic flow (defined as x direction), this 
component of the magnetic dipolar force in equilibrium is opposite to the drag force. We there-
fore consider only the x-component of the magnetic force in the force balance equation.  
Direct simulation of the complete physical model is complicated via standard simulation tools. 
However, the problem can be split into its different physical subdomains and three-dimensional 
(3D) FEM simulations can be combined with Matlab (The Mathworks Inc., Natick, MA) analytical 
calculations. First, the exact distribution of the magnetic induction on the patterned area is simu-
lated via FEM using Comsol 4.2a. The magnetized small bead pattern generates a well-defined 
magnetic induction landscape, whose properties are defined by the external magnetic induction 
and by the specific pattern choice. In Figure 1.4c we report the FEM-calculated magnetic induction 
landscape for the conditions chosen in our experiments. The pattern of small beads results in a 
~25% stronger magnetic induction at the beads’ top surface, where immunocomplex formation 
occurs. However, we have only considered Bext to calculate the magnetic moments of the different 
beads and have imported these data in the Matlab code for calculating the magnetic dipolar force 
on a large bead. In particular, a custom-made Matlab script was developed to simulate the force 
on a large bead at different x-positions (with 10 nm intervals) with respect to the location of the 
small bead pattern. As in the experiments, the distance between adjacent patterns is chosen to 
be large enough to ensure no magnetic cross-interaction. Each single pattern can be therefore 
considered as a modular unit of the array and simulated independently. The dipolar force acting 
on a large bead that is moving on top of a pattern of immobilized small beads is calculated using 
Equation (1.4), employing the “effective” dipole moment method, in which the magnetic moment 
mi of a particle is the effective moment of an “equivalent” point dipole [48]. Full magnetization 
curves [46] are considered for the evaluation of the beads’ magnetic moment. Different patterns 
of small beads have been considered in our simulations, as described further.  For a direct com-
parison with our experimental conditions, we report here the specific case of a large bead moving 
above a pattern of 4 small beads, with an external induction of 27 mT at the microchannel bottom. 
Results are shown in Figure 1.4d, where the x component of the dipolar force acting on either 
bead 1 or bead 2 (see schematic of Figure 1.4a) is plotted with respect to their displacement. As 
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expected, when bead 1 is brought in contact with the small bead pattern, it tends to be immobi-
lized by magnetic interactions at the centre of the 4-bead pattern, where the force is zero. How-
ever, in the presence of a drag force, the large bead will be displaced from the centre and only 
kept on the pattern if the drag force does not exceed the maximum dipolar retention force (~ 65 
pN in this case). Our approach allows easily simulating the magnetic dipolar forces versus displace-
ment of the two types of large beads for any pattern of surface-immobilized small beads and mag-
netic field distribution. For a constant external magnetic field induction, the dipolar retention 
force exerted by the pattern on a flowing large bead varies with the size and the shape of the 
pattern. A comparison of the calculated forces for rectangular patterns of different size is reported 
in Figure 1.5.  
1.3.2 Experimental optimization of the assay specificity 
The validity and the precision of our model are corroborated experimentally on a microfabricated 
PDMS device. A microfluidic PDMS half-channel, 250 µm in width, 60 μm in height, is fabricated 
by standard soft-lithography technique [49]. 1.0 µm diameter MyOne Streptavidin C1 Dynabeads 
(Life Technologies, Zug, Switzerland) are used as the small superparamagnetic beads, and 2.8 µm 
diameter M-280 Streptavidin Dynabeads (Life Technologies, Zug, Switzerland) are used as the 
large superparamagnetic beads. Small and large beads are functionalized off-chip with biotinyl-
ated anti-tumor necrosis factor-α (anti-TNF-α) Ab (Life Technologies, Zug, Switzerland). Then the 
functionalized small beads are electrostatically fixed on a glass substrate, via a micropatterned 
aminopropyl-trietoxysilane (APTES) layer [39]. On circular APTES dots of 1.5 µm in diameter, 1 to 
4 small beads are usually immobilized on each single dot, most of the dots showing 4 beads, as 
depicted in Figure 1.4a. In total the glass substrate carries ~8000 of these small bead patterns. 
The PDMS half-microchannel is then clamped on the glass substrate and connected via external 
tubing to a precision Nemesys syringe pump for the fluid manipulation. Strength and position of 
the permanent magnet have to be chosen to ensure, at the same time, gentle landing of the large 
beads onto the glass substrate and good bead capture efficiency. Magnets of different size and 
geometries are tested, in order to find the configuration that best fulfils both the aforementioned 
 
Figure 1.5 | Magnetic dipolar force calculations. (a) Schematic representation of the modeled geometry: a 
large bead is flowing on top of a nx × ny pattern of immobilized small beads, under the presence of a vertical 
magnetic induction B = 27 mT. (b) Maximum value of the x-component of the attractive magnetic dipolar 
force acting on bead 1, Fdip,1, max, for rectangular small bead patterns consisting of a different number nx × 
ny of small beads. 
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requirements. Finally, a cylindrical permanent magnet (Supermagnete, Uster, Switzerland) is cho-
sen, 1 cm in diameter, 3 mm in height, magnetized along its vertical axis, with magnetization of 
~1040 kA/m. The magnet is positioned at 9 mm-distance from the glass substrate, thanks to a 
proper holder. The average magnetic induction at the glass surface level is measured via a gauss-
meter (Pacific Scientific-OECO, Goleta, CA).  
Experimentally, different regimes of the large bead transport mechanism can be identified, allow-
ing investigating the origin of the good assay performance, as reported in Figure 1.6. From the 
theory, for a pattern of 4 small beads, maximum magnetic dipolar retention forces Fdip,1 = 65 pN 
and Fdip,2 = 59 pN are estimated for bead 1 and bead 2, respectively (see Figure 1.4d). These two 
values can be considered as force thresholds defining the different regimes of large bead transport 
and retention. For flow rate values below 50 nL/s, consistent grouping of large beads is observed, 
leading to uncontrollably high amounts of unspecific adsorption of large beads on the patterned 
area. In this flow rate range, in fact, large magnetic beads experience viscous drag forces lower 
than 35 pN when transported just above the small beads, where they are thus magnetically re-
tained. Following the same reasoning, we can predict the vertical chaining of bead 2 to bead 1, 
the former being subjected to drag forces lower than 60 pN in this regime. The intensity of the 
dipolar interaction grows then with the number of beads chaining, according to Equation (1.4), 
hence the creation of even longer chains can be observed and large bead clustering is eventually 
 
Figure 1.6 | Experimental optimization of the assay specificity. Force-flow rate diagram, indicating differ-
ent regimes for the magnetic bead-based immunoassay, with insets of representative parts of the small 
bead pattern array. The x-components of the forces are indicated for the 2 types of large beads that were 
presented in Figure 1.4a. For flow rate Q < ∼50 nL/s, the maximum intensity of the drag force Fdrag,2 is insuf-
ficient to remove the large magnetic bead(2) from the surface, leading to formation of bead chains (see 
inset (i)). For ∼50 nL/s < Q < 95 nL/s, Fdrag,1 is insufficient to remove the large magnetic bead(1) from the 
surface, which leads to immobilization of single beads (see inset (ii)). For Q > 95 nL/s, drag forces are suffi-
cient to remove non-specifically linked large magnetic beads (see inset (iii)), while, if a large bead is linked 
to the small bead pattern via an immunocomplex, it stays attached (see inset (iv)) and its presence can be 
used for Ag quantification. Circles are drawn around the captured large beads for better visualization. Scale 
bars in the insets are 20 µm. 
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obtained (see Figure 1.6 inset (i)). This working regime is clearly not applicable from an immuno-
assay perspective, as it is compromised by uncontrolled unspecific adsorption phenomena. How-
ever, this bead transport regime has been proven to be extremely interesting for other types of 
integrated bioassays and bio-studies, based on self-assembly of vertical chains of bio-functional-
ized beads [50, 51]. 
Instead, no vertical chains of large beads can be formed at flow rates larger than 50 nL/s. A second 
transport regime can be identified for flow rates between 50 nL/s and 95 nL/s, where isolated 
large beads are magnetically captured on the small bead pattern (see Figure 1.6, inset (ii)). For 
flow rates larger than 95 nL/s, viscous drag forces always exceed dipolar retention forces and large 
beads cannot be magnetically immobilized on the array anymore. In this regime, therefore, the 
capture of a large bead occurs only when an extra force comes into play. In case of reference tests 
(no Ags on the large beads), these extra forces can be only provided by unspecific interactions. 
For Ag-carrying beads (in our case the Ag is recombinant mouse TNF-α obtained from Life Tech-
nologies, Zug, Switzerland), instead, the formation of specific immunocomplexes at the beads’ 
interface is responsible for the retention force Fspec. While magnetic attraction between beads is 
known to act in favor of the immunocomplex formation [36], specific bonds can be disrupted by 
a too large drag force acting on the large beads, resulting in signal loss. Therefore, drag forces 
exerted on the large beads have to be minimized, so that they are just sufficient to remove non-
specifically adsorbed large beads. The rupture force of the TNF-α – anti-TNF-α Ag-Ab pair has not 
been investigated under shear stress conditions. However, since for the biotin-streptavidin bond 
this force has been measured to be ranging between 3 pN and 11 pN [52], we can assume to be 
working with forces approximately in this range of values or slightly lower. Optimized assay spec-
ificity for this biomarker can be therefore expected for flow rate values around 100 nL/s.  For this 
flow rate a clear difference of bead capture is observed between no TNF-α-carrying beads (0 ng/ml 
TNF-α) (see Figure 1.6, inset (iii)) and TNF-α-carrying beads (100 ng/ml TNF-α) (see Figure 1.6, 
inset (iv)).   1.4 Enhancement of specific immunocomplex formation 
In the previous section, we described a physical modeling tool conceived for the optimization of 
the assay selectivity and the reduction of its background noise. In this first description of our im-
munoassay technique, superparamagnetic beads were considered as translating point-like di-
poles, since this approximation allows readily estimating the balance of the forces acting on the 
particles involved in each immunocomplex formation event. When estimating, however, the prob-
ability of the occurrence of each one of this events, a more sophisticated modeling approach 
needs to be built, in which the rotation of each particle in the 3D space needs to be considered as 
well.  In this section, we introduce the concept of “magnetic particle-scanning”: in our assay, large 
particles are actually subjected to successive stochastic reorientations in the engineered magnetic 
energy landscape established by the regular pattern of small magnetic particles, while transported 
by hydrodynamic forces in the microfluidic system. In this mechanism, as the moving particle 
slides over the immobilized ones, the point of contact between the two particles continuously 
explores, or “scans”, a section of the particle surface. If this inter-particle interaction is repeated 
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several times, a large fraction of the moving bead surface can be interrogated, until the presence 
of a bound Ag triggers the particle binding. We explore this phenomenon in a custom-built mag-
neto-microfluidic chip. Finally we introduce a random walk-based model for describing the mag-
netic particle-scanning process, explaining the particular dose-response curves of our protein de-
tection experiments over the whole tested concentration range. Moreover, our analysis provides 
understanding of the features of other particle-based heterogeneous immunoassays. 
1.4.1 Magnetic particle-scanning model 
We will first describe the physics of the inter-particle interactions leading to the particle-scanning 
mechanism. When two superparamagnetic particles are placed in a constant magnetic induction 
B, they acquire each a magnetic moment, m1(B) and m2(B) respectively, and interact via dipolar 
forces. If the first particle is immobilized on a substrate that is normal to B, the second particle 
will be subjected to a torque, the size of which can be calculated as the first angular derivative of 
the dipolar interaction energy between the two particles, as follows: 
𝜏𝜏𝑚𝑚𝑚𝑚𝑚𝑚,𝑑𝑑𝑑𝑑𝑑𝑑 =  − dd𝜃𝜃 � 𝜋𝜋04𝜋𝜋�𝐝𝐝𝟏𝟏,𝟐𝟐�3 �𝐦𝐦𝟏𝟏.𝐦𝐦𝟐𝟐 − 3�𝐝𝐝𝟏𝟏,𝟐𝟐�2 �𝐝𝐝𝟏𝟏,𝟐𝟐.𝐦𝐦𝟏𝟏��𝐝𝐝𝟏𝟏,𝟐𝟐.𝐦𝐦𝟐𝟐��� (1.5) 
where θ is the angle formed by the position vector between the center of mass of the two particles 
(r1,2) and the substrate plane (see Figure 1.7a), µ0 = 4π × 10-7 T m A-1 is the permeability of vacuum, 
and m1 and m2 are the magnetic moments of the two particles that we consider to be point-like 
dipoles. A stable situation is reached when m1 and m2 are aligned along the field direction (θ = 
90°). Figure 1.7b shows the intensity of the magnetic induction B and the spatial distribution of 
the magnetic induction lines within a large and small magnetic particle for an externally applied 
induction of 30 mT, as calculated using a 3D FEM simulation (Comsol Multiphysics). We used a 
magnetic susceptibility χ of 0.7 and 1.4 for the large and small magnetic particle, respectively [46]. 
 
Figure 1.7 | Simulations of the 3D inter-particle interaction. (a) Schematic of a small and a large magnetic 
particle with magnetic moment m1 and m2, respectively, and indicating the angle θ and the position vector 
r1,2. (b) FEM simulation of the field lines for a large and small magnetic particle, placed in an external mag-
netic induction of 30 mT. (c) Contact of the large particle sliding over a small particle under influence of the 
torque τmag,dip as indicated by the arc corresponding to the angle δ. 
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Our calculation shows that the perturbation of the vertical magnetic field lines due to the presence 
of the particles is minimum, thus supporting the assumption that both magnetic moments are 
oriented along the z-direction, as implicitly assumed in Equation (1.5). As domain reorientations 
in a magnetic particle, which consists of an ensemble of magnetic nanocrystals in a non-magnetic 
matrix, are relatively slow [53], m1 and m2 are not expected to change their orientation with re-
spect to the particle surfaces on the time scale of their interaction, leading to a “pinning” of the 
magnetic moments to the particles. As a consequence, an increasing part of the large particle will 
be in contact with the small particle, when the former slides over the latter under influence of the 
torque τmag,dip. The distance on the large particle surface over which this contact takes place is 
indicated by the arc defined by the angle δ (see Figure 1.7c).  
Moreover, as the induced displacement of the large particle occurs in a liquid with viscosity μ, a 
“magnetic tangential velocity” vmag,tan arises from instantaneous equilibrium [23] between mag-
netic and drag forces applied to the particle, as follows: 
𝑣𝑣𝑚𝑚𝑚𝑚𝑚𝑚,𝑡𝑡𝑚𝑚𝑛𝑛 =  − 𝜏𝜏𝑚𝑚𝑚𝑚𝑚𝑚,𝑑𝑑𝑑𝑑𝑑𝑑
�𝐝𝐝𝟏𝟏,𝟐𝟐� ∙ 6𝜋𝜋𝜋𝜋𝜋𝜋𝑓𝑓𝐷𝐷 (1.6) 
where R is the particle radius and fD is the corrective drag coefficient taking into account the vi-
cinity of the particles to the substrate. When the substrate is placed at the bottom of a microfluidic 
channel, in which a constant flow is applied, a Poiseuille flow develops in the microchannel and 
the local fluid velocity v can be calculated by solving the Navier-Stokes equation for incompressi-
ble flow in the microfluidic channel [45]. An additional viscous drag force will act therefore on the 
moving particle, and can be calculated using Equation (1.1), with v conveniently taken as the ve-
locity of the unperturbed Poiseuille flow at the center of mass of the particle [23]. Because of the 
parabolic velocity profile in the microchannel, the drag force acting on the large particle will be 
strongest once it is on top of the small particle. As shown in section 1.3, this microfluidic viscous 
force can be tuned to detach the large particle, when no additional tethering forces are introduced 
to keep the two particles linked.  1.4.2 Experimental observation of the inter-particle interaction 
To verify our theoretical model experimentally, we designed the simple magneto-microfluidic sys-
tem shown in Figure 1.8a. Functionalized small superparamagnetic particles are patterned on a 
glass substrate, which is clamped to a PDMS half-microchannel. A constant vertical field at the 
glass substrate, as induced by a permanent magnet placed above the chip, imposes a constant 
magnetic moment to the immobilized particles. In particular, size, shape and position of the per-
manent magnet employed in our setup are dictated by two main needs: (i) a uniform magnetic 
induction at the glass surface over the whole detection area, with the same intensity of the one 
observed in all our previous protein detection experiments; (ii) an efficient light exposure to the 
immobilized particles, for accurate time-lapse observation of the magnetic particles via a high-
speed camera. A ring magnet (10 mm outer diameter, 4 mm inner diameter, 5 mm height), with 
magnetization of ~1040 kA/m, positioned above the chip at 10 mm distance from the glass sub-
strate allows satisfying both the aforementioned requirements. The central hole allows perfect 
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light transmission through the magnet. The size of the magnet and its position with respect to the 
detection area are adjusted according to the results of 3D FEM Comsol simulations of the magnetic 
induction distribution for different configurations. In Figure 1.8bi we report the spatial distribu-
tion of the magnetic field induction components at the glass chip surface, for the magnet config-
uration used in our experiments and mentioned above. At 10 mm distance from its top face, the 
ring magnet produces a magnetic induction profile on the detection area which is basically equal 
to the one of a disc magnet of same magnetization and similar dimensions (Figure 1.8bii), as the 
one employed in our previous microfluidic experiments (section 1.3). A peak of 27-30 mT in the 
central region of the magnet is obtained in both cases, as further confirmed via Gauss meter meas-
urements. 
In our experiments, a diluted suspension of large superparamagnetic particles is injected in the 
microchannel at 100 nL/s flow rate, this value being obtained from the previously described opti-
mization process of the assay specificity (section 1.3). Under these magnetic and drag force con-
ditions, large particles gently slide over the substrate and interact with the small particles, as de-
scribed further and shown in Figure 1.9. 
Figure 1.9a describes the behavior of a large particle in vicinity of a small particle, as obtained 
from the modeling corresponding to the described experimental conditions. Three distinct phases 
are defined for an inter-particle contact event: (i) transport of a large particle by viscous drag 
forces (in the time interval t2-t1); (ii) encounter with a small particle (at t2) and contact during a 
time interval t3-t2, when the large particle is subjected to the magnetic torque; and (iii) large par-
ticle release inside the channel, in case no tethering force is linking the two particles. The contact 
 
Figure 1.8 | Microfluidic platform for the experimental observation of magnetic particle-scanning. (a) 
Schematic representation of the magneto-microfluidic device used for investigating the “magnetic particle-
scanning” mechanism. (b) Spatial distribution of the magnetic induction components (Bx and Bz, according 
to the axis system defined in text) and the total intensity (Bnorm) along the bottom of the microfluidic chan-
nel, as simulated via 3D FEM for 2 different magnet geometries: a ring magnet (I) and a disc magnet (ii), 
positioned respectively 10 mm and 9 mm below the channel bottom. In both cases the detection area is 
centered with respect to the magnet top face, at x=0. 
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time between the two particles is estimated by taking into account two contributions: the local 
velocity v of the fluid, as simulated by FEM, and the magnetic tangential velocity vmag,tan of the 
rotatory movement, calculated in Matlab using Equation (1.6). Neither in the experiment nor in 
the model, ligand-receptor forces between the two particles are included, yet. A contact time of 
approximately 4 ms between the two particle surfaces is calculated, in good agreement with the 
experimental result of Figure 1.9b. 
In Figure 1.9c we report the trajectories of four different large particles, taken from a 1200 fps 
video, as they flow over the small particle-patterned area. Multiple in-plane reorientations and 
trajectory deviations of each flowing particle can be observed at each encounter with a small par-
ticle. Moreover, the velocity plot associated to each trajectory allows extracting further infor-
mation about the out-of-plane particle movements. Large particles flow at relatively constant ve-
locity (0.8-1 mm/s) on the glass surface and abruptly decelerate while in close proximity to any 
immobilized particle. The small peaks in the velocity profiles correspond to sudden increases of 
the velocity upon detachment of a large particle sitting on top of a small particle (time t3 in Figure 
1.9a), where hydrodynamic flow and drag force is maximum.   1.4.3 Increasing the ligand-receptor encounter probability  
In this subsection we estimate the gain in ligand-receptor encounter probability induced by the 
scanning mechanism, under our standard experimental conditions. Figure 1.7c already showed 
the increase of contact area of a large particle with an immobilized small particle due to the sliding 
motion induced by the magnetic torque. In this schematic picture, all the elements of the system 
were aligned along a symmetry plane defined by the flow direction and the vertical axis, i.e. the 
 
Figure 1.9 | Experimental observation of magnetic particle-scanning. (a) Schematic motion of a large par-
ticle in the detection area in the presence of a small particle, as obtained from a Matlab simulation, for an 
external magnetic field B = 30 mT and flow rate Q = 100 nL s-1. A total contact time of ~4 ms is estimated 
between the two particles. (b) Motion of a large particle over the detection area, for B = 30 mT, Q = 100 nL 
s-1, as experimentally observed via a high-speed camera. Scale bar = 5 µm. (c) Experimental tracks and ve-
locity profiles for four different large particles, for B = 30 mT, Q = 100 nL s-1, extracted from a video taken at 
1200 fps. At each encounter with an immobilized small particle, a large particle undergoes both in-plane 
and out-of plane displacements. Scale bar = 10 µm. 
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trajectory of the large particle is constrained within this plane. However, in reality, as already sug-
gested by Figure 1.9c, this symmetry is rarely conserved. The contact between a large and a small 
particle mainly occurs out of this symmetry plane, giving rise to a lateral displacement and extra 
lateral components of the magnetic and hydrodynamic forces. In successive contact events with 
a number of small particles, this gives rise to the scanning of a significantly larger part of the sur-
face of the large particle than shown in Figure 1.7c. Figure 1.10a, case i. (top) shows the contact 
of the large particle while moving in the presence of the magnetic field that pins the magnetic 
moment, but without the immobilized small particles. In this case, the particle simply slides over 
the flat substrate and “probes” it with only one point, because of the spherical geometry, as al-
ready demonstrated by others [2]. Therefore the ligand-receptor encounter probability is ex-
pected to be very low, especially for single molecule detection. When the large particle moves in 
the symmetry plane and small particles are present, the contact point describes a line on the sur-
face of the large particle (Figure 1.7c), increasing somewhat the chance for ligand-receptor en-
counter (Figure 1.10a, case ii. (center)). Even when multiple small particles are explored, as the 
orientation of the large particle is not altered, the same portion of the large particle surface is 
each time scanned. If we now consider the real case, where lateral displacements of the large 
particle occur, a different section of the large particle surface is explored at each interaction with 
a small particle dot (Figure 1.10a, case iii. (bottom)). It is interesting to note that, up to now, we 
assumed that the particles are solely exposed to magnetic and hydrodynamic forces. Neverthe-
less, other surface interactions of different origin, such as electrostatic, chemical or friction forces, 
may introduce an additional torque [54], which would even be more beneficial for enhancing this 
reorientation phenomenon. 
The attempt frequency of ligand-receptor binding corresponds to the rate of large particle reori-
entation events and can be strongly enhanced by precisely controlling the arrangement of the 
immobilized small particles. In particular, we designed different regular patterns of immobilized 
small particles and developed a particle-tracking Matlab code to predict the trajectory of the large 
particles over them (see subsection 1.5.5). Figure 1.10b shows an array of isolated dots of four 
small particles at 9 μm inter-distance, allowing a high density of small particles while still avoiding 
magnetic cross-interaction between adjacent dots, with the trajectories of five large particles 
moving over the pattern. A 6.5° tilting angle of the dot pattern with respect to the flow direction 
Figure 1.10c) was found to be a good choice for increasing the number of encounters, in compar-
ison to the geometry shown in Figure 1.10b.  Again, we fabricated this optimized small particle 
array via electrostatic self-assembly on a micropatterned APTES layer [39]. The full array is made 
up of ten 250 μm × 250 µm sections, for a total number of ~8000 small particle dots. Under our 
standard experimental conditions (Bext,z=27-30 mT, Q=100 nL/s), we found that a single large par-
ticle encounters on average 20 small particle dots over the length of each section (Figure 1.10d), 
resulting in about 200 encounters over the full length of the array (Figure 1.10e).  
To estimate the gain in ligand-receptor encounter probability induced by the scanning mechanism, 
we calculate below the probability to successfully bind the large particle Pcapture for the three cases 
described in Figure 1.10a, adapted to our real experimental conditions. As shown in Figure 1.10f, 
the scanning mechanism is expected to introduce a dramatic enhancement of the particle capture 
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probability. The large particles can be in first approximation considered as spheres where only a 
fraction of the surface is covered by ligands and can be bound to the receptors on the small par-
ticles. We also assume that the surface concentration of ligands is well below saturation, so that 
there is no interaction between ligands. Ideally, capture is immediately triggered when a ligand-
covered part of the surface encounters the dot pattern. The probability to successfully bind the 
large particle Pcapture is therefore directly related to the capability of the device to intercept this 
small area over the whole particle surface. To estimate Pcapture, we consider three situations: 
(i) No scanning (Figure 1.10a, case i. (top)): in this case, the large particle surface is not scanned 
by small particles, as detailed above. However, its orientation is still pinned by the magnetic field. 
Hence, as detailed by others [2], and assuming a perfectly spherical geometry, the contact be-
tween the large particle and the sensing surface is reduced to a single point and Pcapture is the ratio 
of the part of the particle surface that is effectively covered with ligands over the whole particle 
surface: 
 
Figure 1.10 | Estimation of ligand-receptor encounter probability. (a) Large magnetic particle moving in a 
magnetic field that pins its magnetic moment (top) in absence of immobilized small particles, (center) in 
presence of small particles, but only moving in the symmetry plane (no lateral displacements) and (bottom) 
under our experimental conditions, where lateral displacements of the large particle occur as well. In the 
last case, a different section of the large particle surface is explored at each interaction with a small particle 
dot. (b,c) Simulated large particle trajectories on (b) a non-tilted and (c) a 6.5° tilted regular array of 4 small 
particles per pattern, iteratively traced by combining FEM simulations and Matlab analytical calculations. 
The tilted pattern guarantees more frequent encounters between immobilized small particles and flowing 
large particles. (d) Trajectory of a large particle on a tilted small particle array, under our standard experi-
mental conditions (Bext,z=27-30 mT, Q=100 nL/s), as experimentally observed using a high-speed camera. 
Red dots are used to visualize the large particle reorientation events (~20 over a 250 µm-long array). (e) 
Optical microscopy photograph of the particle array used for protein detection experiments. (f) Capture 
efficiency Pcapture calculated for the three situations of Figure 1.10a as function of the radii of the large and 
small particles using Equation (1.7),(1.8) and (1.9), taking N=1 and rligand = 2.2 nm. The cases i. and ii. are not 
easily distinguishable on this graph (even though case i. always induces a smaller Pcapture than case ii. by at 
least two orders of magnitude) so that this representation merely emphasizes the increased Pcapture from 
case iii. 
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𝑃𝑃𝑐𝑐𝑚𝑚𝑑𝑑𝑡𝑡𝑐𝑐𝑐𝑐𝑐𝑐 = 𝑁𝑁 ∙  𝑟𝑟𝑙𝑙𝑑𝑑𝑚𝑚𝑚𝑚𝑛𝑛𝑑𝑑2  4 ∙ 𝑟𝑟𝑙𝑙𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐2  (1.7) 
   with N the number of ligands on the large particle surface, rligand the average radius of a ligand 
molecule and rlarge the radius of the large particle. This probability is evidently extremely low for 
single molecule carrying particles. 
(ii) Scanning, but no lateral forces (Figure 1.10a, case ii. (center)): all the forces and displacements 
are constrained into a single vertical plane, thus preventing the lateral rotational reorientation 
described earlier. Hence, even if the large particle is scanned by many successive small particle 
dots, the output will be the same for each encounter, and the same fraction of the large particle 
surface will be examined. The particle is expected to keep the same orientation during its trajec-
tory across the full surface of the device. In this case, the length of the device does not enhance 
Pcapture, as only the initial contact point of the arc that is defined by the angle δ will be determining 
for successful capture. Hence: 
𝑃𝑃𝑐𝑐𝑚𝑚𝑑𝑑𝑡𝑡𝑐𝑐𝑐𝑐𝑐𝑐 = 𝑁𝑁 ∙ 𝛿𝛿 ∙ 𝑟𝑟𝑙𝑙𝑑𝑑𝑚𝑚𝑚𝑚𝑛𝑛𝑑𝑑  𝜋𝜋 ∙ 𝑟𝑟𝑙𝑙𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐  (1.8) 
(iii) Scanning and reorientation (Figure 1.10a, case iii. (bottom)): if the full scanning mechanism 
is enabled, the orientation of the large particle can change at every encounter with any of the Ndots 
dots composed of the small particles. Hence, if Pcapture,i is the probability that the large particle is 
captured on the ith dot of small particles, we can write that: 
 𝑃𝑃𝑐𝑐𝑚𝑚𝑑𝑑𝑡𝑡𝑐𝑐𝑐𝑐𝑐𝑐 = � 𝑃𝑃𝑐𝑐𝑚𝑚𝑑𝑑𝑡𝑡𝑐𝑐𝑐𝑐𝑐𝑐,𝑑𝑑𝑁𝑁𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑
𝑑𝑑=1
 (1.9) 
Given the sequential scanning of the large particle by the array of dots, a binding at the ith dot is 
equivalent to (i-1) non-binding encounters with the (i-1) previous dots in the trajectory of the large 
particle, followed by a successful encounter on the ith dot. If we introduce PSB, the probability of a 
successful binding of the large particle upon an encounter with a small particle dot, we obtain the 
following expression for Pcapture,i:  Pcapture,i = PSB(1 − PSB)i−1 (1.10) 
Hence, Pcapture can be written as: 
 Pcapture = PSB � (1 − PSB)iNdots−1
i=0
= 1 − (1 − PSB)Ndots (1.11) 
This expression is equivalent to considering the large particle immmobilization event as a stochas-
tic process in which the binding is tested Ndots times, with a probability of success PSB, until a suc-
cessful event is obtained. As expected, this value tends to 1 as Ndots increases towards infinity. 
Furthermore, PSB is the probability of ligand-receptor binding upon inter-particle encounter. The 
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probability PSB can therefore be evaluated using the expression of Pcapture detailed for case ii (Equa-
tion (1.8)). The Equation can also be linearized, assuming that PSB<<1, so that: 
𝑃𝑃𝑐𝑐𝑚𝑚𝑑𝑑𝑡𝑡𝑐𝑐𝑐𝑐𝑐𝑐 = 1 − �1 −𝑁𝑁 ∙ 𝛿𝛿 ∙ 𝑟𝑟𝑙𝑙𝑑𝑑𝑚𝑚𝑚𝑚𝑛𝑛𝑑𝑑  𝜋𝜋 ∙ 𝑟𝑟𝑙𝑙𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐 �𝑁𝑁𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 ~ 𝑁𝑁𝑑𝑑𝑑𝑑𝑡𝑡𝑑𝑑 𝑁𝑁 ∙ 𝛿𝛿 ∙ 𝑟𝑟𝑙𝑙𝑑𝑑𝑚𝑚𝑚𝑚𝑛𝑛𝑑𝑑  𝜋𝜋 ∙ 𝑟𝑟𝑙𝑙𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐  (1.12) 
In Figure 1.10f, Pcapture has been calculated for these three situations, using the full equation for 
situation iii., with rsmall the radius of the small particle, taking N=1 and rligand = 2.2 nm (the Stokes 
radius of TNF-α monomer was estimated as 2.2 nm at pH=7.0) [35], showing indeed the dramati-
cally higher Pcapture for case iii. 
Finally, it has been here assumed that the large particle can fully rotate, and none of its degrees 
of freedom is constrained. As the orientation of the large particle is magnetically pinned, this as-
sumption can be refined by multiplying the expressions of Pcapture detailed in the text by a factor η, 
equal to the ratio of the large particle surface accessible to the small particle scanning to its total 
surface. Indeed, due to the magnetic pinning, the top section of the large particle ideally will never 
encounter the small particle dots. The value for η can be obtained from the angle δ defining the 
length described by the inter-particle point of contact during large and small particle interactions 
(see Figure 1.7c):  
𝛿𝛿 = arcos�𝑟𝑟𝑙𝑙𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐 − 𝑟𝑟𝑑𝑑𝑚𝑚𝑚𝑚𝑙𝑙𝑙𝑙
𝑟𝑟𝑙𝑙𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐 + 𝑟𝑟𝑑𝑑𝑚𝑚𝑚𝑚𝑙𝑙𝑙𝑙� (1.13) 
The surface of the large particle that is accessible for contact with a small particle dot, Saccessible, is 
described by the solid angle obtained by the rotation of δ around the vertical axis, so that 
𝑆𝑆𝑚𝑚𝑐𝑐𝑐𝑐𝑐𝑐𝑑𝑑𝑑𝑑𝑑𝑑𝑎𝑎𝑙𝑙𝑐𝑐 = 2𝜋𝜋𝑟𝑟𝑙𝑙𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐2 �1 − cos(𝛿𝛿)� (1.14) 
Hence, 
𝜂𝜂 = 2𝜋𝜋𝑟𝑟𝑙𝑙𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐2 �1 − cos(𝛿𝛿)�4𝜋𝜋𝑟𝑟𝑙𝑙𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐2 = 1 − cos(𝛿𝛿)2 = 𝑟𝑟𝑑𝑑𝑚𝑚𝑚𝑚𝑙𝑙𝑙𝑙𝑟𝑟𝑙𝑙𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐 + 𝑟𝑟𝑑𝑑𝑚𝑚𝑚𝑚𝑙𝑙𝑙𝑙 (1.15) 
While this simple model already shows that both the scanning and the reorientation of the large 
particles improve the capture probability, however, this is only an approximation for the behavior 
of the real system. Indeed, in this estimation it was assumed that the changes in the orientation 
of the particle between the interactions with the immobilized surfaces were completely random. 
In our system, these interactions are more appropriately described by a single point of contact 
that is randomly diffusing over the surface of the particle until it hits a bound Ag. A random walk 
description would therefore be a much better approximation than a succession of independent 
tests of the stochastic variable. During a true random walk, the probability for the next movement 
is the same for any direction. In our case, as the molecule is moving in the direction of the flow, a 
movement of the point of contact on the surface of the particle in the direction of the flow is more 
likely. However, as detailed in the previous description, the system is not perfectly symmetric, and 
random rotation along the z axis, changes in direction, out-of-plane contacts, etc. are all expected 
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to enhance the reorientation rate of the bead, so that the trajectory of the point of contact on the 
surface of the sphere is not a straight line in the direction of the flow, but is actually randomized 
by the constant rotation and re-orientation of the particle. Hence, the point of contact can poten-
tially then move in any direction, even though the direction of the flow would be the one associ-
ated to the highest probability. We hence assume that this behavior can be modelled as a random-
walk. Overall, this approximation is found to describe accurately the behavior of the system and 
to be in good agreement with the experimental data, thus supporting this hypothesis (see further).  1.4.4 Evaluation of the particle binding along the detection area 
As the number of particles specifically captured on each section of the small particle dots land-
scape can be easily assessed by microscopic observation, this analysis allows for the study of the 
capture probability as a function of the distance travelled within the channel. As shown in the 
insert of Figure 1.11a, two different regimes can be identified when a particle is injected into the 
detection channel. First, it is transported by the parabolic flow, while magnetophoretically at-
tracted to the bottom of the channel by the external magnetic field. We refer to this as the “land-
ing” regime. The graph of Figure 1.11a shows the fraction of the large particle population that has 
reached the substrate as a function of the distance in the microchannel for our typical experi-
mental conditions (see subsection 1.5.5 for details of the model calculation). Once a particle has 
“landed” on the substrate, the scanning mechanism starts, during which the former slides over 
the surface of the substrate, at a speed v0~0.8-1 mm/s for our typical experimental conditions, 
until it is eventually captured by a small particle dot.  
Figure 1.11b shows the experimental fraction of large particles captured as a function of the chan-
nel distance, for different concentrations of TNF-α molecules spiked in FBS. To emphasize the ca-
pability of the device for detection of very low amounts of target molecules, we report, instead of 
the concentration, the number of molecules present in the 5 µL sample injected in the chip NAg. 
The fraction of large particles is experimentally obtained by simply counting the number of parti-
cles present on each 250 µm long section of the small particle dot pattern (see Figure 1.10e). As 
 
Figure 1.11 | Study of the particle capture efficiency vs. length of the channel. (a) Calculation of the frac-
tion of the large particles that have landed on the substrate as a function of the distance in the microchannel 
for our standard experimental conditions. Insert: schematic illustration of the “landing” and “sliding” re-
gimes of a large particle. (b) Experimental fraction of large particles captured as a function of the channel 
distance, for different concentrations of TNF-α molecules spiked in FBS under our standard experimental 
conditions. (c) Slopes obtained from the experimental curves shown in (b) as a function of the number of 
Ag molecules. The full line shows a fit of the experimental data with the model established in Equation 
(1.24). 
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expected, this fraction increases linearly with distance, and the slope of this line increases with 
NAg. In our experiments, the captured fraction vs. distance curves show an initial offset at the 
beginning of the sensing region (i.e. a non-zero fraction at x=0 mm on Figure 1.11b), increasing 
with NAg. This offset can be explained by the important number of large particles that have landed 
in the micro-channel region upstream of the small particle landscape and are moving over the 
substrate. Upon their encounter with the first small particle detection section, a relatively high 
amount of large particles is therefore initially captured.  
The curves of Figure 1.11b are linearly fitted and the slope (≡ slope(NAg)) of these fits is presented 
as a function of NAg in Figure 1.11c. Very strikingly, the dependence of slope(NAg) on NAg is strongly 
sub-linear, i.e. lower concentrations are much more effectively detected than higher ones. We 
will see in the next section that the physical quantity slope(NAg) can be conveniently used to quan-
tify Pcapture. Furthermore, the result output(NAg) of our assay, defined as the fraction of all injected 
large particles captured over the ten small particle detection sections, is found in good approxi-
mation to be proportional to slope(NAg).  The coefficient of proportionality was evaluated as 
4.4±0.5 mm (for the 5 datasets corresponding to concentrations above the LOD, average ± stand-
ard deviation (SD)). The variation of this coefficient is found to be very small (about 11% of the 
average) over the 8 orders of magnitude considered in our assay. 1.4.5 Random walk description of the scanning process 
In agreement with previously reported results [55, 56], we assume that the binding probability of 
the large particle Pb(l), as a function of the distance l travelled in the microchannel along the small 
particle landscape, satisfies a 1st order reaction kinetics law: 
𝑃𝑃𝑎𝑎(𝑙𝑙) = 𝑃𝑃0 �1 − 𝑒𝑒−𝑙𝑙 𝐿𝐿� � (1.16) 
where L is the characteristic distance of successful binding and P0 the probability of binding for a 
large particle for 𝑙𝑙 → +∞. The factor 𝑃𝑃0 ≤ 1 can be evaluated from the geometry of the system, 
and can be approximated by η, the ratio of the large particle surface accessible to scanning to the 
small particle dots to its total surface (see above). The data of Figure 1.11b show that we are in 
the linear part of the function of Equation (1.16), i.e. l<< L, and that Pb(l) can be approximated by 
the quantity P0 l/L. This fact is also confirmed by the low fraction (< 2%) of particles captured over 
the length of the channel. The linear-like curves shown in Figure 1.11b also allows one to relate 
the variations of slope(NAg) (i.e. the captured fraction vs. l) to Pb(l) and hence to the inverse of the 
characteristic length L. As the particle is moving at an average speed v0 in between the small par-
ticle dots, the value of L can be related to a characteristic binding time τ ≡ 𝐿𝐿 𝑣𝑣0⁄ , so that slope(NAg) 
and Equation (1.16) can be readily expressed as function of time.  
The interactions between the large particle and the immobilized small particle dots can be ap-
proximated by a random walk of the contact point over the surface of the large particle, as illus-
trated in Figure 1.12a. This stochastic displacement is assumed to stop when the point of contact 
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between a large and a small particle coincides with the position of an Ag bound to the large par-
ticle. Mathematically, the mean first passage time (tMFP) for a point randomly walking over the 
surface of a sphere from a starting point to a target position can be generally expressed as [57] 
𝑡𝑡𝑀𝑀𝑀𝑀𝑀𝑀 ∝ 𝐴𝐴 + 𝐵𝐵 𝑙𝑙𝑙𝑙(𝑑𝑑) (1.17) 
where d is a dimensionless distance separating the starting point of the walk on the sphere from 
its target position, and A and B are constants depending on the scales of the system. Additionally, 
it can be proven that the factor A is significant only for low d [57]. We therefore formulate the 
assumption that the contribution of A can be neglected, in agreement with the observation that 
Pb(l) is low (L is large), and hence the random walk length d necessary to encounter an Ag is large 
as well. This approximation is highly suited for low densities of bound Ags on the large particle 
surface, and especially for single molecule detection. The distance d can be approximated by con-
sidering the optimal uniform distribution of NAg,bound points, which correspond to locations of Ags 
bound on the surface of a sphere. We assume here a homogeneous distribution of Ag over the 
surface of the particle with radius rlarge. In this case, it can be demonstrated that [58, 59]  
𝑑𝑑~ �8𝜋𝜋
√3�1 2⁄ 𝑟𝑟𝑙𝑙𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐�𝑁𝑁𝐴𝐴𝑚𝑚,𝑎𝑎𝑑𝑑𝑐𝑐𝑛𝑛𝑑𝑑 (1.18) 
and hence that 
𝑡𝑡𝑀𝑀𝑀𝑀𝑀𝑀 ∝ 𝑙𝑙𝑙𝑙 (𝛾𝛾′ 𝑁𝑁𝐴𝐴𝑚𝑚,𝑎𝑎𝑑𝑑𝑐𝑐𝑛𝑛𝑑𝑑) (1.19) 
where γ’ is a constant. To express NAg,bound as a function of NAg, we assume a Langmuir relationship 
between these two values [60, 61], with α being a constant and NAg,bound max the maximum number 
of Ag that can be bound to the particle surface: 
𝑁𝑁𝐴𝐴𝑚𝑚,𝑎𝑎𝑑𝑑𝑐𝑐𝑛𝑛𝑑𝑑 = 𝑁𝑁𝐴𝐴𝑚𝑚,𝑎𝑎𝑑𝑑𝑐𝑐𝑛𝑛𝑑𝑑 𝑚𝑚𝑚𝑚𝑚𝑚 𝛼𝛼𝑁𝑁𝐴𝐴𝑚𝑚1 + 𝛼𝛼𝑁𝑁𝐴𝐴𝑚𝑚 ∝ 𝛼𝛼𝑁𝑁𝐴𝐴𝑚𝑚1 + 𝛼𝛼𝑁𝑁𝐴𝐴𝑚𝑚 (1.20) 
 
Figure 1.12 | Random walk description of the particle scanning. (a) Schematic representation of the ran-
dom walk modeling approach: the contact point between large and small beads describes a random-walk 
on the surface of the large beads, from the initial contact point to the location of a captured ligand molecule. 
(b) Calculation of the large bead coverage of captured ligand molecules, assuming a Langmuir relationship 
for molecule capture, and different values of the parameter α (10-3, 10-6 and 10-9 molecule-1).  
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The Langmuir relationship typically describes the amount of molecules adsorbed onto a surface in 
equilibrium with a solution of known concentration. For low amounts of Ag molecules, the relation 
between the amount of free and bound Ag is linear. Above a certain concentration of Ag, the 
response saturates, as all the possible adsorption sites are occupied. Figure 1.12b shows profiles 
obtained from Equation (1.20) for different values for α. The Langmuir equation shows a sigmoid 
shape when displayed with a logarithmic abscissa axis. In this case, the parameter α controls the 
Ag concentration at which the system switches from the linear to the saturated response. It largely 
accounts for the affinity of the ligand to the receptor as well as the mixing efficiency in the chip. 
The system saturates at lower Ag concentrations for larger α values. 
Finally, tMFP can be expressed as a function of the experiment-derived time τ. To do so, we define 
the instantaneous capture probability pc(t), i.e. the probability that the particle is captured exactly  
at the time t. The latter is by definition the probability density function of Pb(t) : 
𝑝𝑝𝑐𝑐(𝑡𝑡) ≡ 𝑑𝑑𝑃𝑃𝑎𝑎𝑑𝑑𝑡𝑡 (𝑡𝑡) (1.21) 
As we assumed that the random walk stops when the point of contact between a large and a small 
particle coincides with the position of an Ag bound to the large particle, the first passage of this 
point of contact at the position of an Ag will result in the binding of the large particle. Hence, tMFP 
can be evaluated from pc(t) following 
𝑡𝑡𝑀𝑀𝑀𝑀𝑀𝑀 = � 𝑢𝑢 𝑝𝑝𝑐𝑐(𝑢𝑢)𝑑𝑑𝑢𝑢+∞
0
= � 𝑢𝑢 𝑑𝑑𝑃𝑃𝑎𝑎
𝑑𝑑𝑢𝑢
(𝑢𝑢)𝑑𝑑𝑢𝑢+∞
0
 (1.22) 
And, by solving the integral by partial integration, we find that 𝑡𝑡𝑀𝑀𝑀𝑀𝑀𝑀 = 𝑃𝑃0𝜏𝜏 and tMFP is directly 
proportional to τ. We can therefore write the following expression for slope(NAg): 
𝑠𝑠𝑙𝑙𝑠𝑠𝑝𝑝𝑒𝑒�𝑁𝑁𝐴𝐴𝑚𝑚� = 𝑃𝑃0𝐿𝐿 =  𝑃𝑃0𝜏𝜏 𝑣𝑣0 = 𝑃𝑃02𝑡𝑡𝑀𝑀𝑀𝑀𝑀𝑀 𝑣𝑣0 (1.23) 
As output(NAg) is proportional to slope(NAg), and using the expression for tMFP (Equation (1.22)), 
we can write that 
𝑠𝑠𝑢𝑢𝑡𝑡𝑝𝑝𝑢𝑢𝑡𝑡�𝑁𝑁𝐴𝐴𝑚𝑚� = 𝛽𝛽
𝑙𝑙𝑙𝑙 (𝛾𝛾 𝛼𝛼𝑁𝑁𝐴𝐴𝑚𝑚1 + 𝛼𝛼𝑁𝑁𝐴𝐴𝑚𝑚) (1.24) 
where β and γ are constants. For NAg=0, an output value of 0 is obtained. 
This analysis shows that α, which is obtained from the Langmuir equation, controls the concen-
tration from which the Ag coverage over the bead is sufficiently high, so that the assumption l<< 
L is not satisfied anymore. As shown in Figure 1.13a, the curves actually diverge towards +∞ for 
𝑁𝑁𝐴𝐴𝑚𝑚 = 1 (𝛾𝛾 − 1)𝛼𝛼⁄ . The parameter therefore accounts for the binding affinity and the mixing ef-
ficacy in the system. The effect of the negative parameter β is shown in Figure 1.13b. Here, no 
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obvious effect can be observed, as this is merely a multiplication constant which scales the mag-
nitude of the response. More importantly, it is expected that this value depends on P0 and v0, from 
Equation (1.23), and more generally on the beads size. Indeed, through the intercept angle δ, 
these can modulate the surface of the large bead that is accessible to the small bead, and there-
fore the overall capture probability. This parameter also accounts for the random walk over the 
bead surface (Equation (1.17)). In this case, a slower random walk (or a larger tMFP) would indicate 
a larger parameter B in Equation (1.17), and a smaller β. This would result in a lower output, at 
fixed NAg. This also corresponds, qualitatively, to an increase in L. Finally, in the case of γ (Figure 
1.13c), a behavior similar to α is observed. High γ values induce a divergence of the curve for lower 
Nag. From Equation (1.19), γ accounts for the distribution of the ligands over the large bead surface 
(Equation (1.18)). It is therefore determined by the geometry of the large bead. Large γ values 
therefore indicate a faster saturation of the large bead surface with Ag because of a shorter inter-
adsorbed Ag distance d (Equations (1.18) and (1.19)). 
As stated above, this model is valid only for low Ag amounts. At higher concentrations, Equation 
(1.16) cannot be linearized anymore, and a different expression for the output(NAg) function is 
expected. Moreover, the Ag concentration is largely assumed to be a continuous function in the 
model, whereas it actually describes a low number of discrete molecules. The result from this fact 
is that the response of the system is discrete too. For instance, if only one Ag is injected, only two 
results can theoretically be obtained for output(NAg), 0 and 1/3500 (as 3500 large beads were 
injected). In this case, it is expected that the result obtained from output(NAg) would then be bet-
ter described by the average of several experiments. We can therefore speculate that, at very low 
Ag amounts, the output of the assay would be seen as a stochastic variable with two states (out-
put(NAg)= 0 and output(NAg)= 1/3500) and the model would return the expected value of this ran-
dom variable. Technically, this case was not encountered in our analysis, as the LOD of the assay 
was found to be ~200 Ag and the signal obtained for this value is at least an order of magnitude 
above 1/3500. 
 
Figure 1.13 | Analysis of the model fitting parameters. Plots of the function describing the assay readout 
(Equation (1.24)), for different values of the fitting parameters (a) α is a parameter, β= -0.15, γ =2.6, (b) β is 
a parameter, α= 1.3x10-12 molecule-1, γ=2.6, and (c) γ is a parameter, β= -0.15 and α= 1.3x10-12 molecule-1. 
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1.4.6 Explanation of protein detection experiments 
The biotin/streptavidin binding experiments performed in FBS can be now fitted with Equation 
(1.24), as shown on Figure 1.14a. Furthermore, the data obtained for the detection of TNF-α in 
FBS are also fit with this model (Figure 1.14b). The different values obtained from the fitting, i.e. 
the parameters α, β and γ and the maximum coverage of the particles over the range of concen-
trations considered in the experiment, as described by the Langmuir equation, are presented in 
Table 1.1. The critical factor for this fitting, the Langmuir adsorption constant α, is found to be 
much higher for the biotin/streptavidin ligand/receptor system than the one computed above for 
the TNF-α system (Table 1.1). This result is in good agreement with the very high binding affinity 
of biotin to streptavidin, in comparison to an Ag/Ab system. Table 1.1 shows, in addition to the fit 
parameters, some representative dissociation constants KD reported in the literature for the dif-
ferent systems detailed in this study. As mentioned above, α is an indicator of the efficacy of the 
Ag binding. A high α and a low KD indicate a high binding affinity, as observed from the values 
shown on Table 1.1. Furthermore, the low values found for α are still in good agreement with the 
central assumption in the random walk model, i.e. that the coverage of Ag on the large particle 
surface is low. This guarantees that the system is far from saturation, and that Equation (1.16) can 
be approximated by a linear behavior. 
 It is interesting to compare our protein detection method with other magnetic particle-based 
techniques. Several recent reports have highlighted the capabilities of magnetic micro- and nano-
particles as carriers of the Ag or as detection labels for sensitive analyses [23, 24]. In a first class 
of devices, the Ag are initially bound to the surface of a microchannel, and are then detected by 
injecting Ab-labeled particles (“Ag on substrate”, see Figure 1.15). Other devices, like the one dis-
cussed here, present the specificity of tethering the Ag of interest on the particles and bringing 
the latter to the detection area by a microfluidic flow (“Ag on particles”). First of all, both ap-
proaches of these so-called “surface coverage” assays have resulted in an extremely low limit of 
detection. However, by comparing the dose-response curves, obtained over similar ranges of con-
centrations for these two types of devices (“Ag on substrate” vs “Ag on particles”), different be-
haviors have been observed. 
 
Figure 1.14 | Explanation of the assay dose-response curves. Experimental data for the detection of (a) 
biotinylated anti-streptavidin and (b) TNF-α in FBS (n= 3-4, the error bars are SD), with the corresponding 
fitting curves. The solid lines are fit to the experimental values following the expression for output(NAg) 
detailed in Equation (1.24). The R2 values are 0.99 and 0.86 for the fittings of the biotin/streptavidin and 
TNF-α datasets, respectively. 
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In the ‘Ag on substrate’ setup (Figure 1.15), the Ag is bound to the bottom of a channel. Here, the 
detection process can be reduced to particles scanning linearly the surface of the channel, until 
they encounter an Ag. At low Ag concentrations, if enough particles have passed in the channel, 
so that all the adsorbed Ag are detected, the output is the amount of particles adsorbed onto the 
surface. As a consequence, the calibration curve is an adsorption isotherm, such as the Langmuir 
equation described on Equation (1.20). Interestingly, for this type of device, the concentration 
response drawn over a logarithmic scale typically is a sigmoid saturating at high concentrations 
[33, 64]. We note that a sigmoid is a good approximation of a Langmuir isotherm on a logarithmic 
scale. The flattening of the curve typically limits the capabilities of these chips at very high con-
centrations. For a Langmuir adsorption isotherm, this saturation theoretically occurs for concen-
trations larger than 1/α (where α is the Langmuir constant from Equation (1.20)). It is important 
to note that the 1/α parameter is actually setup-dependent. As seen from the curves shown in 
refs. [33, 64], the 1/α value is quite low in this type of devices (below 1010 Ag). The plateau, on the 
right side of the sigmoid, can be observed on the same range of concentrations considered in our 
device, indicating concentrations above the 1/α limit. However, for comparable ranges of concen-
trations, the “Ag on particles” setup is not saturating, even at the highest concentration consid-
ered, which are still below their 1/α limit (Table 1.1). This phenomenon is beneficial for widening 
the dynamic range of the device, and stems from the sub-saturation coverage of the Ag on the 
large magnetic particles. The regime of this device is therefore sub-linear, but saturation of the 
output will nevertheless occur if NAg exceeds 1/α. Furthermore, the particle surface scanning pro-
cess, described extensively before, is expected to improve the behavior of the device especially at 
low Ag surface coverage, as indicated by the graphical representation of Pcapture (Figure 1.10f), and 
by the comparison of Equation (1.7) and (1.12). It is important to notice that, for both geometries, 
the dose-response curves are expected to flatten for extremely high concentrations. This can be 
due to saturation of the binding sites or steric hindrance effects and is taken into account by the 
adsorption isotherm, present in the two different designs, describing the binding of the free Ag to 
their substrate. Also, in this high concentration limit, steric hindrance related to the size of the 
large particle will comparatively limit the efficiency of substrate binding as, above a certain Ag 
concentration on the surface of a large particle, not all Ags can contribute in improving the binding 
efficiency of the particle. 
Table 1.1 | Fitting parameters obtained from the data shown in Figure 1.14. The “maximum coverage” 
parameter shows the maximum fraction of the surface of the large particle covered by Ag over the experi-
mental concentration range, assuming that this value follows a Langmuir isotherm dependence over NAg. 
Some representative values of the dissociation constants KD of these ligand-receptor systems are also re-
ported for comparison. 
System α / molecule-1 β / a.u. γ / a.u. 
Maximum 
coverage 
KD / M 
Biotin/ strep-
tavidin in FBS 
1.3x10-12 -1.5x10-1 2.6 2.5x10-3 4x10-14 from ref. [62] 
TNF-α in FBS 3.6x10-14 -1.6x10-1 1.3x10-1 6.4x10-4 
2.2x10-9 – 7.8 x10-9 
from ref. [63] 
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1.5 Materials and Methods 1.5.1 Chemicals and materials 
4-inch 550 µm thick Si and float glass wafers, de-ionized water (DIW) were obtained from the 
Center of Micro- and Nanotechnology of EPFL. GM 1075 SU-8 negative photoresist was purchased 
from Gersteltec (Pully, Switzerland). AZ ECI 3027 positive photoresist was purchased from AZ Elec-
tronic Materials (Wiesbaden, Germany). PDMS Sylgard 184 was acquired from Dow Corning (Wies-
baden, Germany). 1 mL borosilicate H-TLL-PE syringes were purchased from Innovative Labor Sys-
teme (Stutzerbach, Germany). Micro-line ethyl vinyl acetate tube with 0.51 mm inner and 1.52 
mm outside diameters was bought from Fisher Scientific (Wohlen, Switzerland). Neodymium mag-
nets were acquired from Webcraft (Uster, Switzerland): (i) disc magnets with 6 mm diameter, 2 
mm thickness (product no: S-06-02-N, magnet-magnet attraction force: ~ 10 N); (ii) disc magnets 
with 10 mm diameter, 3 mm thickness (product no: S-10-03-N, magnet-magnet attraction force: 
~ 18 N); (iii) ring magnets with 4 mm inner and 10 mm outer diameters, 5 mm thickness (product 
no: R-10-04-05-N, magnet-magnet attraction force: ~ 25 N ) The APTES solution (product no. 
440140), Phosphate Buffered Saline (PBS) 10x concentrate solution (product no. 5493), Tween-20 
(product no. 1379) and biotin (product no. B4501) were purchased from Sigma-Aldrich (Buchs, 
Switzerland). Dynabeads MyOne Streptavidin C1 (small particles), Dynabeads M-280 Streptavidin 
(large particles), recombinant mouse TNF-α, biotinylated polyclonal rabbit Ab specific to mouse 
TNF-α and FBS dialyzed were purchased from Life Technologies (Zug, Switzerland). Biotinylated 
goat anti-streptavidin and streptavidin were obtained from Vector Laboratories (Reactolab SA, 
Servion, Switzerland). Fetal Bovine Serum (FBS) standard quality was bought from PAA Laborato-
ries (Chemie Brunschwig AG, Basel, Switzerland) and Pluronic F-127 was purchased from BASF 
(Basel, Switzerland). A PBS (0.15 M NaCl, 0.01 M phosphate, pH 7.4) solution was prepared by 
diluting a PBS 10x concentrate solution. PBS-Tween 1% solution was made by diluting 1% (volume 
/ volume) Tween-20 in PBS. A buffer solution was prepared by diluting 0.08% (weight/volume) 
 
Figure 1.15 | Principle of the “Ag on substrate” magnetic particle-based system. The target Ag molecules 
are bound on the substrate and Ab-functionalized large particles scan the surface for detection. Counting 
of the immobilized particles quantifies the number of ligand-receptor bindings and hence the Ag concen-
tration on the surface.  
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Pluronic F127 in PBS. To reach Ag concentration levels used in the experiments, the biotinylated 
anti-streptavidin was diluted in PBS or FBS dialyzed and mouse TNF-α was prepared in FBS stand-
ard quality. 1.5.2 Fabrication of the glass detection chip via electrostatic self-assembly of mag-netic particles 
0.6 µm thick AZ ECI 1512 photoresist was patterned on a glass wafer using standard photolithog-
raphy techniques [40].The pattern features a 250 μm x 2.5 mm area containing ~8000 dots, 1 μm 
in diameter, with a 10 μm inter-distance between adjacent dots. The wafer was diced into chips 
with 28 mm × 25 mm area. The chip surface was activated in air plasma for 40 s at 12 W and 1 
mbar pressure. 1 % (volume / volume) APTES solution diluted in DIW was spin-coated at 5000 rpm. 
The chip was baked at 100°C for 10 min. The resist was ultrasonically removed in acetone for 2 
min. The chip having a pattern of 1.5 µm APTES dots was stored at -18°C until further use. For 
small particle patterning, the chip was reversibly bonded to a dedicated PDMS chip, containing a 
microfluidic channel with 60 µm height and 500 µm width. The glass detection chip and this PDMS 
chip were tightly clamped for leak-proof sealing. For electrostatic binding of the small particles to 
the APTES dot pattern, a 10 µL solution of small particles was introduced inside the microfluidic 
channel at a 150 nL s-1 flow rate using a syringe pump. Hereafter, a 30 µL PBST 1% washing step 
was conducted at 5 µL s-1. Finally, the glass detection chip was separated from the PDMS and was 
ready to be clamped to the PDMS microfluidic chip. 1.5.3 Fabrication of the microfluidic chip for the experimental analysis of the mag-netic-particle scanning 
PDMS microchannels were replicated using SU-8 microstructures on Si wafers. First a 60 µm-thick 
SU-8 layer was patterned through photolithography processes. Liquid PDMS mixture (10:1 
base:cross-linker weight ratio) was degassed, poured on the SU-8 mold and cured at 100 °C for 1 
h. The cured PDMS layer was peeled off from the mold and the fluid injection holes were punched 
through the chip. The PDMS chip was then surface-activated with air plasma at 12 W for 1 min, 
together with a glass support, to which the PDMS was successively bonded. For experiments with 
magnetic particles patterned on APTES (i.e. glass detection chips), the cured PDMS piece was in-
stead clamped to the glass substrate by using a custom-made polymethylmetacrylate (PMMA) 
holder. PDMS channels used for these analyses size 60 µm in height and 250 µm in width. 1.5.4 Magneto-microfluidic setup for the experimental analysis of the magnetic-par-ticle scanning 
1 µm-diameter superparamagnetic particles were randomly patterned at the bottom of the mi-
crofluidic channel by strong unspecific adsorption on the glass substrate. A ring magnet (10 mm 
outer diameter, 4 mm inner diameter, 5 mm height) was positioned below the microfluidic chip, 
at 10 mm distance from the channel bottom, by using a custom-built PMMA holder. This resulted 
in a constant vertical field induction Bext,z = 30 mT over the substrate detection zone at the level of 
the immobilized particles, as measured via Gauss meter and simulated by FEM. The full assembly 
was flipped upside down and positioned on the stage of an inverted microscope (Zeiss Axiovert 
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S100), to allow light transmission through the ring magnet and light collection from below the 
chip, via a high magnification objective (LD EC Epiplan-Neofluar, 50x, Zeiss). The flow manipulation 
in the microfluidic channel was performed by precision syringe pumps (Nemesys, Cetoni, Korbus-
sen, Germany). 3 µm-diameter superparamagnetic particles were diluted in buffer solution to a 
final concentration of 0.01 mg (~7 × 104) particles per mL. The particle suspension was then in-
jected in the microchannel at 100 nL/s flow rate. High-speed camera tracking (MC-1363 camera, 
Mikrotron, Unterschleissheim, Germany) was used to accurately monitor individual particles dur-
ing their transport in the microchannel, at 1200 frames-per-second rate. The gradient of the ex-
ternal magnetic field in the direction normal to the substrate plane resulted in the effective mag-
netophoretic attraction of the particles towards the glass substrate. The field intensity was chosen 
to be weak enough not to capture large particles on the glass surface, where they could hence still 
move and being transported by the flow across the small particle pattern. Image analyses were 
performed using the ImageJ software (Bethesda, Maryland, USA).  1.5.5 3D particle tracking in the magneto-microfluidic chip  
Magnetophoretic separation of magnetic particles in microfluidic channels has been previously 
explored both experimentally and via numerical calculations [65]. The transport of superparamag-
netic particles through a two-dimensional potential energy landscape has been empirically and 
numerically studied as well [66]. In this work, however, we propose a new versatile simulation 
method, which allows predicting and analyzing both these phenomena with the same approach. 
Our method is based on three main steps: (i) a finite element method (FEM) calculation of the 3D 
magnetic field landscape using COMSOL 4.2a software (COMSOL Multiphysics, Zürich, Switzer-
land); (ii) a FEM calculation of the 3D velocity distribution in the microfluidic flow, using COMSOL 
4.2a; (iii) importing the magnetic and fluidic results in Matlab (Mathworks, Natick MA, USA), for 
the analytical calculation of the magnetic particle trajectories. Specifically, to construct the large 
particle trajectories reported in Figure 1.10b-c, the values of magnetic induction in the presence 
of the small particle pattern are first simulated by FEM (see Figure 1.7b). Discrete values of mag-
netic flux density components are extracted in a 3D grid format (with 200 nm spacing between 
adjacent points) and imported in Matlab, where intermediate values inside the grid can be ob-
tained by 3D interpolations among adjacent points. A zoom on the central portion of the channel 
is considered, and a flow velocity v of about 1 mm/s is calculated via FEM over the whole selected 
area, for the portion of the fluid in proximity of the small particle pattern, where the large particles 
are flowing. The magnetophoretic velocity of a large particle at each specific location is succes-
sively calculated on Matlab, by imposing instantaneous equilibrium between magnetic and drag 
forces acting on the particle. A few trajectories for different particles are iteratively traced, with a 
sampling time of 1 µs, by tracking particle positions and recalculating velocities at every step. The 
same approach is employed to simulate the magnetophoretic attraction of the particles towards 
the glass substrate upon their injection in the microfluidic channel (Figure 1.11a). The magnetic 
induction distribution inside the full microchannel volume in the presence of the permanent mag-
net is calculated via COMSOL, as well as the fluidic flow profile. Discrete values of magnetic flux 
density components in the 3D microchannel space are then imported in Matlab, together with the 
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values of the local fluid velocity components. Trajectories for large particles entering the channel 
at different locations are iteratively traced, with a sampling time of 1 µs (Figure 1.16a). 
In our assay, only the central region along the microchannel width (from 50 µm to 200 µm on 
Figure 1.16b), corresponding to flow velocities higher than 90% of the maximum velocity, was 
considered for the particle counting. From the 3D tracking presented here, we evaluate than only 
~22% of the large particles enter in contact with this area and are therefore potentially taken into 
account for the Ag detection. As detailed in the main text, for the lowest concentration of Ag 
detected (about 200 molecules), about 0.5 % of the 3,500 large particles, i.e. ~18 large particles, 
are captured on this region. If we now assume that all the large particles, instead of only 22 % of 
the total number, were to land on this detection zone, this would mean that about 80 large parti-
cles would be captured, corresponding to the detection of 80 single molecules out of 200. This 
fact further emphasizes the capabilities of our technique at low Ag concentration. 1.6 Conclusions 
We presented a novel magnetic bead surface coverage assay, in which “large” (2.8 μm) antibody 
(Ab)-functionalized magnetic beads captured their antigen (Ag) from a serum and these Ag-carry-
ing beads were subsequently exposed to a surface pattern of fixed “small” (1.0 μm) Ab-coated 
magnetic beads. When the system was placed in a magnetic field, the magnet dipole attractive 
interactions between the two bead types were used as a handle to approach both bead surfaces 
and assist with the Ag-Ab immunocomplex formation, while unspecific binding (in absence of an 
Ag) of a large bead was limited by the viscous drag forces in the microfluidic flow. Despite the fact 
that this novel immunoassay technique showed unprecedented performance, an extensive un-
derstanding of its enhanced specificity and sensitivity were still lacking. Therefore, a predictive 
 
Figure 1.16 | Simulated 3D trajectories of superparamagnetic particles. (a) Magnetophoretic trajectories 
of 9 large particles entering the microfluidic channel at different locations, as iteratively traced by employing 
our 3D particle tracking approach, for our standard experimental conditions.  (b) Projection of the large 
particle trajectories on the channel inlet section. The trajectories of particles entering the channel at each 
possible position are simulated to predict their landing location inside the microchannel.   If a homogeneous 
distribution of particles is assumed at the channel inlet, this simulation directly allows estimating the num-
ber of particles effectively reaching the detection area (Figure 1.11a). 
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model for the engineering and optimization of this type of assay was highly desirable, as it would 
have become the key towards a further assay development and exploitation.  
We first focused on the understanding and enhancement of the assay specificity, mainly aiming 
at optimizing the main parameters of the assay ptotocol (i.e.: magnetic fields, flow rates,…), to 
minimize its background noise signal. By combining FEM simulations with analytical calculations, 
we built a predictive model of the force balance acting on the two types of superparamagnetic 
beads employed in our method. We demonstrated that the fine-tuning of magnetic dipolar and 
microfluidic viscous forces acting on the microparticles represents the key for extremely selective 
protein detection in our assay. The dynamic nature of the detection method is moreover believed 
to be crucial, as well. Thanks to our model, in fact, the perfect balance between magnetic dipolar 
and viscous forces could be set during the whole assay time, so that Ag-carrying beads do not have 
to be first immobilized and then washed out of the detection area to eliminate the unspecifically 
adsorbed ones. This dynamic way of operating, where the “washing step” occurs somehow at the 
same time of the immunocomplex formation itself, allows not only minimizing unspeficic Ag-Ab 
binding, but also reducing the overall assay time and complexity. These results were confirmed by 
experimental observations.   
In a second phase of the project, we dealt with a more sophisticated modeling of the assay, where 
the whole 3D motion of the microparticles was considered, to enhance the probability of specific 
immunocomplex formation and, hence, further increase the assay sensitivity. In this context, we 
introduced and investigated the principle of “magnetic particle-scanning” for on-chip detection of 
biomolecules. We experimentally observed this phenomenon in a new custom-built magneto-mi-
crofluidic chip and theoretically described it by a random walk model. This analysis emphasizes 
the basic mechanisms controlling our type of assay. As the ligand and receptors are bound to 
surfaces, it is critical to increase the probability that they encounter each other, thus triggering 
recognition and a capture event. Simulating the trajectory of the point of contact with a random 
walk can account well for the behavior of the system. This fact also suggests that the working 
principle of the whole immunoassay can, under certain assumptions, be reduced to this stochastic 
motion of the contact point. Our model shows that magnetic particle-scanning results in a very 
high probability of immunocomplex formation for very low Ag concentrations, which directly 
translates into an extremely low limit of detection, down to the single molecule-per-particle level. 
On the other hand, for high Ag concentration the binding efficiency is lowered, which is key to the 
large dynamic range of the dose-response curves. This new modelling approach finally allowed to 
fully understand key unexplained features of the dose-response curves of our assay:  (i) its ability 
to detect an output signal (i.e. the bead number count) for extremely low Ag concentrations, and 
(ii) an output signal of the assay that was non-linear with respect to the Ag concentration. Our full 
theoretical description resulted in the accurate fit of experimental dose-response curves obtained 
previously for two different ligand-receptor systems (biotin/streptavidin and anti-TNF-α/TNF-α).   
Our modeling tools moreover allowed better understanding the behavior of other types of parti-
cle-based heterogeneous immunoassays, which also exhibited very low limits of detection. Several 
so-called “magnetic surface coverage immunoassays” based on fluidic flow discrimination have in 
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fact recently shown extreme sensitivity [1, 3, 19]. We can now assert that this may be related to 
the possibility of fine-tuning immunocomplex-induced binding forces between the magnetic 
beads and the surface, and viscous drag forces induced by the flow that remove/wash non-specif-
ically attached beads from the substrate. Also the rapid and dynamic extraction of target Ags from 
the raw sample, and subsequently processing the magnetic beads in clean buffer solution is in 
favour of reproducibility and accuracy of an assay. Although ultrasensitive protein detection has 
been demonstrated generally at the cost of more complex and sophisticated assay principles and 
protocols, we think that the mentioned magnetic bead surface coverage assays will provide inter-
esting options for the development of future sensitive and accurate immunoassays. Besides sen-
sitivity, robustness, low-cost, large dynamic range, accuracy and multiplexing capability are other 
important criteria that will determine the success of such analytical system, and these mostly out-
standing issues will have to be addressed in future.  
Overall, we therefore think that, despite the specific nature of the magnetic particle scanning prin-
ciple we proposed, our analysis has wider application potential and will be helpful for designing 
and explaining new types of on-chip surface coverage immunoassays, which exploit the binding 
of a particle to a substrate via an Ag. 
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 Microwell templates for lens-array and cell-array self-assembly 
Abstract We propose a novel versatile method for the rapid and versatile fabrication of 
arrays of microspheres to be used as lenses of desired geometry and optical properties. Our 
method is based on the electrostatic self-assembly of dielectric microspheres in Parylene-C/glass 
well templates, with the array geometry patterned in the Parylene-C layer via standard microfab-
rication techniques. While different particle sizes and materials can be used to tune the light fo-
cusing properties of the microlenses, we demonstrate here a process that uses 3 μm size mela-
mine spheres. We use optical tweezers to assess the electrostatic nature of the microsphere bind-
ing mechanism by manipulating the patterned spheres. We demonstrate that our method ensures 
extremely fast and reliable array formation and offers moreover the possibility to reversibly as-
semble and disassemble the lens array by tuning the pH of the microsphere patterning and wash-
ing solutions. We then successfully employ our self-assembled lens arrays to detect gold and flu-
orescent nanoparticles (NPs) during their motion in water-based medium, through a standard low 
magnification/low numerical aperture microscope objective. The same technique could also used 
for immunodetection of biomolecules immobilized on gold NPs in buffer and, in future, it may 
develop into a versatile tool to detect nanometric objects of environmental and biological im-
portance, such as toxic nanomaterials, viruses or other biological agents. An analogous self-as-
sembly strategy is then proposed for isolating yeast cells (Saccharomyces cerevisiae) in femtoliter 
wells for subsequent analyses within the microwell array at single-cell resolution. In this work, the 
single-cell patterning technique is combined with the use of a digital microfluidic (DMF) platform 
to create a tool for conducting studies on isolated non adherent cells in a high-throughput way 
and with enhanced spatio-temporal resolution. 
This chapter is an adapted version of the following publications: 
o M. Cornaglia, H. Yang, T. Lehnert, and M.A.M. Gijs. Electrostatic self-assembly of microsphere 
lens arrays. MNE 2014 - the 40th International Conference on Micro and Nano Engineering, 
Lausanne, Switzerland, September 2014. 
o H. Yang, M. Cornaglia, and M. A. M. Gijs, Photonic Nanojet Array for Fast Detection of Single 
Nanoparticles in a Flow. Nano Lett 15, 1730-1735, doi: 10.1021/Nl5044067 (2015) 
o P. Tewari Kumar, K. Vriens, M. Cornaglia, M. A. M. Gijs, T. Kokalj, K. Thevissen, A. Geeraerd, 
B.P.A. Cammue, R. Puers and J. Lammertyn, Digital microfluidics for time-resolved cytotoxicity 
studies on single non-adherent yeast cells. Lab Chip, doi: 10.1039/C4LC01469C (2015) 
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2.1 Introduction 
Different methods for the fabrication of microlenses and microlens arrays have been developed 
in the last years, reflecting the key role of optics, opto-electronics and photonic systems at en-
hancing the performance of communication, processing, sensing and display systems [67]. Most 
of these techniques are however rather expensive, time-consuming and definitely not suitable or 
versatile enough for fast prototyping of lab-on-a-chip systems. Furthermore, considerable interest 
recently arose for high-resolution sensing systems that can detect nano-objects and even individ-
ual molecules in liquids [68, 69]. Advanced optical techniques have been proposed for sensitive 
detection of nano-objects, but typically required high-end, expensive, and bulky experimental set-
ups [70, 71]. If direct optical detection of NPs in liquids could be possible using a standard micro-
scope, this would lead to more affordable and portable sensing applications. However, conven-
tional optics only permits detecting relatively large objects, because the scattered light intensity 
decreases with decreasing size and the light collection capability of a standard microscope objec-
tive is limited by its numerical aperture (NA) [72]. Therefore only NPs that are either larger than 
several hundred nanometers or having extremely enhanced scattering probability can be de-
tected. While a microsphere is known to act as a focusing microlens [73], when it has a refractive 
index contrast relative to the fluid medium that is less than 2:1 and a diameter between several 
to tens of wavelengths (λ), a highly-focused propagating beam from the shadow-side surface of 
the microsphere is generated due to constructive interference of the light field [74]. This beam is 
termed as “photonic nanojet” and has a sub-λ full-width-at-half-maximum (FWHM) transverse 
dimension and typically is several λ in length. A very interesting predicted property of a photonic 
nanojet is that the presence of a particle, much smaller than λ and positioned within the nanojet, 
significantly enhances back-scattering of the light through the microsphere. High-refractive index 
microspheres embedded in a PDMS medium containing dispersed 50 nm size gold NPs confirmed 
a back-scattering intensity two times larger than that caused by the isolated microsphere itself 
indeed [75]. If appropriate microspheres could be integrated into microfluidic devices for direct 
detection of objects with a dimension much smaller than λ, this could be of high interest for many 
environmental and biological sensing applications.  
Yang et al. [76] recently demonstrated the use of 3 and 9.75 μm dielectric microspheres as in situ 
lenses for the enhancement of fluorescent signals for on-chip immunoassays (Figure 2.1a). In their 
system, fluorescent immunocomplexes were built by successive incubation steps on APTES micro-
structures, which were patterned on a glass substrate, at the bottom of a microfluidic channel. 
Microparticles were then carefully positioned on top of the immunocomplexes for signal amplifi-
cation, by transporting them through the microfluidic channel via a 2 nL/s flow. Such a very low 
flow rate value had to be used to allow the particles’ temporary immobilization on top of the 
patterned microstructures by weak electrostatic interactions with the APTES features themselves. 
For direct nanoparticle observation within the microfluidic flow, a more robust and versatile 
method for the on-chip microsphere integration was however highly desirable. Among other tech-
niques for particle micropatterning, an interesting approach was recently proposed by Witters et 
al. [77]. In their method, a droplet containing the microparticles to be immobilized is transported 
multiple times above a microwell array, by means of electrostatic droplet actuation on a DMF 
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platform (Figure 2.1b). As the microwell size is designed to host single microparticles, this tech-
nique ideally allows “printing” isolated particles over the whole array area. However, a relatively 
low patterning efficiency was observed in absence of additional forces pulling the particles to-
wards the microwells’ side. High loading yield was only demonstrated for magnetic beads, in com-
bination with external magnetic forces, while the patterning of dielectric particles still remained 
an open question. 
To provide an answer to the aforementioned needs, we developed a new method for rapid and 
versatile fabrication of dielectric microsphere arrays at the bottom of microfluidic channels. Our 
technique relies on the electrostatic self-assembly of the microspheres in a microfabricated 
Parylene-C template on a glass substrate.  The chip was then illuminated through an optical mi-
croscope for the generation of photonic nanojets in the microfluidic medium, where we tested 
the capability of our device of detecting moving NPs. Furthermore, we managed to generalize our 
microsphere patterning method to create a more versatile technique for micro-arraying various 
entities of similar size, being them particles of different materials, shapes and properties or even 
single non-adherent cells.  
Such a technological development brought us at addressing another crucial biological question by 
means of our micro-arraying technique. An emerging need in the bio-medical research community 
is in fact represented by the development of platforms that support single-cell analysis of non-
adherent cells with high spatio-temporal resolution. The free-floating nature of non-adherent cells 
usually complicates their analysis with respect to the case of adherent cells. When large popula-
tions of non-adherent cells have to be studied at single-cell level, flow-cytometry is usually the 
preferred solution, which however does not allow obtaining data which are spatially and tempo-
rally resolved [78]. Moreover, only a few systems are currently available for precise positioning of 
non-adherent cells. Hence, many microfluidic-based solutions are currently being proposed as 
new tools for cell manipulation, by means of hydrodynamic forces [79, 80] or forces of other na-
ture, such as, for instance, electrical [81], optical [82] or gravitational [83]. Nevertheless, most of 
these solutions still suffer from a combination of drawbacks: (i) the demand for large sample and 
reagent consumption for cell manipulation and analysis; (ii) microchannel clogging events when 
 
Figure 2.1 | Microsphere optical properties and micropatterning technique. (a) Schematic representation 
of the use of microlenses for on-chip immunofluorescence amplification, as reported by Yang et al. (repro-
duced from [76]). Fluorescent immonocomplexes are immobilized onto APTES microstructures. Dielectric 
particles are then used as spherical microlenses to amplify the fluorescent signals, therefore enhancing the 
immunoassay sensitivity. (b) Schematic representation of the magnetic bead patterning technique de-
scribed by Witters et al. (reproduced from [77]). Beads are attracted inside a microwell array by an external 
magnetic field, while transported by a DMF actuated microfluidic droplet. 
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cell-rich samples have to be handled [84]; (iii) undesired biological effects, such as cell stresses, 
introduced by fluidic shear forces or other forces. To solve these issues, we developed a modified 
version of our microsphere self-assembly technique, which proved to be a new powerful tool to 
create micro-arrays of isolated non-adherent cells, for their study at high spatio-temporal resolu-
tion.  
2.2 Microlens arrays for single-nanoparticle detection 2.2.1 Microwell template fabrication 
Fused silica glass wafers (Ø4 in., 525 μm in thickness), photoresist AZ 1512, Parylene-C dimer, 
A174 silane and DIW were obtained from EPFL’s Center of MicroNanoTechnology. The main fab-
rication steps of the template are schematically illustrated in Figure 2.2. A transparent and color-
less layer (100 nm in thickness) of indium tin oxide (ITO, 90 wt% In2O3 and 10 wt% SnO2) was first 
 
Figure 2.2 | Microfabrication process flow for Parylene C/glass well templates. (i) ITO is deposited on the 
back-side of the glass wafer, followed by the deposition of (ii) Parylene-C and (iii) amorphous Si on the front-
side of the wafer. (iv) Photoresist is spin-coated on the wafer and (v) patterned by standard photolithogra-
phy processing. (vi) Amorphous Si is etched by a Cl2 plasma. (vii) The photoresist layer and Parylene-C are 
etched by an O2 plasma. (viii) The amorphous Si hard-mask is etched by a Cl2 plasma and the Parylene-C 
layer is treated by SF6 plasma to enhance its hydrophobicity. 
 
 
Figure 2.3 | Characterization of microfabricated array templates. (a) Micrograph of the microwell array 
template after fabrication. Microwells with a diameter of 3 μm are interspaced by 20 μm in both x- and y-
directions. (b,c) AFM measurement on a 3 μm microwell, showing (b) the topography and (c) the profile 
along the dashed line in (b). 
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deposited on the backside of a clean wafer via magnetron sputtering (Pfeiffer SPIDER-600, Pfeiffer 
Vacuum, Switzerland) and used as conductive layer for upcoming inductively coupled plasma (ICP) 
etching. After the silanization of the wafer by A174, the back-side was protected by ultraviolet 
(UV) tape. Then, a Parylene-C layer (3 μm in thickness) was coated on the glass wafer by chemical 
vapor deposition (Comelec C-30-S Parylene deposition system, Comelec, Switzerland). After-
wards, the UV tape was removed from the back-side of the wafer, leaving the Parylene-C mem-
brane only on the front-side. An amorphous silicon hard mask (100 nm thickness) was deposited 
on the front side of the wafer by sputtering. This hard mask was then patterned by standard pho-
tolithography using AZ1512 positive photoresist (1.1 μm thickness) and ICP Cl2 plasma etching (STS 
Multiplex ICP etcher, Surface Technology Systems, Newport, UK). The exposed Parylene-C was 
etched by O2 plasma, and the photoresist layer was removed at the same time. The amorphous 
silicon hard mask was stripped by Cl2 plasma, leaving the microwell array on the glass substrate. 
As the last step, the Parylene-C layer was treated with SF6 plasma for 30 sec to increase its hydro-
phobicity [85]. Afterwards, the glass wafer was diced into small chips (16 mm × 30 mm) that were 
ready to be used for microsphere patterning.  
In our design, microwells with a diameter of 3 μm were arranged over an area of 2 × 6 mm2 in a 
hexagonal pattern, and separated in the x- and y-directions by an interspacing of 20 μm. The fab-
ricated microwell array template is shown in Figure 2.3a. The topography of the microwells was 
characterized by AFM at room temperature using a Bruker FastScan AFM (Bruker AXS Inc., Madi-
son, USA). Figure 2.3b shows the height measurement on a microwell, while the corresponding 
cross-section profile is shown in Figure 2.3c. The measurements show that the depth of the mi-
crowell after the fabrication is 2.86 μm and the diameter of the microwell is ~3 μm, which ensures 
single-microsphere-per-well patterning and accurate positioning of the microspheres. 2.2.2 Patterning of the dielectric microspheres 
After the fabrication of the microwell array on the glass chip, the dielectric microspheres were 
patterned with an off-chip experimental protocol. Carboxyl-functionalized melamine micro-
spheres with diameter of 3 μm were selected to be patterned into the microwells to generate a 
microlens array due to their high refractive index (n = 1.68), low light absorbance, and optimum 
light focusing capability in water [76]. According to previously published work [76], 3 μm diameter 
melamine microspheres generate maximum light intensity and smallest transverse dimension of 
the photonic nanojet, when the microspheres are immersed in water. For the patterning of the 
microlenses, the carboxyl-functionalized melamine microspheres were suspended in a droplet, 
which was then transported over the microwell surface multiple times (see Figure 2.4a). While 
the droplet was repelled from the hydrophobic surface of the Parylene-C, single microspheres 
were trapped inside the microwells, having hydrophilic glass bottoms.  
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Figure 2.4 | Electrostatic self-assembly of dielectric microsphere arrays. (a) Schematic representation of 
the microsphere patterning process: (i) microfabricated Parylene-C microwell array; (ii) a droplet with sus-
pended microspheres is transported over the hydrophilic microwells multiple times, during which micro-
spheres get trapped; (iii) due to the geometry and surface charge of the microwells, the microspheres stay 
immobilized in the microwell pattern, also after removal of the droplet. (b) Microsphere loading efficiency 
as function of pH of the droplet. (c) Schematic illustration of the microsphere patterning at different pH 
conditions, indicating the electrostatic charges involved in the patterning process.  
 
 
Figure 2.5 | Analysis of lens patterning and immobilization efficiency. (a) Micrograph of a representative 
microwell array after microsphere patterning at pH = 2. Over an area comprising 1160 microwells, only 6 
microwells do not contain a microsphere after patterning (i.e.: patterning efficiency ~99.5 %). (b) Number 
of microspheres Nsph left within the microwell array as a function of well size w after application of optical 
tweezer forces, at relatively high pH conditions (pH>7). At constant pulling force, lower pH values and well 
size closer to the sphere size are beneficial for stronger electrostatic self-assembly forces, so that less mi-
crospheres can get removed from the microwells. (c) Representative micrographs of portions of 4 µm and 
5 μm well arrays with patterned microlenses, before and after the application of optical tweezer forces on 
the spheres. 
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We investigated the electrostatic nature of the microsphere patterning mechanism by performing 
the experiments with microspheres diluted into buffer with different pH values. The working 
buffer was prepared by mixing different amounts of HCl or NaOH into PBS buffer. Thereafter, the 
stock solution of the carboxyl-functionalized melamine microspheres was 10× diluted into buffer 
samples at different pH values, ranging from 2 to 11. For each sample at different pH condition, a 
6 μL droplet was transported over the microwell array for 10 patterning cycles (1 cycle = 1 passage 
of the droplet over the array) by using a pipette. As shown in Figure 2.4b, the microsphere loading 
efficiency strongly depends on the pH of the buffer used for patterning, which revealed the elec-
trostatic nature of the patterning process. Indeed, higher loading efficiencies were obtained for 
lower pH values, as confirmed by considering the isoelectric point of the microspheres (~ 3), the 
Parylene-C layer (< 2) and the glass substrate (< 3) [86, 87].The best loading efficiency was ob-
tained at pH = 2, condition at which the microspheres carry a positive surface charge (see Figure 
2.4c). By this patterning procedure a very high loading efficiency (> 99%) could be achieved, as 
shown in Figure 2.5a. Moreover, perfect lens immobilization was achieved, since all the micro-
spheres stayed captured inside the microwells during the NP detection experiments – which were 
instead performed at pH=7. 
A further analysis of the lens immobilization efficiency was moreover carried on by employing 
optical tweezers (NanoTracker, JPK instruments AG, Germany) to exert a constant pulling force on 
single patterned microspheres, immobilized within microwells of different sizes (Figure 2.5b,c). 
This analysis illustrates the crucial role of the interaction between spheres and microwell walls for 
the stable lens immobilization as well as the possibility of reversibly assemble and disassemble 
the lens array via electrostatic forces. In fact, all the microspheres are perfectly locked inside the 
microwells for well sizing less than 4 μm in diameter, while for larger microwells, the spheres can 
be still extracted from the template at relatively high pH values (i.e. pH ≥ 7). The strong depend-
ence of this phenomenon on the pH of the microsphere solution is a further evidence of the elec-
trostatic nature of the sphere “locking mechanism” inside the microwell template. 2.2.3 Microlens effect of the dielectric microspheres and NPs detection 
In order to be employed for detection of NPs in a flow, the microsphere array was embedded in a 
microfluidic stream, by clamping the glass substrate to a PDMS half-channel. In order to verify the 
lens effect of the microspheres, PBS solution was first introduced into the microfluidic channel 
and the chip was illuminated by a mercury arc lamp from the bottom of the glass substrate (Figure 
2.6a). A 20× objective with NA of 0.22 was used to image the top of the microsphere array, focus-
ing on the focal plane of the microspheres. The microscopic image (see Figure 2.6b) indicated that 
the optical signal propagating through a microsphere is focused in a highly localized spot with 
enhanced intensity, i.e. the photonic nanojet, and the light intensity obtained along the cross sec-
tion of the microsphere demonstrated that the microlens can provide a >3-fold light focusing ca-
pability, as shown in Figure 2.6c. 
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We successfully employed our microlens array to detect the presence of gold and fluorescent na-
noparticles in the microchannel, with NP size down to 50 nm and 20 nm respectively – i.e. well 
below the diffraction limit of the 20× microscope objective used for the detection. By using an 
array format for the microlenses, the same NP can be transported through a sequence of photonic 
nanojets placed in the same flow stream. The optical signal obtained from a row of lenses is then 
easily correlated to unambiguously prove the transit of even a single moving NP. Another ad-
vantage of using an array is that a larger region of the microfluidic channel is probed, which is 
advantageous for detecting low NP concentrations. First gold NPs in the 50-400 nm range were 
dispersed in DIW and introduced into the microfluidic channel at a flow velocity of ~10 μm/sec. 
Figure 2.7a shows that the presence of a 400 nm gold NP in the nanojet results in a back-scattered 
light intensity that is significantly enhanced with respect to that of a NP outside of the nanojet. 
Figure 2.7b shows the results obtained for 50 nm gold NPs: direct optical microscopy (without the 
microspheres) cannot resolve these NPs, which are instead still observable through the microlens 
array. We further tested our technique by using calibrated polystyrene fluorescent NPs with emis-
sion wavelength λem = 515 nm. NPs with size from 20 nm to 460 nm were dispersed in phosphate 
buffered saline (PBS)-Tween 20 (0.5% v/v) solution and introduced into the microfluidic channel. 
Figure 2.8 shows the experimental results for NPs with diameter of 460 nm and 20 nm. When a 
fluorescent NP passed through a photonic nanojet, its fluorescent excitation was highly enhanced. 
For the used flow conditions, the NPs were typically exposed to the strong optical field in the 
nanojet for ~20 milliseconds. The fluorescent emission of the NPs was extremely bright, so that 
NPs down to 20 nm in diameter could be still distinguished when passing through a nanojet. 
 
Figure 2.6 | Light focusing property of the microlens array. (a) Schematic representation of an array of 
microspheres while illuminated through a microscope objective. The light source beneath each microsphere 
is focused in a highly localized and intense spot, also named “photonic nanojet”. (b) Microscopic image 
focused onto the plane of the nanojets emitted from the melamine microspheres (the focal plane corre-
sponds to the plane at which the nanojets have maximum light intensity). The light intensity along the 
dashed line in (b) is shown in (c): the intensity of a photonic nanojet is typically >3 times higher than the 
background signal coming from the area with no microlenses. 
2.2   Microlens arrays for single-nanoparticle detection 
43 
 
 
Figure 2.7 | Detection of gold NPs in a microfluidic flow. Backscattering intensity from gold NPs under 
white-light illumination. Microscopic images (left column) and intensity profiles along the dashed lines in 
the left panels (right column) for gold NPs sizing (a) 400 nm and (b) 50 nm. 400 nm gold NPs are still detect-
able when they are outside a nanojet, and their intensity profile is plotted on the corresponding right panel 
too.  
 
 
Figure 2.8 | Detection of fluorescent NPs in a microfluidic flow. Emission at λem=515 nm of fluorescent NPs 
when excited at a wavelength of λex=505 nm. Microscopic images (left column) and intensity profiles along 
the dashed lines in the left panels (right column) for fluorescent NPs sizing (a) 460 nm and (b) 20 nm. 460 
nm fluorescent NPs are still detectable when they are outside a nanojet, and their intensity profile is plotted 
on the corresponding right panel too.  
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2.3 Non-adherent cell patterning for single-cell analyses 2.3.1 Microwell template fabrication and well size optimization 
For this set of studies, microwell templates were fabricated at the ESAT-MICAS cleanroom facility 
at KU Leuven (Leuven, Belgium), according to the process flow described by Witters and col-
leagues. [77] This microfabrication process flow is similar to the one described in Figure 2.2, with 
some process modifications related to the use of different materials for the template fabrication. 
In particular, microwells are here etched in a Teflon-AF® layer, deposited on an aluminum-coated 
glass substrate. This choice is dictated by the fact that, for this application, microwell templates 
are designed to be integrated in a DMF platform, instead of in a “channel-based” microfluidic 
device. Specifically, the microwell templates are employed in an electrowetting-on-dielectric 
(EWOD) DMF platform, which allows manipulating discrete liquid droplets on hydrophobic sur-
faces, by locally controlling the surface hydrophobicity via application of electric fields [88]. To 
ensure reliable droplet displacement, highly hydrophobic surfaces – such as Teflon-AF® layers – 
need to be used, while contacts for the local application of the electric field are patterned in the 
underlying aluminum layer.  
The microwell size had to be tailored to allow fast reproducible patterning of single yeast cells of 
the Saccharomyces cerevisiae strain BY4741. The cell size distribution of this strain was measured 
via flow cytometry (BD Biosciences, San Jose, CA, USA) and ranges between 3.5 µm and 8 µm, with 
the majority of cells included in the 4.5-5.5 µm size interval. Cell seeding on the EWOD platform 
was first simulated off-chip, by displacing multiple times a droplet of cell suspension over the mi-
crowell template, similarly to what is described in Figure 2.4a. Templates with different microwell 
sizes where tested and microwells sizing 5.3 ± 0.1 µm resulted to be the most suitable for pattern-
ing single yeast cells over the whole array (see Figure 2.9). An interspace of 14 µm among adjacent 
wells was eventually chosen to prevent undesired contact among budding seeded cells, which 
could prevent correct cell isolation or extract seeded cells from the microwells at successive drop-
let passages. 2.3.2 Single cell seeding and cytotoxicity assays on the DMF platform 
After the off-chip protocol optimization, the cell seeding technique was transferred onto the DMF 
platform and used for the rapid assembly of large arrays of thousands single-cells, for subsequent 
on-chip cytotoxicity assays. Specifically, this method was used to investigate the response of single 
yeast (Saccharomyces cerevisiae) cells to Amphotericin B (AmB), a cell membrane permeabilizing 
antifungal drug, able to induce programmed cell death when applied over a certain dose. A de-
tailed description of the DMF device operation and of the performed assays is presented in [89]. 
Here only an overview of this work will be reported.  
Briefly, 1 hour before seeding the yeast cells within the microwell array, cells were pre-treated 
with AmB at different concentrations, ranging from 0 µM to 200 µM, in a dimethyl sulfoxide 
(DMSO) background of 1 % (v/v). Afterwards, for each pre-treated sample, a 2.7 µL cell suspension 
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droplet was dispensed on the DMF chip actuation plate, aside another droplet containing the cor-
responding AmB concentration and 2 µg/mL propidium iodide (PI) in 1/5 YEPD (1 % Yeast Extract; 
2 % Peptone; 2 % Dextrose, diluted in distilled water). 
The DMF grounding plate, where the microwell template was fabricated, was then assembled to 
the chip, with the cell suspension droplet positioned below the microwell array and sandwiched 
between the two DMF plates (Figure 2.10a). To prevent droplet evaporation and cell drying, the 
air gap between the 2 plates was filled with 80 µL silicon oil. The chip was then flipped upside 
down and incubated for 10 min at room temperature to allow the sedimentation of the cell sus-
pension onto the microwell array. At this point, the cell seeding protocol was reproduced on-chip, 
 
Figure 2.9 | Microwell size optimization for single-cell patterning. Micrographs of microwell templates 
upon off-chip cell patterning, with wells sizing (a) 12 µm, (b) 8 µm and (c) 5.3 µm. Both 12 µm and 8 µm well 
sizes result in patterning of multiple cells per well (see zooms of picture (a) and (b)). 5.3 µm wells allow 
instead patterning single cells in every microwell (see zoom of picture (c)), with high cell loading efficiency 
(e.g. ~97% in this case). Picture scale bars = 10 µm; zoom scale bars = 5 µm. 
 
 
Figure 2.10 | Cytotoxicity assays on the DMF platform. (a) Schematic representation of the DMF platform 
configuration and (b) experimental results of the cytotoxicity assays. 
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by displacing multiple times the cell suspension droplet over the array, by means of EWOD actua-
tion. Successively, the cell suspension droplet was moved away from the array, and replaced by 
the second droplet, in order to incubate the patterned cells within the AmB/PI medium. AmB can 
induce cell death either via necrosis – a type of non-apoptosis in which cells die with a compro-
mised cell membrane – or through apoptosis – i.e. programmed cell death [90]. PI is used as a 
fluorescent marker for non-apoptotic cell death, since it can enter the cells only if their plasma 
membrane is compromised. For each AmB concentration, the response of the cells to the treat-
ment was monitored by counting the number of PI-positive cells each 15 min, for 5 hours. After-
wards, the whole array was exposed to intense UV irradiation for 20 min to abruptly kill and per-
meabilize all the cells and render them PI-positive, to easily count the total number of cells seeded 
in the array. A dose-dependent increase of the number of PI-positive cells over time was observed 
(Figure 2.10b). Furthermore, higher dosages of AmB (200 µM) resulted in faster membrane per-
meabilization with respect to lower AmB dosages (< 50 µM). This result further highligths the im-
portance of time-dependent analyses for screening purposes, for instance towards the identifica-
tion of fast-killing antifungal agents. 2.4 Materials and Methods 2.4.1 Fabrication and assembly of microfluidic chips for NPs detection 
Upon microsphere patterning on a glass substrate, the substrate was ready for clamping to a 
PDMS half-channel, which was replicated from a SU-8 structure that was fabricated on a silicon 
wafer. A 5:1 mixture of PDMS prepolymer and curing agent (Dow Corning) was cast over the SU-
8 mold and cured at 70 °C overnight. Then the PDMS replica was peeled off from the mold, result-
ing in a microfluidic half-channel with a height of 20 μm, a width of 800 μm and a length of 24 
mm. Two PMMA plates were used to clamp the PDMS replica and the glass chip with the Parylene-
C microwell array containing the microlenses. 2.4.2 Image acquisition for NPs detection 
An Axiovert S100 (Carl Zeiss) inverted microscope, equipped with a 20× objective with NA of 0.22 
(Zeiss Objective LD EC Epiplan-Neofluar 20×/0.22 DIC M27, 422452-9900), was used for illumina-
tion and signal detection. The microscope was configured with a mercury vapor arc lamp (X-Cite 
120, Carl Zeiss) and appropriate fluorescent filter sets. Image acquisition and light detection were 
achieved using a CCD camera (ORCA-C4742-80ER, Hamamatsu Photonics). The integration time 
for recording an image was set to 20 milliseconds, which was determined by the flow velocity (~10 
μm/sec) and the FWHM of the photonic nanojet (~240 nm). This integration time was just long 
enough to record the signal intensity of the NP during its full transit at the best focused part of 
the nanojet.  2.4.3 Yeast cell culture 
Saccharomyces cerevisiae strain BY4741 was used in all experiments. Reagents were supplied by 
Lab M Ltd. (Lancashire, England), unless stated otherwise. Media used were YEPD (1 % Yeast Ex-
tract; 2 % Peptone; 2 % Dextrose) or 1/5 YEPD (YEPD diluted in distilled water). A yeast overnight 
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culture grown at 200 rpm and 30°C, was diluted to an optical density (OD) measured at λ=600 nm 
of 0.15 in a flask containing 50 mL YEPD and further cultured at 200 rpm and 30°C for 5 hours to 
obtain exponentially grown cells. Cells were then pelleted by centrifugation at 4000 rpm for 3 min, 
washed and re-suspended in 1/5 YEPD to OD 3. 2.4.4 Fabrication of DMF plates and platform operation 
Fabrication of DMF chips was performed in the ESAT-MICAS cleanroom facility of KU Leuven, as 
described in [89]. For the fabrication of the actuation plate, cleaned glass wafers (1.1 mm thick-
ness) were sputter coated with chromium (100 nm) and patterned using standard photolitho-
graphic processes. The plates were cleaned in acetone and isopropyl alcohol (IPA) twice, and the 
surface was plasma-activated (O2-plasma, 150 mtorr, 100 W). To promote adhesion, the plates 
were primed with silane A174 and then coated with a layer of Parylene-C (3 µm) using chemical 
vapour deposition. A thin layer of Teflon-AF® (approx. 200 nm thickness using 3 % w/w in Fluo-
rinert FC-40) was subsequently spin-coated (1200 rpm) on top of the Parylene-C layer, baked for 
5 min at 110°C and 5 min at 200°C. Crenelated actuation electrodes of 2.8 mm × 2.8 mm were 
selectively actuated to manipulate individual droplets of 2.7 µL. The grounding plate of the DMF 
device was fabricated as follows: cleaned glass wafers (1 mm thickness) were coated with alumin-
ium electrodes (40 nm) using thermal evaporation, leaving two 2.5 × 2.5 mm visualization win-
dows. The surface was then coated with the fluoroalkylsilane F8263, followed by spin-coating Tef-
lon-AF® (approx. 3 µm). Fluoroalkylsilane improved the adhesion between Teflon-AF® and alumin-
ium. In order to pattern the Teflon-AF® surface, a hard mask was developed by depositing 
Parylene-C (1 µm) and aluminium (60-80 nm). A thin layer of AZ1505 photoresist was then spin-
coated on the aluminium hard mask. Using standard photolithography processes, the aluminium 
was patterned and etched. Finally, for transferring the pattern from aluminum to Teflon-AF®, the 
plates were subjected to O2 plasma (150 mtorr, 100 W) for 10 min. At last, the aluminum-Parylene-
C mask was peeled off using tweezers, revealing the two microwell arrays (1.9 mm × 1.9 mm) on 
a single grounding plate, consisting of 22,000 microwells each. The patterned microwells meas-
ured approximately 5.3 µm in width and 3 µm in depth, and were arranged in a hexagonal pattern 
with a pitch distance of 14 µm. 
For DMF platform operation, a double-sided sticky tape of 160 µm thickness was applied on the 
actuation plate as a spacer and for adhering the grounding plate to the actuation plate. The as-
sembled plates were installed in a custom-made DMF microfluidic chip holder. The actuation se-
quence of electrodes was controlled with a customized Labview program (National Instruments 
Corp., Austin, TX, USA) and an in-house developed Matlab based program (MathWorks Inc., Na-
tick, MA, USA). Droplets were driven by an AC-voltage of 120–130 Vrms, an activation time of 1 s 
and a relaxation time of 40 ms. The AC-actuation voltage was realized by the oscillating wave-
forms, produced by the function generator operating at 1 kHz (GFG-8216A-ISO-TECH, England) 
and further amplified by an amplifier (FLC Electronics A600, Origin Sweden). 
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2.5 Conclusions 
In this chapter we presented a new general method for rapid self-assembly of large arrays of mi-
cro-entities of different nature and materials – from dielectric microbeads to non-adherent cells. 
In our technique microfabricated well arrays are used as templates for micro-entity patterning. 
We exploit lateral capillary forces to simultaneously “seed” thousands of single beads/cells per 
microwell template, starting from a droplet of bead/cell suspension which is simply deposited on 
top of the template and transported over the microwell surface multiple times. The hydrophobic 
nature of the template surface allows moving the droplet, while wetting of the inner volume of 
the microwells – and, thus, access of the micro-entities to the wells – is triggered by the hydro-
philic nature of their bottom surface. The whole patterning process can be performed off-chip in 
a few seconds and the obtained bead/cell micro-arrays can then be readily integrated within mi-
crofluidic devices, such as a PDMS channel or a DMF platform.  
By using Parylene-C/glass well templates to pattern melamine microspheres, we moreover intro-
duced the use of electrostatic forces to improve the self-assembly process and enhance the im-
mobilization of the patterned spheres within the microwells. This specific combination of materi-
als was chosen to generate robust microlens arrays for the detection of NPs in a microfluidic flow. 
Specifically, we achieved the detection of NPs with a size far below the classical diffraction limit in 
a microfluidic device by using a conventional brightfield and fluorescence microscope. In contrast 
to optical detection-based analytical techniques, such as those that use laser excitation and light 
scattering, our technique did not rely on complex experimental setups and had the ability to easily 
distinguish individual NPs and do live counting of these NPs by using a standard microscope set-
up. In our experiments, the microscope objective was used in combination with the dielectric mi-
crosphere array to generate an array of photonic nanojets. When NPs were transported by a flow-
ing medium through a nanojet, their light scattering or fluorescence intensity was typically en-
hanced by a factor ~40, allowing the detection of gold particles down to 50 nm and fluorescent 
particles down to 20 nm. All the further developments of this work have become subjects of a 
new PhD project at the LMIS2 laboratory.      
By using the same patterning method with Teflon/glass well templates, we then managed to iso-
late yeast cells (Saccharomyces cerevisiae) in femtoliter wells for subsequent analyses within the 
microwell array at single-cell resolution. The versatility of our patterning method was once again 
confirmed by the fact that for these experiments the cell arrays were used in combination with a 
microfluidic platform of a completely different format, i.e. a DMF platform. This part of the project 
was performed in collaboration with the biosensors group at KU-Leuven (Leuven, Belgium), where 
further developments of this work are currently being carried on by two other PhD students.  
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 Hydrodynamic micro-arrays for long-term imaging and phenotyping of 
C. elegans embryos 
Abstract Studies of the real-time dynamics of embryonic development require a gentle em-
bryo handling method, the possibility of long-term live imaging during the complete embryogen-
esis, as well as of parallelization providing a population’s statistics, while keeping single embryo 
resolution. We describe an automated approach that fully accomplishes these requirements for 
embryos of Caenorhabditis elegans, one of the most employed model organisms in biomedical 
research. We developed a microfluidic platform which makes use of pure passive hydrodynamics 
to run on-chip worm cultures, from which we obtain synchronized embryo populations, and to 
immobilize these embryos in incubator micro-arrays for long-term high-resolution optical imaging. 
We successfully employ our platform to investigate morphogenesis and mitochondrial biogenesis 
during the full embryonic development and elucidate the role of the mitochondrial unfolded pro-
tein response (UPRmt) within C. elegans embryogenesis. Our method can be generally used for 
protein expression and developmental studies at the embryonic level, but can also provide clues 
to understand the aging process and age-related diseases in particular. 
This chapter is an adapted version of the following publications: 
o M. Cornaglia, L. Mouchiroud, A. Marette, S. Narasimhan, T. Lehnert, V. Jovaisaite, J. Auwerx, 
and M. A. M. Gijs, An automated microfluidic platform for C. elegans embryo arraying, phe-
notyping, and long-term live imaging, Sci Rep 5, 10192, doi: 10.1038/srep10192 (2015) 
o M. Cornaglia, L. Mouchiroud, A. Marette, S. Narasimhan, T. Lehnert, V. Jovaisaite, J. Auwerx, 
and M. A. M. Gijs, Multi-dimensional imaging and phenotyping of C. elegans embryos via an 
automated microfluidic device. Proc. of 19th International Conference on Miniaturized Sys-
tems for Chemistry and Life Sciences (microTAS 2015), Gyeongju, Korea, October 2015.  
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3.1 Introduction 3.1.1 New model organisms for drug discovery 
Improving human health and evaluating the health status is nowadays a completely multi-discipli-
nary topic, involving research fields from medicine and biology, to physics, chemistry and engi-
neering.  At the core of the main issues concerning human health, still resides the lack of a global 
understanding of the physiology of whole organisms, due to an extreme complexity that is very 
hard to grasp without multiple-parameter and integrated analytical techniques. Many efforts are 
constantly being done to progressively dig deeper into the secrets of the human biology to better 
treat diseases. Obviously, there is no possibility to directly conduct this research on humans as a 
whole. Hence, researchers mainly base their work on studies performed on cells and tissues, which 
are however not able to preserve the full information about the entire organism they originate 
from. When this information is absolutely necessary, thus, scientists need to address analyses on 
entire organisms such as mice, rats, pigs, monkeys, etc, which represent the so-called “model or-
ganisms” for investigating the different aspects of human health. Nevertheless, this approach 
fairly originates inevitable ethical concerns and, from a practical viewpoint, raises several other 
issues in terms of time and cost of the analyses. These studies, in fact, cannot involve a high num-
ber of specimens and they are therefore usually not suitable for high-throughput analyses, which 
are however more and more crucial for the healthcare domain. For all these reasons, in recent 
years, the so-called “small model organisms” are gaining particular attention in the field, since 
they allow circumventing most of these issues [91, 92]. Analyses on small animals such as Caeno-
rhabditis elegans, Drosophila melanogaster, Danio rerio, or Xenopus laevis provide in fact a high 
amount of biological information about the organization of a full organism, while avoiding time, 
cost and, often, ethical concerns. The small size of these animals, however, highly complicates 
these analyses, especially when only the traditional manual pick-and-place and other manipula-
tion techniques are available, which lack the reproducibility and throughput standards required 
for massive usage of the technique. Microfabricated solutions, though, can definitely solve this 
last issue, since they allow directly operating on the same length-scale of the organisms under 
test, paving the way towards absolute control over the protocols and the high-throughput-type 
analyses required by this field.  3.1.2 C. elegans as an emerging model organism 
Among the small model organisms, the nematode C. elegans has some particularly interesting 
features, which give it increasing attention in the whole biomedical research community. Estab-
lished as a model organism by Sydney Brenner in 1965, C. elegans was the first animal to get its 
genome entirely sequenced in 1998[93]. Since then, it has become a widely accepted model for 
investigations into different bio-medical fields, while key discoveries made in C. elegans have al-
ready been awarded with 3 Nobel Prizes. Many biological processes have been conserved be-
tween worms and humans and high-level biological questions about complex human diseases can 
be addressed by studies on C. elegans. Interestingly, in fact, C. elegans and human beings share a 
high amount of genes and molecular pathways (e.g. 40% of worms’ genes have their human coun-
terpart) [93]. Therefore, through the years, the C. elegans research community has generated an 
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extensive library of mutant strains as well as a broad toolkit for worms’ genetic manipulation. RNA 
interference (RNAi), for instance, can be implemented in a relatively easy way in worms – i.e. by 
feeding them with bacteria expressing double-stranded RNA (dsRNA) for the gene of interest – 
and represents a powerful technique for gene silencing and investigation of loss-of-function phe-
notypes [94]. Moreover, C. elegans nematodes are transparent at all their developmental stages 
and a large amount of fluorescent reporter-gene strains has been made available to visualize gene 
expression and signaling patways in real-time. C. elegans’ relatively short life cycle (Figure 3.1) 
and lifespan (around 20 days in laboratory conditions) makes it a very convenient model organism 
for the investigation of developmental processes and for the aging research as well. C. elegans 
hermaphrodite adults have 959 somatic cells and their complete lineage is known [95]. 302 of 
these cells are neurons and their selective ablation has been demonstrated as well, for both nerve 
regeneration analyses and nervous system disease investigation. C. elegans possesses one of the 
simplest central nervous systems and by far the best characterized. Despite this simplicity, both 
physiological behaviors – e.g. feeding, locomotion, egg-laying – as well as complex behavioral 
traits – e.g. sensory responses, social behaviors, learning – can be observed and studied in worms.  
As mentioned before, microfluidic-based technologies operate on the same length-scale of C. el-
egans size and hold therefore enormous potential for improving C. elegans manipulation and stud-
ies in terms of both automation and accuracy. In this context, a significant amount of work has 
been done in the last 5 to 10 years and some excellent reviews have been recently published to 
provide overviews of the advancements in this field. The potential of microfluidic technologies for 
phenotyping, imaging and screening of multicellular organisms has been reviewed by Yanik et al. 
[97], Crane et al. [98], Wlodkowic et al. [99], Chronis et al. [100], and Baker [101]. Bakhtina et al. 
 
Figure 3.1| Life cycle of wild-type C. elegans at 22°C, in agar plate culture conditions. 0 min is fertilization. 
Numbers in blue along the arrows indicate the length of time the animal spends at a certain stage. First 
cleavage occurs at about 40 min postfertilization. Eggs are laid outside at about 150 min postfertilization 
and during the gastrula stage. The length of the animal at each stage is marked next to the stage name in 
micrometers (Reprinted from [96]). 
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presented a wide overview of the microfluidic solutions which have been proposed so far to en-
hance C. elegans manipulation and studies [102]. Sivagnanam et al. reviewed the use of microflu-
idic systems for the exploration of living multicellular organisms, organs, and tissues [103]. Hulme 
at al. provided then an interesting analysis about C. elegans as a platform for integrating chemical 
and biological research [104].  3.1.3 Challenges and opportunities for C. elegans embryogenesis analysis 
Before reaching the adult stage and upon egg hatching, C. elegans nematodes pass through four 
larval (L1-L4) stages (Figure 3.1). In most oganisms, exposure to particular environmental condi-
tions during early life is often decisive for their successful development. In C. elegans, events oc-
curring during larval stages are known to have a strong impact on the animal’s lifespan [105]. 
Whether conditions in the embryonic phase of life have an influence on the later development is 
however a much more challenging question to answer, mainly because systematic C. elegans em-
bryonic morphogenesis studies are still difficult from a technical point of view. In fact, C. elegans 
worm culture is performed on the surface of nematode growth medium agar plates covered with 
Escherichia coli bacteria for feeding. This technique proves especially tedious if large numbers of 
animals are to be analyzed. Moreover, for embryonic studies, currently available protocols are 
based on animal dissection and embryo mounting on agar pads [106], which typically require spe-
cialized and advanced skills and lacks reproducibility and high-throughput potential. Recently, it 
has been shown that various aspects of functional exploration of C. elegans can be significantly 
improved using microfluidics [102-104, 107-109]. “Worm-chips” have successfully demonstrated 
their high potential at enhancing worms’ handling and accurate imaging, for applications in 
lifespan studies [110], phenotyping and screening [111, 112], nerve regeneration analyses [113], 
as well as for the investigation of worms’ behavioral dynamics [114]. So far, however, such robust 
methods to study C. elegans embryos do not exist yet, whereas a microfluidic solution has been 
only proposed to study early embryo development for larger size model organisms, namely fruit 
fly (Drosophila melanogaster) [115] and zebrafish (Danio rerio) [116].  
Chung et al. [115] recently proposed a microfluidic array for large scale ordering and orientation 
of Drosophila embryos. Their microfluidic device uses hydrodynamic forces to immobilize hun-
dreds of embryos in a vertical position, exploiting their anisotropic embryonic shape (Figure 3.2a). 
By means of this method, the authors could quantify morphogen gradients in the dorsoventral 
patterning system of the embryos, a task that was before complicated by the technical challenge 
of manually orienting individual Drosophila embryos, featuring about 0.5 mm in size. By using an 
analogous embryo-trap approach and chip geometry, Akagi et al. [116] proposed then a mesoflu-
idic device for the immobilization, drug perfusion and high-resolution imaging of zebrafish em-
bryos (Figure 3.2b). The authors then demonstrated that the “embryo-array technology” can be 
effectively used for the analysis of anti-angiogenic compounds using transgenic zebrafish lines. 
C. elegans embryos are 10-100 times smaller than those of the other small model organisms and 
thus basically impossible to handle manually. However, no technological solution for their manip-
ulation and study has been proposed so far. To enable systematic analysis of C. elegans embryonic 
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morphogenesis, we hence developed a microfluidic platform for automated on-chip worm cul-
ture, creation of synchronized embryo arrays, and for long-term parallel live imaging at the single 
embryo level. We successfully employed our platform to investigate mitochondrial biogenesis dur-
ing the embryonic development. Using our method to study a large number of embryos of differ-
ent wild-type and mutant worm strains, we elucidated an outstanding issue regarding the role of 
UPRmt during early worm embryogenesis. 
3.2 Microfluidic platform design and automated operation 3.2.1 Overview of the microfluidic device 
The robustness and automation of our system completely relies on passive hydrodynamics, with 
no need of any active component on-chip, such as integrated valves. This approach allows simpli-
fying fluidic protocols and significantly minimizing fabrication constrains of the device, which 
simply consists of a monolithic PDMS microfluidic chip, sealed to a ~150 μm-thick glass coverslip. 
Our microfluidic chip features two main components: a “worm culture chamber” and an “embryo-
incubator array" (Figure 3.3a,bi). External flow control through four independent inlets is achieved 
via computer-controlled syringe pumps, while two external valves are used to open and close two 
separate outlets. The worm culture chamber is delimited by specific microfluidic channel arrange-
ments for generating uniform flow distributions in the chamber and for filtering entities of differ-
ent size (Figure 3.3bii): a “worm injection filter”, for gentle insertion of mixed worm suspensions 
 
Figure 3.2| Embryo-array technologies for Drosophila and zebrafish studies. (ai) Schematic representation 
of the Drosophila embryo trapping process proposed by Chung et al. (reproduced from [115]): an embryo 
is first guided into the trap and vertically oriented by fluidic forces; the trap then contracts for the embryo 
immobilization and imaging (yellow plane = imaging focal plane). (aii) A section of the array with trapped 
embryos. Scale bar = 500 μm. (b) Picture of the mesofluidic device for zebrafish embryo arraying, as pro-
posed by Akagi et al. (reproduced from [116]). The right panel depicts a magnified section of the device with 
a single trap holding an immobilized zebrafish embryo. 
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into the chamber; a “worm synchronization filter”, to select the age of the worm population to be 
tested, by only retaining either adult worms or L4 larvae inside the chamber; an “E. coli/drug de-
livery filter”, to homogeneously introduce feeding and treatment solutions inside the chamber; 
an “embryo transfer filter”, to reliably displace embryos from the chamber to the embryo-incuba-
tor array upon egg laying. The embryo-incubator array consists of a serpentine channel in which 
each pair of branches is connected by isolated micro-compartments, specifically tailored for the 
trapping of C. elegans embryos and their high-resolution imaging through the glass coverslip (Fig-
ure 3.3biii). 
Embryos, which are transferred to the embryo-incubator array are automatically positioned in the 
micro-incubators by passive hydrodynamic trapping (Figure 3.3c). The design of this section of the 
chip is optimized according to both general microfluidic rules and specific needs related to the 
characteristics of C. elegans embryos, as it will be extensively discussed in the next subsections. 
Overall, our fluidic design results in enhanced efficiency of capture and stable positioning of single 
embryos, with unprecedented performance in terms of control and reliability of the trapping 
mechanism for non-spherical objects. The flow rate distribution inside the array has to ensure the 
capture of a single embryo for each micro-incubator. Since the number of available embryos is 
being limited by the egg production inside the chamber, a perfect efficiency of the hydrodynamic 
trapping method has to be established in order to recover all eggs. At the same time, however, 
high trapping efficiency is typically associated to higher fluidic pressures through the micro-incu-
bators. Therefore, forces exerted on the incubated eggs have to be considered as well, to prevent 
the flow from introducing undesired mechanical stresses on the captured embryos.  
A crucial role for the system performance is clearly played by the geometry of the micro-incuba-
tors, hence different types of micro-incubators have been fabricated and tested (details of this 
optimization process are reported in subsection 3.2.4). For high-resolution parallel time-lapse im-
aging of the whole embryo population and automated image processing, all the embryos have to 
be perfectly arrayed in stable positions and kept correctly aligned and well-oriented for several 
hours. We optimized the incubator size and shape mainly according to these needs, with our final 
design featuring elongated semicircular incubators, which are 35 μm wide, 38 μm long and 35 μm 
high (Figure 3.3d). Using these dimensions, single embryos can be reliably positioned and aligned 
inside the incubator array (Figure 3.3e). Only slight variations in their angular positions are ob-
served, given the natural size variability of the embryos (see subsection 3.2.4).  
The whole incubator array features 20 micro-incubators, which are progressively filled by embryos 
as soon as they are naturally laid. This number is chosen to provide a significant data statistics for 
each experiment, while still maintaining a good level of age-synchronization among all the em-
bryos in the array. For a worm culture which is at the peak of its egg production, complete filling 
of the incubator arrays typically takes around 1 hour. The whole embryo population is studied 
using fully automated multi-dimensional imaging, covering six independent dimensions: the 3 spa-
tial coordinates, the development time, the exposure (brightfield, fluorescent) duration, and the 
embryo number in the array (Figure 3.3f).     
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3.2.2 Multi-functional cross-shaped culture chamber  
In our chip, the cross-shape of the worm culture chamber (Figure 3.4) is designed to decouple the 
worm loading/washing protocols from the embryo transfer operations, by allowing liquid flows 
through the chamber along two orthogonal directions (In1-Out1 and In2/3/4-Out2, respectively). 
Since both the aforementioned operations rely on precise flow rate thresholds for their correct 
functioning, a crucial requirement is represented by flow uniformity across the whole width of the 
chamber, in both directions. For this reason, the chamber is connected to its inlets and outlets by 
binary trees of microfluidic channels, in which any inflow – or outflow – is symmetrically split – or 
merged – in equal portions, hence ensuring controlled and homogeneous flow speed across the 
chamber. For worm loading, this channel configuration is particularly crucial not to damage the 
 
Figure 3.3 | Overview of the microfluidic device. (a) Picture of the microfluidic device, sizing 25 mm x 75 
mm (standard microscope slide size), including lateral microfluidic connections, which make the device 
compatible for imaging with every upright or inverted microscope. Scale bar = 10 mm (bi) Schematic repre-
sentation of the central part of the microfluidic chip, having as main constitutive parts: the worm culture 
chamber, the embryo-incubator array, four inlets (In1 to In4) and two outlets (Out1 and Out2). Scale bar = 
2 mm (bii) Zoom on the worm culture chamber, including a drawing of young adult C. elegans for size com-
parison. The chamber is delimited by specific microfluidic channel arrangements, tailored for different func-
tions: (top) worm injection, (bottom) worm synchronization, (left) E. coli / drug delivery and (right) egg 
transfer. Scale bar = 1 mm (biii) Three-dimensional schematic zoom on a portion of the embryo incubator 
array. (c) FEM simulation (Comsol Multiphysics) of the fluid dynamics in the incubator array region, showing 
the principle of passive hydrodynamic arraying of single embryos. Fluidic velocity and streamlines are cal-
culated for a flow rate of 100 nL/s at the inlet In3. Scale bar = 50 μm (d) Micrograph of a single incubator on 
the SU-8/silicon master mold used for PDMS casting. (e) Micrograph of a section of the array with immobi-
lized embryos. Scale bar = 100 μm (f) Illustration of the multi-dimensional imaging that is enabled on the 
array of embryos and spans six dimensions: the 3 spatial coordinates, time, exposure type and embryo 
number in the array. 
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worms during the injection, since it ensures uniform worm distribution across the In1-Out1 filters, 
avoiding their accumulation at narrowing channels which might cause unpredictable flow patterns 
and overpressures over their bodies. During the progeny transfer, flow speed homogeneity en-
sures then that all the embryos present in the chamber are subjected to similar drag forces. This 
allows moving them all towards the incubator array, without losing some of them in the worm 
chamber or damaging some of them by excessive forces. 
3.2.3 Design of the hydrodynamic trapping micro-array 
The efficiency of the hydrodynamic trapping mechanism in the embryo incubator can be esti-
mated by calculating the ratio between Q1 and Q2, i.e. the volumetric flow rates through each 
incubator and its bypass channel, respectively (Figure 3.5ai). This can be done by first considering 
the pressure drop between points A and B, along the two different fluidic paths and then imposing 
equal pressure drop along them (ignoring minor losses due to channel bends, widening/narrow-
ing, etc.) [117]. At steady-state flow conditions, for incompressible Newtonian fluids flowing 
through straight microchannels (i.e. Poiseuille flow), this operation actually corresponds to calcu-
lating the inverse of the ratio between the hydraulic resistances of the two paths, R2/R1. For 
straight channels with rectangular cross-sectional shape, the hydraulic resistance can be calcu-
lated as [45]: 
𝜋𝜋 =  12𝜋𝜋𝐿𝐿1 − 0.63 (ℎ𝑤𝑤) 1ℎ3𝑤𝑤 (3.1) 
where μ is the fluid viscosity, L the channel length, h and w the channel height and width, respec-
tively.  
 
Figure 3.4 | Geometry of the worm culture chamber. Schematic representation of the worm culture cham-
ber, with zooms on the surrounding microfluidic channel arrangements and their specific dimensions. 
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It has been shown that, for spherical objects (e.g. micro-beads), good trapping efficiencies are 
achieved for ratios Q1/Q2= R2/R1>3 [117]. However, no data were available on the hydrodynamic 
trapping of non-spherical objects for an incubator/bypass microfluidic design. Hence, we first es-
timated the trapping efficiency of our device for different array geometries and then fabricated 
Table 3.1 | Microfluidic designs to test embryo capture efficiency. Geometrical parameters, as defined in 
Figure 3.5aii, Q1/Q2  ratio, and experimental embryo capture efficiency of two microfluidic designs. 
 
 Wc (µm) Lc (µm) Wi (µm) Li (µm) Wd (µm) Ld (µm) Q1/ Q2 E (%) 
Design A 100 1000 35 50 12 8 ~4 ~50 
Design B 80 1200 35 30 12 8 ~13.5 ~100 
 
 
 
Figure 3.5 | Design of the hydrodynamic trapping micro-array. (a) Schematic representation of the design 
of the hydrodynamic embryo trapping system, with (ai) indication of the flow rates Q1 and Q2 through a trap 
and a bypass channel, respectively, and (aii) definition of the geometrical parameters. (b) Optical micro-
graph of an E. coli suspension flowing through an embryo incubator, in which a 30 µm PMMA bead has been 
trapped to study the hydrodynamic trapping mechanism. Flowing E. coli bacteria allow visualizing the flow 
streamlines and assessing the presence of residual flow through the occupied incubator. Dashed white lines 
trace a few of the streamlines, while the solid lines are guides to the eye that indicate the boundary between 
the main flow in the bypass channel and the residual flow in the incubator. (c) Schematic representation of 
the embryo trapping mechanism, (ci) in absence and (cii) in presence of residual flow through an occupied 
incubator. The residual flow enhances the correct embryo orientation and positioning inside the next incu-
bator of the array. 
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two microfluidic devices with different Q1/Q2 ratios to experimentally evaluate their capturing ef-
ficiency for C. elegans embryos. The efficiency E is defined as the number of experimentally cap-
tured embryos over the total amount of embryos injected into the microfluidic device.  
The geometrical parameters of Table 3.1, as defined in Figure 3.5aii, have been chosen following 
specific needs related to the capture of C. elegans embryos. For instance, the bypass channel 
width has to be large enough to allow the passage of embryos at any orientation and avoid chan-
nel clogging, even when a group of embryos is flowing through the serpentine. Another constraint 
is the height of the microchannels (h = 35 µm in our design), as the microfluidic device must allow 
stable and flat embryo positioning inside the incubators, while still avoiding squeezing of the cap-
tured embryos. The exact geometry of the embryo incubator plays here an important role, as dis-
cussed in detail in subsection (3.2.4). From our experimental analysis, we concluded that the Q1/Q2 
ratio of ~13.5 guarantees 100% embryo trapping efficiency, while for a ratio of ~4, only 50% of the 
flowing embryos are typically trapped. We mainly attribute this behavior to the fact that the by-
pass channel width has to be designed large enough with respect to the embryo size for the rea-
sons explained above. 
Another option to reduce mechanical stresses on captured embryos could have been the reduc-
tion of the height of the bypass channel with respect to the incubator’s one. This would result in 
enhanced sealing of the incubator, when occupied by an embryo [118]. However, while spherical 
objects simply need to be directed towards an empty incubator to be trapped, egg-shaped objects 
must be properly oriented, in order to ensure their correct capture and positioning in the incuba-
tor. By setting equal trap and bypass channel heights, we therefore deliberately allowed the pres-
ence of a residual flow through occupied incubators (Figure 3.5b). Such residual flow modifies the 
flow pattern in the vicinity of the subsequent downstream trap and generates an additional flow 
that is beneficial for guiding the embryo towards its correct re-orientation and trapping into the 
adjacent empty incubator (Figure 3.5c).  
Another hydrodynamic trapping design has been recently proposed, in which multiple incubators 
were positioned side-by-side in between adjacent serpentine branches [115]. On the one hand, 
this design undoubtedly allows optimizing the number of captured embryos in a given field of 
view, but, on the other hand, it does not allow deterministically setting a 100% trapping efficiency, 
mainly because of the undesired residual flow through occupied incubators, perturbing the ex-
pected flow rate through the unoccupied ones. As a result, we considered this alternative design 
to be less suitable for our application, where the number of available embryos is limited and where 
trapping efficiency and accuracy are more important than having a larger number of trapping sites.  3.2.4 Optimization of the embryo incubator geometry 
The design of an embryo incubator that perfectly matches the requirements of our application is 
based on the following considerations. The incubator width (Wi in Figure 3.5aii and Figure 3.6a) 
has to be large enough to gently accommodate a single C. elegans embryo, while not introducing 
any lateral pressure on it during its complete development. On the other hand Wi cannot be too 
large with respect to the average width of an embryo, to guarantee its alignment exactly along 
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the same direction, which represents an important requirement for the automated parallel imag-
ing over the whole incubator array. The incubator length (Li in Figure 3.5aii and Figure 3.6a) has 
been chosen taking into account that long incubators would result in multiple embryo trapping at 
a single incubator site, while too short ones would expose each captured embryo to flow patterns 
that would change its position during the imaging process or even remove it from the incubator. 
Dimensions of the drain connecting each incubator to the adjacent branch of the main serpentine 
channel (Wd and Ld in Figure 3.5aii and Figure 3.6a) also need to be carefully designed, as C. ele-
gans embryos have a limited mechanical stiffness and can be squeezed through the drain by ex-
cessive fluidic pressures. On the one hand, the drain has to be narrow and long enough to retain 
the embryo inside the incubator, even at the relatively high flow rates used for their capture, 
while, on the other hand, its fluidic resistance has to be sufficiently low for efficient hydrodynamic 
trapping.  
In order to take into consideration all the aforementioned constraints, we designed a dedicated 
microfluidic device for studying the optimization of the embryo incubator size and shape (Figure 
3.6b). Our device features parallel arrays of embryo incubators with different geometries for ex-
perimentally studying the embryo capture, positioning and imaging for the different designs. C. 
elegans embryo suspensions in M9 buffer were prepared following standard biological protocols 
 
Figure 3.6 | Optimization of the embryo incubator geometry. (a) Picture of a PDMS embryo incubator, with 
main geometric features the incubator width (Wi) and length (Li), and drain width (Wd) and length (Ld). (b) 
Schematic representation of the microfluidic device designed and fabricated for the experimental charac-
terization of different embryo incubator geometries. (c) Representative pictures of 16 different embryo in-
cubator geometries, showing possible issues in single embryo trapping, positioning and imaging, such as 
mechanical stress induced on the captured embryo, wrong embryo positioning/orientation, multiple em-
bryo capture, etc.. Scale bars = 30 μm. 
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[119] and directly injected into the microfluidic device. The various aspects and artefacts, which 
were theoretically predicted and described above, were experimentally observed indeed (Figure 
3.6c). Among the tested incubators, we eventually selected, as optimized design, an elongated 
semicircular incubator with Wi = 35 μm, Li = 30 μm, Wd = 12 μm, Ld = 8 μm (Figure 3.3d). Interest-
ingly, our final design allows moreover emptying the full array in a few seconds, by expelling the 
captured embryos from the incubators by means of a flow pulse at relatively high flow rate (5-10 
µL/s). 
Computer-controlled image processing was used on our platform to further extend its analytical 
possibilities towards fully automated real-time screening and phenotyping. To enable this possi-
bility, however, the exact positioning of each embryo inside the incubator array has to be carefully 
considered, since image processing tools should always be able to automatically recognize and 
analyze the embryos in the array. In our device, only slight variations in the embryo angular posi-
tion inside its incubator are observed (Figure 3.7). This variations are dictated by the natural size 
variability of the embryos themselves, sometimes resulting in slight vertical tilting (Figure 3.7, 
panel E3, where the embryo seems to have a more circular shape resulting from the vertical tilt 
angle) or horizontal tilting (Figure 3.7, panel E9), but always these angles are lower than 10°.  3.2.5 Automated operation of the platform 
A live-cell microscopy environmental control system (Visitron, Puchheim, Germany) allowed con-
trolling the chip temperature over the whole duration of each experiment. The microfluidic oper-
ations were controlled using Nemesys syringe pump control software (Cetoni, Korbussen, Ger-
many). Experimentally, the microfluidic chip was first filled with Pluronic F127 solution, incubated 
for 30 min inside the device, to prevent E. coli sticking and accumulation inside the microchannels 
 
Figure 3.7 | Angular position of embryos inside the incubators. Pictures of a representative array of em-
bryos (E1 to E20), upon complete filling of the incubator array. The hydrodynamic trapping mechanism re-
sults in stable embryo positioning, with angular deviations within a 5-10° solid angle, due to the natural size 
and shape variability of the embryos themselves. Scale bars = 10 μm. 
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[120]. Few worms from a non-synchronized population were suspended in 10 μL of M9 buffer and 
sucked in a microfluidic tube, which was then connected to the device. From this point on, the 
system was completely controlled by software, through the automated sequential steps described 
in Figure 3.8.  
In each experiment, worms and embryos are manipulated via sequences of fully automated oper-
ations. A worm suspension is first injected into the microfluidic device through the top port (In1 
of Figure 3.8a) and directed towards the “worm synchronization filter” by opening the valve at 
“Out1”. The geometry of the chip is optimized for retaining inside the worm culture chamber only 
adult worms by simply selecting the correct flow rate for the sample injection. In practice, at a 
flow rate of 500 nL/s, in a few tens of seconds, all the larvae present in the suspension are directly 
washed out of the chip, while adult worms are kept inside the chamber both due to their larger 
size and their better swimming abilities/resistance against the flow (zoom of Figure 3.8a). The 
number of worms retained inside the chamber is controlled by the concentration of young adults 
in the worm suspension injected into the device (typically, 5 to 10 young adults per 10 μL suspen-
sion). Alternatively, a L1-L4 larvae suspension can be injected at a flow rate of 100 nL/s to retain 
 
Figure 3.8 | Operation of the microfluidic device. (a) First a 10 µL suspension of worms in M9 buffer is 
injected into the microfluidic device along the In1-Out1 direction at a flow rate of 500 nL/s. Symbols used 
for the in- and outlets: dot and arrow = syringe in use (e.g. In1); dot = syringe not in use (e.g. In2); circle = 
open valve (e.g. Out1); cross and circle = closed valve (e.g. Out2).  The “worm synchronization filter” is 
tailored to retain inside the chamber only adult worms, as selected by their larger size and their better 
swimming abilities (see picture in zoom). (b) Subsequently worm culture is controlled by periodically inject-
ing E. coli in M9 buffer along the In2-Out2 direction, typically at 50 nL/s flow rate. This ensures normal 
development of the worms in the liquid environment and continuous embryo production during their adult 
life span (see picture in zoom). Optionally, drugs or chemicals can be introduced at the In4 inlet for on-chip 
worm treatment. (c)  Injection of M9 buffer at 200 nL/s flow rate along the In3-Out2 direction triggers the 
transfer of all the eggs present in the chamber towards the incubator array, where they are captured by 
passive hydrodynamics, as shown by the superposition of 13 video frames in the zoom. (d) The perfusion of 
E. coli suspension towards both Out1 and Out2 simultaneously ensures proper worm feeding inside the 
culture chamber and stable embryo positioning inside the incubators, enabling parallel time-lapse imaging 
of the embryos at cellular resolution (see picture in zoom). 
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just L4 larvae inside the chamber. When needed, the number of captured worms can be adapted 
by running an optional “washing step”, where M9 buffer is injected for a few seconds along the 
In1-Out1 direction at higher flow rates (1 to 5 µL/s).  
Upon isolation of a defined worm population inside the chamber, worms are cultured and can be 
eventually treated on-chip with specific drugs or chemicals (Figure 3.8b). For worm culture/treat-
ment, an E. coli suspension is injected in the chamber at a desired rate, through the In2-Out2 
direction, while drugs or chemicals can be introduced in the chip at controlled concentration and 
precise instants of the worms’ lifespan. A simple increase of the flow speed inside the chamber 
along the In3-Out2 direction is then used to transfer the eggs present in the chamber towards the 
embryo-incubator array. In practice, a 200 nL/s flow of M9 buffer allows recovering all the eggs 
present in the chamber and isolating each of them in a single micro-incubator via passive hydro-
dynamic trapping up to complete array filling (Figure 3.8c). Parallel time-lapse imaging is then 
started, either for the full array or by scanning each individual embryo at high resolution, at de-
sired frame rate, magnification and light wavelength, depending on the analysis of interest (Figure 
3.8d). Alternatively, parallel time-lapse imaging could be started at the beginning of the embryo 
collection phase, in order to monitor each embryo from the first moment of its trapping on. Bright-
field imaging of the 20 trapped embryos takes 20 seconds, and this procedure is repeated every 
minute. In the fluorescence experiments, combined brightfield and fluorescent imaging of the 20 
trapped embryos is done in 180 seconds, and this procedure is repeated every 15 minutes, to 
avoid phototoxicity effects on the embryos. The synchronization point in the development for all 
embryos can be chosen by using either the appearance of the bean stage or hatching.  
During live imaging, we apply a slow flow (5-10 nL/s) of M9 buffer along the In3-Out2 direction to 
assure stable positioning of the embryos in the array. Because of the large section difference be-
tween chamber and incubators, the flow speed is slower inside the culture chamber and this very 
gentle flow is strong enough to keep captured eggs in position, but not fast enough to transfer 
new eggs from the chamber to the array. Optionally, for sequential studies on embryo populations 
produced by the same worms at different periods of their full adult lifespan, worm culture can be 
maintained in the chamber by the perfusion of E. coli from In2 inside the chip. Both the valves at 
Out1 and Out2 are left open in this case, and the different hydrodynamic resistances of the two 
orthogonal directions result in a partitioning of the flow between the two outlets, with most of 
the liquid flowing through Out1. This establishes a slow flow through the incubator array, ensuring 
stable positioning of the embryos over long periods, while still reducing E. coli accumulation in the 
array area, which could compromise the results of embryo fluorescent imaging, because of the 
autofluorescence of E. coli bacteria.    3.3 Embryogenesis studies at single-organism resolution 3.3.1 Automated analysis of embryonic morphogenesis  
A microscopy environmental control system maintains a constant temperature on the chip (typi-
cally 25°C) over the whole duration of each experiment. An automated xy-positioning stage is used 
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to scan sequentially all positions of interest on the embryo-incubator array. Embryos can be mon-
itored at cellular resolution through a 63x, NA 1.4 oil immersion objective, thus allowing accurate 
observation and analysis of C. elegans embryonic morphogenesis stages (Figure 3.9a) over the 
whole time-span, from egg capture to hatching (Figure 3.9b). Two key events with clearly different 
morphological changes in the embryo shape can be distinguished: (i) the onset of the so-called 
“bean stage”, beginning of morphogenesis (Figure 3.9c, top), and (ii) the onset of the “1.5-fold 
stage”, followed by the twitching inception (Figure 3.9c, middle). Together with egg hatching (Fig-
ure 3.9c, bottom), these morphological changes could be detected by software-controlled pattern 
recognition codes, for the full automation of the image processing. 
We recorded the duration of the two last development phases of Figure 3.9c for full arrays of 
embryos (n=20) belonging to different strains. Our platform allowed accurate measurement of 
the duration of these phases for individual N2 wild-type embryos at 25°C (Figure 3.9di). The ap-
parent variability is an indication of variations in the exact moment of egg laying (and subsequent 
trapping) of each embryo, which represents another interesting phenotype to be studied with our 
 
Figure 3.9 | Study of C. elegans embryogenesis for wild-type worms. (a) Time-lapse of the main embryonic 
stages of development with typical time indications for T= 25°C and wild-type worms. (b) Full embryonic 
development from egg capture in the incubator till hatching, as observed in a sequence of brightfield mi-
croscopy images (63× oil immersion objective, NA 1.4)  taken from a movie (1 frame per minute) at 45 min 
intervals for a N2 wild-type worm strain at 25°C; the hatching time defines t=0. Scale bars = 10 μm (c) Illus-
tration of main embryonic development phases –1 cell to bean; bean to 1.5-fold; 1.5-fold to hatching– that 
are clearly morphologically distinguishable. (d) Duration of development phases, as observed for an array 
of 20 embryos for a N2 wild-type worm strain at 25°C; (di) variation of the time duration the embryo spends 
in an incubator, originating from differences in the exact moment of egg laying and trapping of the embryo; 
(dii) average duration of development phases, as obtained from the data in (di).  
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method as well. The average duration of the development phases could be monitored with good 
accuracy, even from this single array experiment (Figure 3.9dii). Moreover, as worms could be 
cultured and maintained on the same chip for several days, we demonstrated the capability of our 
device to be employed for studying age-related changes in worm reproduction and progeny de-
velopment. Wild-type worms were used for these proof-of-concept experiments. A mixture of L1-
L4 larvae was injected into the microfluidic device, to isolate a small population of 5 to 10 L4 larvae 
inside the worm culture chamber. Worms were then cultured on chip during their full adult 
lifespan and different embryo populations were isolated at different moments of the worms’ re-
productive period. We compared then arrays of embryos shortly captured after the start of egg 
production (Day 1) with other arrays that have been filled approximately 72 hours later (Day 4). 
For the first generation of embryos (Day 1), about 50% of the captured eggs were in phase 1 or 
phase 2 (i.e. before the bean stage or before the onset of twitching, respectively). As worms get 
older, however, we observed a general decrease in egg production and brood viability, as well as 
an increase of the average age of the embryos at laying. These observations are in good agreement 
with off-chip results (data not shown). 
In a further set of studies, we systematically investigated the duration of the different develop-
ment phases for several transgenic strains and mutants (Figure 3.10a). In particular, we used 
SJ4100, SJ4103 and SJ4143 transgenic strains of worms, which express Green Fluorescent Protein 
(GFP) under the control of the hsp-6 (homolog of mtHSP70 in mouse), the myo-3 (homolog of 
Myosin-3 in mouse) and the ges-1 (homolog of Carboxylesterase in mouse) promoters, respec-
tively, in a N2 wild-type background [121, 122]. These strains are typically employed for the study 
of the gene expression level and/or localization, either through the GFP quantification or imaging 
approaches. Also we used the transgenic strain AGD1073 obtained by crossing hsp-6::GFP reporter 
worms with a neuron-speciﬁc cco-1 hairpin line [123]. The resulting Prab-3::cco-1HP;hsp-6::gfp 
 
Figure 3.10 | Study of C. elegans embryogenesis for transgenic, mutant and treated worms. (a) Duration 
of different development phases –bean to 1.5-fold; 1.5-fold to hatching– for the N2 wild-type strain of 
worms and a number of transgenic strains and mutants. Bar graphs are expressed as mean+SEM, *** 
p≤0.001.  (b) Pictures of a full array of 20 embryos taken 600 min after trapping in the incubators, illustrating 
the blocked development when the embryos are laid by N2 wild-type worms that were exposed in the cul-
ture chamber to 2 mM of the anticancer drug 5-fluorouracil (5-FU) in M9 buffer. Scale bars = 10 μm. 
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strain of worms displays a specific cco-1 (homolog of the cytochrome c oxidase-1 subunit Vb/COX4 
in mouse) silencing in the neurons driven by the pan-neuronal promoter rab-3. Finally, we inves-
tigated the TK22, DA465 and MQ887 strains, carrying a loss-of-function mutation in the mev-1, 
eat-2 and isp-1 genes, respectively [124-126]. mev-1 encodes the cytochrome b large subunit (Cyt-
1/ceSDHC) in complex II of the mitochondrial electron transport chain. The mev-1 mutation was 
shown to shorten lifespan and the mutants display a large panel of age-related phenotypes and 
metabolic disorders [127]. eat-2 encodes a ligand-gated ion channel subunit closely related to the 
non-alpha-subunits of nicotinic acetylcholine receptors (nAChR). Mutation in the eat-2 gene af-
fects primarily pharyngeal pumping rates, slowing pumping down to 10–20% of the normal 
rhythm, which mimics a caloric restriction state and increases the lifespan [128]. isp-1 encodes a 
Rieske iron sulphur protein, which is a subunit of complex III of the mitochondrial electron 
transport chain. A mutation in this gene affects the rates of physiological processes like reproduc-
tion and development, and extends the longevity [126]. 
As for the wild-type, we could reliably determine the average duration of the bean to 1.5-fold 
stage phase (phase 2) (~90 min) and the average duration of the 1.5-fold stage to hatching phase 
(phase 3) (~280 min) in the eat-2(ad465), Pges-1::mito::gfp, hsp-6::gfp and Prab-3::cco-1HP;hsp-
6::gfp strains. A weak increase of the phase 3 was measured with the Pmyo-3::mito::gfp transgenic 
strain, which is in accordance with the slight developmental delay observed during the larval stage 
(data not shown). A more significant 1.3-fold increase of phase 3 is instead observed in the mev-
1 mutants, while for the isp-1(qm150) mutants, both phases 2 and 3 were more than two times 
longer compared to the control worms. These results already highlight the importance of the mi-
tochondrial electron transport chain function during embryogenesis. 
Eventually, the possibility of automated on-chip chemical or drug treatment was validated by ex-
posing the worms to the anticancer drug, 5-fluorouracil (5-FU). This compound induces cell-cycle 
arrest and apoptosis of germ-line cells in C. elegans [129]. In our experiment, wild-type worms 
were isolated in the culture chamber at the L4 larval stage and treated on-chip with 5-FU at a 
concentration of 2 mM, while being cultured at 25°C towards the adult stage. After washing the 
chamber with clean M9 buffer, successively laid embryos were transferred to the incubator array 
and monitored for 12 h. All embryos prematurely died, proving the efficiency of the drug exposure 
of the worms in the culture chamber of the chip (Figure 3.10b). 3.3.2 Study of mitochondrial biogenesis during embryonic development  
Knowing that the knockdown of many mitochondrial genes can induce embryonic lethality or re-
sult in an infertile phenotype, we investigated mitochondrial function and biogenesis during em-
bryogenesis, focusing on the molecular pathway known as mitochondrial unfolded protein re-
sponse (UPRmt). The latter is an adaptive response that monitors and subsequently repairs abnor-
mal proteostasis within the mitochondria and, as such, ensures the proper function and integrity 
of the mitochondria [130, 131]. In C. elegans, it has been shown that UPRmt is most effective when 
triggered during larval development, resulting in a permanent adaptive protection of the mito-
chondria throughout life and, as such, increasing the animal’s survival rate (Figure 3.11). This care-
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ful control of mitochondrial activity early in life seems to setup a proper rate of aging, which per-
sists throughout life, probably through the establishment of epigenetic imprints [132]. However, 
it is still unknown whether the UPRmt is operational during the earliest phases of the life, i.e. em-
bryonic development. As tackling this problem requires the careful analysis of multiple parame-
ters in a spatio-temporal controlled fashion in a living embryo, we used our platform to address 
this challenging question. 
Before measuring the UPRmt activity, we first investigated whether mitochondrial biogenesis could 
be detected and monitored in two different tissues in embryos, i.e. the muscle and the intestine. 
Indeed, a proper mitochondrial activity is a prerequisite for the induction of a mitochondrial 
stress. Two transgenic strains of worms were used, expressing GFP either in the mitochondria of 
the body wall muscle cells, i.e. the Pmyo-3::mito::gfp worm strain SJ4103, or in the intestinal cells, 
i.e. the Pges-1::mito::gfp worm strain SJ4143 [122]. Larvae or adult worms of these strains are 
commonly used to monitor the mitochondrial activity, proliferation and morphology [133, 134]. 
Brightfield and fluorescent pictures of the same embryo were quasi-simultaneously recorded and 
superimposed, permitting accurate localization of the fluorescent signal. Interestingly, our analy-
sis revealed that mitochondrial proliferation takes place in both muscle and intestinal cells (Figure 
3.12a-f and Figure 3.12g-l, respectively). The mitochondrial biogenesis looks different in terms of 
intensity between muscle and intestinal cells, probably due to the different number and role of 
mitochondria, as it is clear when comparing Figure 3.12a-c with Figure 3.12g-i. Indeed, after the 
1.5-fold stage of embryogenesis, most cellular proliferation and migration of the body wall mus-
cles are completed and the worm starts twitching in the eggshell, requiring a sustained energy 
supply provided by the mitochondrial activity [135]. Beside the intensity of mitochondrial biogen-
esis during embryogenesis, our study revealed that mitochondrial proliferation behaves inde-
pendently of tissue morphogenesis. While genetic markers of the body wall muscle and the intes-
tinal cells significantly appear before the bean stage [136], we observed a rather large delay re-
garding the onset of mitochondrial proliferation, highlighting a specific increase of the energy sup-
ply during the late phase of the embryo development (Figure 3.12d-f and Figure 3.12j-l). Further-
 
Figure 3.11 | Mitochondrial unfolded protein response. (a) Schematic representation of the mitochondrial 
unfolded protein response (UPRmt), as known for the larval and adult stages of the nematode C. elegans. 
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more, as already observed in mouse embryos, this late proliferation of mitochondria could coin-
cide with the pronounced structural and functional differentiation of the mitochondria within the 
different tissues [137]. 
 
Figure 3.12 | Study of mitochondrial biogenesis. (a-c) Merges of optical brightfield and fluorescent pictures 
of the Pmyo-3::mito::gfp embryos and (d-f) the corresponding GFP quantification over the whole time-span 
from embryo capture to hatching (n=4). Pictures are grouped in blocks of same experimental observation 
and image representation conditions (exposure time and maximum displayed pixel intensity). (g-i) Merges 
of optical brightfield and fluorescent pictures of the Pges-1::mito::gfp embryos and (j-l) the corresponding 
GFP quantification over the whole time-span from embryo capture to hatching (n=14). Pictures are grouped 
in similar blocks as for the Pmyo-3::mito::gfp embryos. For (d-f) and (j-l), the curves correspond to the rela-
tive GFP induction compared to the initial time point in (d) and (j), respectively, of the experiments. Bar 
graphs are expressed as mean+SEM, * p≤0.05, points below a horizontal line are significantly different from 
the corresponding control.  Scale bars = 10 μm. 
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Interestingly, a previous study showed that the mitochondrial DNA copy number – which is indic-
ative of the relative number of mitochondria in the organism – remains unchanged from the late 
embryo stage up to the L3 larval stage, whereas a five-fold increase occurs with the transition 
from L3 to L4 [138]. Our experimental observations suggest that a first increase in mitochondrial 
biogenesis actually takes place earlier, during the embryogenesis (Figure 3.12f and Figure 3.12l). 
Although embryonic mitochondrial biogenesis is less pronounced compared to that occurring dur-
ing the L3 to L4 transition, it is significant and we speculate that it provides the necessary amount 
of mitochondria and energy, required for the first steps of the larval development.  3.3.3 Study of mitochondrial unfolded protein response during embryogenesis 
We investigated whether the UPRmt can also be detected during embryogenesis. To monitor the 
mitochondrial stress response in living embryos, we used a transgenic strain of worms that reports 
on the activity of the UPRmt with integrated GFP genes driven by the regulatory DNA region of the 
mitochondrial chaperone hsp-6 [121]. In these transgenic worms, an increase of hsp-6::gfp ex-
pression is indicative of the presence of a mitochondrial stress and the subsequent induction of 
the UPRmt [123, 139]. We first examined the UPRmt induction in unstressed embryos. Despite a 
pronounced mitochondrial proliferation occurring during the late phase of the embryogenesis, we 
did not observe a matching increase of hsp-6::gfp expression (Figure 3.13a,d). This result is in 
agreement with previous reports showing an activation of the UPRmt during the L3 to L4 transition 
period, where a similar burst of mitochondrial biogenesis occurs only when a mitochondrial stress 
is experimentally induced [123, 138]. Nevertheless, a careful monitoring and surveillance of mito-
chondrial stress is fundamental for the embryogenesis, as the loss of function of some UPRmt me-
diators, such as hsp-6 and dve-1, has been reported to lead to an early death of the worm em-
bryos[140, 141].  
Studies performed at the larval stages indicated that the UPRmt can be robustly induced by apply-
ing direct mitochondrial stress. These stresses include oxidative stress and the inhibition of the 
mitochondrial transcription and translation machinery, resulting in the disturbance of the mito-
nuclear proteostatic balance [121, 139, 142]. Mitonuclear imbalance results from the disruption 
of the stoichiometric balance between components of oxidative phosphorylation (OXPHOS) com-
plexes encoded by the mitochondrial and/or the nuclear genome and robustly activates the UPRmt 
[139]. Examples of such a mitonuclear imbalance are provided by the loss-of-function mutation of 
the nuclear-encoded complex III protein, isp-1, and/or the complex IV protein, cco-1, which in-
duces a robust UPRmt and extends worm lifespan. These genetic manipulations deplete single com-
ponents of specific OXPHOS complexes, overloading the mitochondrial matrix with their respec-
tive partner proteins, which cannot be assembled into multiprotein complexes. 
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Figure 3.13 | Study of mitochondrial unfolded protein response (UPRmt) during embryogenesis. (a-c) Rep-
resentative optical brightfield and corresponding fluorescent pictures that show the hsp-6::gfp expression 
in (a) wild type, (b) isp-1(qm150), and (c) Prab-3::cco-1HP strains. (d-f) Quantification of the hsp-6::gfp in-
duction in (d) wild type, (e) isp-1(qm150) and (f) Prab-3::cco-1HP strains over the whole time-span from 
embryo capture to hatching (n=17, 7, and 21, respectively). The curves correspond to the relative GFP in-
duction compared to the initial time point of each experiment. The blue area in each graph represents the 
base level 95% interval of confidence for each experiment. Bar graphs are expressed as mean+SEM, * 
p≤0.05, points below a horizontal line are significantly different from the corresponding control. (g-h) Com-
parison of the relative wild type hsp-6::gfp induction with the one of the (g) isp-1(qm150) and (h) Prab-
3::cco-1HP strains. Bar graphs are expressed as mean+SEM, * p≤0.05, *** p≤0.001. (i-j) Localization of the 
hsp-6::gfp expression in the embryonic tissues, as observed in a period starting 60 min before hatching, for 
the (i) isp-1(qm150) and (j) Prab-3::cco-1HP strains. Scale bars = 10 μm. 
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To trigger a potential constitutive UPRmt in embryos, we first used the mutant strain MQ887 car-
rying a mutation in the isp-1 gene, which we crossed with the hsp-6::gfp worms. The resulting isp-
1(qm150);hsp-6::gfp strain showed a constitutive activation of hsp-6::gfp in larvae and adult 
worms, revealing a strong and continuous mitochondrial stress [123]. By monitoring the hsp-6::gfp 
expression during the embryo development, we observed a 4- to 5-fold induction of the UPRmt, 
which matches the onset of mitochondrial biogenesis (Figure 3.13b,e,g). Interestingly, this mito-
chondrial stress response seems to be more pronounced in the intestinal cells, which is in accord-
ance with previous observations in larvae and adults and confirms that this tissue is one of the 
prime sites for the activation of the UPRmt (Figure 3.13i) [123]. 
While UPRmt can be activated in a cell-autonomous manner, as here illustrated in the intestine, 
this stress response can also be triggered in a cell-non-autonomous manner [123]. To explore this 
hypothesis, we used the hsp-6::gfp strain of worms carrying an additional transgene, which drives 
the knockdown of the mitochondrial gene cco-1 only in neurons, i.e. the Prab-3::cco-1HP;hsp-
6::gfp worm strain AGD1073. In this strain, the down-regulation of cco-1 in neuronal cells induces 
not only a localized mitochondrial stress and UPRmt in the nervous system, but also induces a so-
called “mitokine” signal, which will relay and induce UPRmt in peripheral tissues, such as the intes-
tine [123]. This mitochondrial communication between central and distal tissues seems to be fun-
damental, as it can synchronize the rate of aging for the whole organism independently of the cell-
autonomous functions [143]. In the post-embryonic phase of worm development, the silencing of 
cco-1 exclusively in neurons is sufficient to promote a mitochondrial stress that is propagated in 
distal tissues [123]. In this regard, we asked whether a similar mitochondrial cross-talk between 
tissues would already occur during the embryogenesis. One would in fact expect that the perfect 
organisation of this developmental period could involve a watchful communication between tis-
sues in terms of mitochondrial biogenesis and stress response regulation. We observed a robust 
2-fold induction of UPRmt when cco-1 is silenced in neuronal cells during the embryogenesis (Fig-
ure 3.13c,f,h). Interestingly, the activation of the mitochondrial stress response seems independ-
ent of the rab-3 promoter activity – rab-3 starts being expressed in the early cell division stages 
[136] – but rather a consequence of the concomitant mitochondrial proliferation and cco-1 knock-
down. Furthermore, while the UPRmt induction takes place in the intestinal cells of the isp-
1(qm150) embryos, neurons seem to be the primary cells for the mitochondrial stress response in 
the case of cco-1 silencing in the neuronal system (Figure 3.13j). This difference between embryos 
and larvae concerning the lack of cell-non-autonomous activation of UPRmt could be explained by 
the fact that the neuronal and hormonal signalling pathways required for signal transmission are 
not yet fully developed at the embryonic stage. 3.4 Materials and methods 3.4.1 Chemicals and Materials  
4-inch 550 µm thick Si wafers and DIW were obtained from the Center of Micro- and Nanotech-
nology of EPFL. GM 1070 SU-8 negative photoresist was purchased from Gersteltec (Pully, Swit-
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zerland). PDMS Sylgard 184 was acquired from Dow Corning (Wiesbaden, Germany). 1 mL boro-
silicate H-TLL-PE syringes were purchased from Innovative Labor Systeme (Stutzerbach, Germany). 
Microline ethyl vinyl acetate tube with 0.51 mm inner and 1.52 mm outside diameters was bought 
from Fisher Scientific (Wohlen, Switzerland). Pluronic F-127 was purchased from BASF (Basel, Swit-
zerland). M9 buffer was obtained by adding 3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl, 1 mL 1 M MgSO4, 
H2O to 1 litre and sterilization by autoclaving. Pluronic F127 solution was prepared by diluting 
0.02% (weight/volume) Pluronic F127 in M9. 3.4.2 C. elegans strains and culture  
C. elegans strains were cultured at 20°C on nematode growth media agar plates seeded with Esch-
erichia coli strain OP50, unless stated otherwise. Strains used were wild-type Bristol N2, DA465 
eat-2(ad465) II, MQ887 ips-1(qm150) XX, SJ4100 (zcIs13[hsp-6::GFP]), SJ4103 (zcIs14[myo-
3::GFP(mit)]), SJ4143 (zcIs17[ges-1::GFP(mit)]), TK22 mev-1(kn1). Strains were provided by the 
Caenorhabditis Genetics Center (University of Minnesota). The AG1073 (Prab-3::cco-1HP;hsp-
6::gfp) strain of worms was kindly provided by Andrew Dillin (UC Berkeley, CA, USA). Worms were 
suspended in M9 solution prior to each microfluidic experiment. Microfluidic worm synchroniza-
tion procedures are detailed in Figure 3.8.  3.4.3 Fabrication of the microfluidic chips  
Microfluidic devices were prepared by soft lithography [144] using 2-layer SU-8 molds. Briefly, 
conventional photolithography was used to pattern a 35 μm-thick layer of SU-8 photoresist on 4-
inch wafers. A 85 μm-thick layer of SU-8 was then patterned on top of the first one. The silicon 
mold was then diced in 15 mm × 18 mm microchips, which were inserted at the bottom of an 
aluminum/PMMA mold for PDMS casting. 1.5 mm diameter steel pins were used to define the 
lateral connections of the device for the external tubing insertion. A liquid PDMS mixture (10:1 
base:cross-linker weight ratio) was degassed, injected into the mold and cured at 100 °C for 1 h. 
Upon extraction from the mold, each PDMS chip was bonded by plasma-activation to a 150 μm-
thick glass coverslip. The chip was then connected to external tubing and enclosed in a PMMA 
holder (Figure 3.3a), designed for the observation of the device through any upright or inverted 
microscope and with any kind of objective. 3.4.4 Image acquisition and processing 
The microfluidic chip was integrated onto an inverted microscope (Axio Observer, Zeiss) equipped 
with two illumination systems: (i) a precisExcite High-Power LED Illumination system (Visitron, 
Puchheim, Germany) for brightfield imaging and (ii) a Lambda DG4 illumination system (Sutter 
instruments, Novato, CA, USA) for fluorescence imaging. The microscope had a motorized xy-
stage, equipped with an ASI piezo controller for z-displacement (Visitron, Puchheim, Germany) 
and the automated imaging process was controlled using VisiView Premier Image acquisition soft-
ware (Visitron, Puchheim, Germany).  
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To start the automated imaging process, the position of the first egg in the array was set as initial 
point of the xy-stage scanning, while the locations of the other eggs were automatically deter-
mined by the interdistance between adjacent incubators (118 μm). A “wavelength program” was 
set on the software, to automatically switch between brightfield and fluorescent imaging modes, 
by controlling both the illumination systems. “Time-lapse” and “stage position” programs were 
set to automatically perform scanning and imaging over the full array at a desired rate, hence 
resulting in parallel time-lapse imaging of all the embryos. To avoid phototoxicity effects during 
these fluorescence imaging experiments, we minimized the exposure time of the embryo to the 
fluorescent excitation light (t < 100 ms) and pictures were recorded at a single focal plane of the 
microscope (i.e. at a single z value), despite the possibility of taking z-stacks with our setup. The 
movement of the embryo inside its eggshell during the twitching phase could sometimes intro-
duce instantaneous modulations in the collected fluorescent intensity, because of the time-de-
pendent positioning of the developing larva inside the focal volume of the microscope objective, 
but variations of the average fluorescent intensity of the embryo in a given xy-plane remained 
relatively small. The fluctuations in fluorescent intensity due to twitching of the embryo are 
smaller than the error bars in Figure 3.12 and Figure 3.13. For each fluorescent picture, GFP in-
tensity values were measured as average pixel intensity over the area occupied by the single em-
bryo under observation. A background value was then measured for each picture as average pixel 
intensity over the microchannel area and this value was subtracted from the previously calculated 
one, to exclude the influence of any external autofluorescence sources from the measurement.  
Moreover, unspecific GFP expression is avoided by the use of tissue-specific promoters, e.g. the 
myo-3 promoter triggers GFP expression in the body wall muscles, while the ges-1 promoter in 
the intestinal cells only. 
A simple Matlab script (MathWorks, Natick, MA, U.S.A) was written to reorder the large amount 
of data of each experiment according to the image xy-coordinates, time, light wavelength and 
exposure time. Image processing was performed with Fiji software (http://imagej.nih.gov/ij; ver-
sion 1.47b). 3.5 Conclusions 
In our platform, a well-defined and synchronized C. elegans embryo population can be isolated 
from an on-chip worm culture and studied in a fully automated way at extremely high spatial and 
temporal resolution. The device allows operation and analysis at the single-organism level, thus 
preserving the identity of each individual embryo, while at the same time providing statistics of 
the complete population. We demonstrate the capability of our platform to accurately analyze 
the real-time dynamics of different phases of the embryonic development, to monitor live protein 
expression in developing embryos during the complete embryogenesis, and to perform systematic 
studies that address outstanding issues in developmental biology.  
Our approach allows suppressing the bleaching step in the classical method, which is used for 
embryo harvesting and could affect the embryo integrity. Furthermore, our on-chip embryo syn-
chronization allows using a minimal amount of gravid worms to obtain an accurate number of laid 
eggs. Finally, the limitation of the manual handling and the full automation of our protocol provide 
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great advantages compared to the actual standard procedure, requiring several manual prepara-
tion steps (maintenance of a large worm population on solid agar plate, recovery of this worm 
population with the bleaching solution, washing of the egg preparation, egg transfer, etc.). 
In particular, we validated our platform by characterizing development, mitochondrial biogenesis 
and UPRmt in worm embryos at a precision that would have been very difficult or impossible to 
achieve with standard techniques. The imaging and monitoring of the embryogenesis require spe-
cific techniques, which imply single embryo isolation and its mounting [106]. Our microfluidic de-
vice was specifically designed to simplify and automate embryo handling, and only requires load-
ing of a few adult worms into the chip. Furthermore, classical protocols for embryo analysis do 
not allow the concomitant monitoring of multiple replicates in identical biological conditions. The 
incubator array format of this platform provides a unique opportunity to study the intra-embryo 
variability in terms of viability, development or gene expression. This platform allows the identifi-
cation in a reproducible and accurate manner of the different phases of the C. elegans embryo-
genesis that occur after the egg laying, from the early cell division stages to hatching. We were 
able to discriminate variations in terms of embryonic development and describe how perturba-
tions of the mitochondrial functions can profoundly impact on the embryogenesis.  
In C. elegans, the mitochondrial biogenesis mainly occurs during the late larval phase, i.e. during 
the L3 to L4 larval transition [138]. Here we described that another burst of mitochondrial biogen-
esis takes place during the last phase of the embryo development. This late embryonic prolifera-
tion of mitochondria seems to overlap with the differentiation of the mitochondria within the 
tissues, as revealed by the different profiles in term of biogenesis intensity and timing observed 
in muscle and intestinal tissues. Furthermore, while the mitochondrial biogenesis that occurs dur-
ing the embryogenesis is less intense compared to the L3 to L4 transition, it is tempting to specu-
late that this late event in the embryo could be a prerequisite for the first steps of the larval de-
velopment, by providing the required amount of mitochondria and energy. The crucial importance 
of the late phase of embryonic mitochondrial biogenesis is corroborated by the observation that 
several disturbances of the mitochondrial function during this specific period can impact later in 
the worm life [145]. 
In addition, we demonstrate that such perturbations of the mitochondrial function can trigger the 
UPRmt pathway in embryos. The activation of this specific mitochondrial stress response matches 
the onset of mitochondrial biogenesis, which is in accordance with what is observed in larvae. 
Furthermore, the UPRmt seems to work mainly in a cell-autonomous manner in embryos, probably 
because the signalling pathways required for the signal transmission between neurons and the 
distal tissues are not yet fully developed at this stage of life. These observations are the first proof 
that UPRmt is functional during the embryogenesis. One could hypothesize that a mitochondrial 
stress restricted to the late phase of the embryo development could trigger a beneficial effect 
during the rest of the life, opening the concept of a potential “mitochondrial imprinting” during 
the first step of the organism’s life. 
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In the future, due to the versatility of our platform design, its live imaging capability can be readily 
extended to include other types of microscopies, like differential interference contrast micros-
copy, for high-contrast brightfield live imaging, and confocal microscopy to achieve extreme spa-
tial resolution. Finally, we expect that similar microfluidic designs will be used to perform live im-
aging of a multitude of development events, like gastrulation and tissue morphogenesis during 
embryogenesis in other species of nematodes or other model organisms.  
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 Microfluidic culture chamber arrays for embryo-to-adulthood studies of 
C. elegans at single-organism resolution 
Abstract In small-animal model research, a common issue for most of the applications is 
represented by animal isolation and monitoring, as well as by their age synchronization. In most 
of the biological laboratories these operations are manually performed via long and tedious pro-
tocols, prone to low reproducibility due to human errors and low control on the environmental 
conditions. For C. elegans research, this issue is amplified by the particularly small size of this 
model organism, which further complicates its manipulation and study. Thus, microfluidic tools 
for the automated handling of nematodes are recently gaining a lot of attention in the whole C. 
elegans research community. However, all the existing techniques for C. elegans isolation and 
monitoring – both manual and microfluidic-based – still base their population synchronization 
protocols on the selection of worms of different larval stages (typically L1 or L4), with no univer-
sally accepted standards and complete loss of information about all the developmental stages 
occurring prior to the synchronization itself. To solve these issues, we introduce a new microfluidic 
device which uses passive hydrodynamic trapping of C. elegans embryos as a method for worm 
isolation and age synchronization, for subsequent monitoring of the full development of the iso-
lated worms at single-organism resolution. Our method allows synchronizing and starting moni-
toring a worm population at the earliest possible stage – i.e. upon laying of the embryos – and 
could thus set a new standard in the field. In our device, all the operations are driven via computer 
controlled syringe-pumps and performed inside a monolithic PDMS microfluidic chip. In this chap-
ter, we discuss the microfluidic chip design and working principles and we describe an automated 
on-chip protocol for embryo isolation and transfer to individual microfluidic chambers, tailored 
for single-worm culture, treatment, and phenotypic study. With our device, we demonstrate the 
possibility of monitoring the whole development – from embryogenesis to adulthood – of individ-
ual worms at unprecedented levels of accuracy and automation. Moreover, being the embryos 
collected upon on-chip egg-laying (see chapter 3), the link between each worm population and its 
previous generation is conserved and can be tracked. Therefore, we foresee the use of our plat-
form for transgenerational and epigenetic studies across successive worm generations. 
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4.1 Introduction 4.1.1 Microfluidic tools for long-term longitudinal studies on C. elegans  
Biological processes are dynamic by their nature and the possibility of performing accurate time-
resolved analyses of biological phenomena is a key need in the biomedical field. Many biological 
processes can be successfully studied in cell systems and several technological solutions have been 
proposed in the last years for long-term observation of dynamic phenomena in living cells [146-
149]. However, to investigate time-dependent processes in which the interaction between multi-
ple cells and/or different tissues plays a crucial role, long-term longitudinal studies of full organ-
isms are required. The nematode C. elegans represents one of the best model organisms for this 
kind of analyses, mainly because of its very fast life cycle, combined with the ease of its genetic 
manipulation. Complex biological processes related to human dysfunctions developing through-
out many years – such as metabolic or neurodegenerative diseases – can be potentially investi-
gated in C. elegans in a matter of a few days or even hours [150]. Such an outstanding possibility 
triggered the development of different micro-technological tools for improving C. elegans han-
dling and increasing the throughput of their analyses [103]. For instance, several miniaturized de-
vices have been recently proposed to study worms’ neurobiology [151], chemical sensitivity [152], 
behavior [153], and development [120], whereas different microfluidic designs offered the possi-
bility of on-chip worm sorting [154], culture [110], immobilization [155], imaging [156], and/or 
screening [157]. 
A “worm-clamp” microfluidic device has been developed by Hulme et al., with the goal of arraying 
and immobilizing C. elegans [158].  This system consisted of a PDMS-based array of gradually ta-
pered microfluidic channels, with width ranging from 100 µm down to 10 µm, over 5 mm length. 
All these microchannels were merging into a common inlet on one side and a common outlet on 
the other side. As the animals were introduced into the microchannel network, they were pushed 
at the end of the tapered channels, where they got stuck. Almost all the trapped worms could 
moreover be eventually removed from the clamps by reversing the flow direction inside the de-
vice. In another study, then, the same group added circular confinement chambers to each branch 
of the microfluidic array described above (Figure 4.1a) [110]. In this chip, worms could be cultured 
in the different chambers and immobilized for imaging at the adult stage by suction in the worm-
clamps.  Each line of the array could be selectively addressed using prefabricated screw valves 
[159]. To prove the suitability of this device for performing longitudinal studies/measurements, 
individual worms were loaded via suction at the fourth larval stage (L4) into each confinement 
chamber and investigated over their lifespan.  
Applicability of droplet-based microfluidic devices for creating an array of droplets containing C. 
elegans was also demonstrated. Clausell-Tormos et al. managed to encapsulate C. elegans eggs, 
along with E. coli bacteria as animal feed, inside 660 nL aqueous plugs. This system was then em-
ployed to monitor the larvae after egg hatching, during the various phases of their development 
[160]. While, on the one hand, this droplet-based system is relatively simple to design and does 
not require a complex microfluidic architecture, on the other hand, it lacks of flexibility, since it 
cannot isolate mother animals from their own progeny. In another work, Shi et al. designed a 
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microfluidic device for worm encapsulation in isolated droplets and subsequent droplet immobi-
lization in a trap array [161] (Figure 4.1b). This microfluidic device consisted of a T-junction droplet 
generator combined with a serpentine microchannel, short-circuited at each branch by a cavity 
for droplet trapping. The different fluidic resistances of the main flow path and the cavity-based 
short-circuited flow path ensured efficient droplet trapping, while around 60% of the trapped 
droplets contained a single worm.  
Chung et al. [162] proposed then a “chamber array” microfluidic design for behavior-based chem-
ical screening on C. elegans (Figure 4.1c). The specific geometry of the device was tailored for the 
injection of single adult worms in separated chambers and their subsequent exposure to chemical 
stimuli with precise temporal control. As a proof of concept, worms were exposed to sodium azide 
at different concentrations and the time-dependent descrease in their locomotion was quantified 
by determining the worms’ body bend frequency over time. 
 
Figure 4.1 | Worm-chips for longitudinal studies at single-worm resolution. (a) Schematic representation 
of (ai) the “lifespan chip” geometry and (aii) the worm handling process proposed by Hulme et al. (repro-
duced from [110]). Worms are loaded into the chip at the L4 larval stage, cultured towards the adult stage 
and periodically sucked into a narrowing channel for temporary immobilization and imaging. (b) Pictures of 
the droplet-based system for C. elegans assays proposed by Shi et al. (reproduced from [161]): (bi) droplets 
encapsulated with worms and (bii) representative images of worms during an on-chip motility test. (ci-cii) 
Optical micrographs of the worm chamber array device proposed by Chung et al. (reproduced from [162]). 
A “loading channel” associated to each chamber is used for worm injection. (ciii) Schematic drawing showing 
a cross-section of the device, with 2 different PDMS compositions to tune the elasticity of the microchan-
nels. 
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4.1.2 Challenges and opportunities for C. elegans synchronization and lifespan stud-ies  
Most of the platforms conceived for C. elegans lifespan studies rely on worm synchronization at 
the L4 larval stage and allow monitoring the duration of worms’ adult life, but do not provide any 
information about their embryonic and larval development. Very few platforms have been pre-
sented for C. elegans studies starting from earlier larval stages, while there is no currently availa-
ble technological solution for monitoring the actual full worms’ lifespan, i.e. from embryogenesis 
to death. This operation is particularly challenging since it requires accurate manipulation of bio-
logical entities of very different sizes and motilities. Embryos are 30-50 μm in size and they are 
enclosed in their eggshells: they have to be gently and accurately transported by fluidic forces if 
they need to be displaced at specific locations within a microfluidic chip. During larval develop-
ment, both worms’ length and diameter increase by a factor of about 10. C. elegans are moreover 
very motile: their overall force increases together with their size, while their motility is significantly 
amplified in liquid culture conditions (i.e. swimming gait) with respect to solid media cultures (i.e. 
crawling gait). All these factors need to be carefully taken into account when designing chip ge-
ometries for confinining and studying worms during their whole development from the embryonic 
to the adult stage. Starting from the experience achieved by developing on-chip solutions for C. 
elegans embryogenesis analyses (see chapter 3), we propose here a new microfluidic platform 
which aims at extending the worms’ monitoring and analysis period from its embryonic develop-
ment to its complete lifespan.  4.2 Microfluidic device design and automated operation 4.2.1 Overview of the microfluidic device 
The geometry of our microfluidic device is conceived according to two main design rules: (i) a 
monolithic PDMS chip structure, ready to use upon a single bonding step (Figure 4.2a); (ii) use of 
pure passive hydrodynamics to carry on a full set of automated microfluidic operations. The first 
requirement is set to fasten and ease the chip preparation, by avoiding tedious manual operations, 
such as chip-by-chip alignment and bonding of several PDMS layers. The second rule allows mini-
mizing the device connections and simplifying its control: first, our device does not need any extra-
circuit or tubing for pneumatic valve control; second, all the microfluidic operations are handled 
by controlling inflow speed via automated syringe-pumps and outflow direction through two ex-
ternal valves. The absence of any active component in our device is however possible only by 
careful design of all the constitutive parts of our planar microfluidic geometry (Figure 4.2b).  
Our chip is made up of two main building blocks: (i) the “parents’ culture chamber”, tailored for 
the isolation of young adult worms from a mixed population and their successive culture and 
treatment (Figure 4.2c); (ii) the “progeny’s culture chamber matrix”, featuring 16 micro-compart-
ments for the capture of 16 embryos laid in the parents’ chamber and their subsequent culture 
and phenotyping over several days, at single-worm level (Figure 4.2d). The parents’ culture cham-
ber is connected to arrangements of microfluidic channels of different size and geometry, de-
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signed for different specific functions, as previously described in chapter 3. A mixed worm popu-
lation is loaded into the chamber from the channels connected to the In1 inlet: adult worms are 
retained inside the chamber by the filter associated to the Out 1 outlet, while larvae are directly 
washed out of the chip. Three separate inlets (In 2-4) are used to inject into the chip E. coli sus-
pension, S-medium and chemicals, respectively. The adjacent channel arrangement promotes uni-
form liquid perfusion through the culture chamber, while preventing any passage of worms to-
wards the inlets. Finally, the filter geometry connecting the parents’ chamber to the progeny’s 
chamber matrix is designed to ensure efficient transfer of embryos towards the matrix, while re-
taining all the worms inside the parents’ chamber.  
Each embryo which is transported through the serpentine channel connecting the 16 culture 
chambers is redirected towards the first empty micro-incubator and captured there by passive 
hydrodynamic trapping (Figure 4.2e). This mechanism allows automatically associating a single 
embryo to each culture chamber. The 16 captured embryos are then transferred to each dedi-
cated chamber, for their successive hatching, culture towards the adult stage, monitoring and 
phenotyping at single-worm resolution (Figure 4.2f). 
4.2.2 Automated device operation 
The device is operated through sequences of automated processes (Figure 4.3). At the beginning 
of each experiment, a worm suspension is injected into the microfluidic chip from the In1 inlet 
 
Figure 4.2 | Overview of the microfluidic device. (a) Picture of the microfluidic device. Scale bar = 5 mm (b) 
Schematic representation of the microfluidic chip layout, featuring as main constitutive parts: the parents’ 
culture chamber, the progeny’s culture chamber matrix, five inlets (In1 to In5) and two outlets (Out1 and 
Out2). Scale bar = 2 mm. (c) Zoom on the parents’ culture chamber, including a drawing of young adult C. 
elegans for size comparison. The chamber is delimited by specific microfluidic channel arrangements, tai-
lored for different functions: (top) worm injection, (bottom) worm synchronization, (left) E. coli / drug de-
livery and (right) egg transfer. Scale bar = 500 μm. (d) Schematic representation of a portion of the progeny’s 
culture chamber matrix (Scale bar = 200 μm), with (e) a further zoom on a single embryo micro-incubator, 
used for hydrodynamic trapping of one C. elegans embryo for each chamber (Scale bar = 100 μm). (f) Illus-
tration of the parallel time-lapse imaging that is enabled on the array of worms within the progeny’s culture 
chamber matrix. Single worms are accurately monitored from embryogenesis to adult life. 
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towards the Out1 outlet (Figure 4.3a). We typically employ 10 μL suspensions containing about 
10 adult worms. For flow rates in the 500-1000 nL/s range, the geometry of the filter at the Out1 
outlet (800 μm long straight channels, 60 × 35 μm2 in section) ensures that all the larvae which 
are present in the suspension are simply washed through the chip towards the Out1 outlet, while 
adult worms are retained in the culture chamber, because of their larger size and better resistance 
against the flow. Afterwards, adult worms are cultured on-chip by perfusing E. coli suspension 
through the chamber (from In2), whereas for worm treatment, drugs or chemicals can be intro-
duced in the chip as well (at In4) (Figure 4.3b).  
For 10 young adults at their peak of reproduction, tens of eggs are typically laid inside the parents’ 
culture chamber in about 1 h upon their loading on-chip. At this point, a 200 nL/s flow rate of S-
medium buffer along the In3-Out2 direction is used to transfer all the embryos present in the 
chamber towards the progeny’s culture chamber matrix. As will be detailed further, the geometry 
of this part of the chip is conceived to ensure the isolation of a single embryo aside each round 
 
Figure 4.3 | Operation of the microfluidic device. (a) First a 10 µL suspension of worms in M9 buffer is 
injected into the microfluidic device along the In1-Out1 direction at a flow rate of 500 nL/s. Symbols used 
for the in- and outlets: arrow = flow; cross and circle = closed valve.  The “worm synchronization filter” is 
tailored to retain inside the chamber only adult worms, as selected by their larger size and their better 
swimming abilities. (b) Subsequently worm culture is controlled by periodically injecting E. coli in M9 buffer 
along the In2-Out2 direction, typically at 50 nL/s flow rate. This ensures normal development of the worms 
in the liquid environment and continuous embryo production during their adult lifespan. Optionally, drugs 
or chemicals can be introduced at the In4 inlet for on-chip worm treatment. (ci)  Injection of M9 buffer at 
200 nL/s flow rate along the In3-Out2 direction triggers the transfer of all the eggs present in the chamber 
towards the progeny’s culture chamber matrix, where (cii) they are captured by passive hydrodynamics in 
single micro-incubators. (d) A flow pulse is used to simultaneously trigger the transfer of all the captured 
embryos from a micro-incubator to the adjacent chamber. (e) The perfusion of E. coli suspension across the 
whole progeny’s culture chamber matrix ensures proper worm feeding and development, while (f) auto-
mated parallel time-lapse imaging is used to trace multi-phenotipic profiles of the worms at single-worm 
resolution. 
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culture chamber, by positioning it in a specifically designed micro-incubator via passive hydrody-
namic trapping (Figure 4.3c). Complete filling of the array of 16 micro-incubators is achieved in a 
few seconds, and the remaining eggs are automatically directed towards the Out2 outlet. As a 
final step of the embryo transfer protocol, a 2 s pulse of 40 μL buffer is injected towards Out2. 
Because of the relatively high fluidic resistance of the chamber matrix, this single flow pulse builds 
temporary overpressure inside the chip and slightly deforms the PDMS structure of the micro-
incubators to trigger the transfer of each embryo to its chamber (Figure 4.3d).  
Successively, perfusion of E. coli suspension from the In5 inlet towards the Out2 outlet allows 
distributing bacteria across the whole chamber matrix and feeding of the 16 worms after egg 
hatching (Figure 4.3e). At the same time, liquid flow along the In5-Out2 direction allows decou-
pling the use of the two sections of the chip, so that parents and progeny could be cultured at the 
same time, with no further transfer of embryos or worms from one side to the other. Alternatively, 
the parents’ can be easily washed out of the chip after the embryo transfer inside the progeny 
chambers. Flow pulses of 5-10 μL/s along the In1-Out1 direction allow in fact inducing the passage 
of adult worms through the filter at Out1, with no perturbation of the progeny inside the 16 cham-
bers aside. Worms in the progeny’s chamber matrix can be cultured, monitored and analysed over 
consecutive days, at single worm resolution, while extracting precious phenotypic information – 
e.g. growth rates, protein expression, motility, etc. – related to all the different phases of its de-
velopment, from early embryogenesis to adulthood (Figure 4.3f).  
Finally, it is worth noticing that the whole presented set of complex microfluidic operations is 
allowed in our chip by mere changes in flow rate and/or in direction of the injected flows, con-
trolled via software by automated syringe pumps. In this chip, the protocol complexity is trans-
ferred towards the chip engineering and design optimization, rather than to the multiplication of 
active controls and operations. 4.3 Engineering of the chip functionalities 4.3.1 Single embryo hydrodynamic trapping 
In our device, when a C. elegans embryo is transferred to the progeny’s chamber matrix, it first 
enters a 80 μm wide serpentine channel, interconnecting the 16 chambers. The geometry of the 
system is optimized to guarantee that each embryo flowing through this channel will get trapped 
aside the first available culture chamber, i.e. the chamber associated to the first empty micro-
incubator along the path. Moreover, to ensure single-worm resolution for the successive analyses, 
the design needs to guarantee the trapping of a single embryo per incubator and that all the em-
bryos transferred after the complete filling of the array will be directed towards Out2 and washed 
out of the chip. Finally, the trapping system must be optimized to maximize its capture efficiency. 
To control the transgenerational passage and prevent perturbations of the egg laying process, 
embryos are in fact transferred towards the trapping sites only upon their natural egg laying in 
the parents’ culture chamber. This limits the number of available synchronized embryos per ex-
periment, so that the loss of even a few embryos during their transfer could compromise the ex-
periment and should be avoided.  
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The efficiency of our embryo trapping mechanism can be predicted by calculating the ratio be-
tween the volumetric flow rates through each chamber and its bypass channel, respectively. In 
very first approximation, this ratio can be theoretically estimated by considering the pressure drop 
between inlet and outlet of each chamber along the two parallel fluidic paths and imposing equal 
pressure difference along them, assuming Poiseuille flow conditions [117]. This calculation, how-
ever, ignores losses due to channel bends, widening/narrowing, etc., which are indeed quite rele-
vant in our design because of its composite geometry. In particular, spreading flow profiles at the 
boundary of pinched and broadened segments are completely neglected under this assumptions, 
which make therefore this calcualtion a very rough estimate of the real situation. Nevertheless, 
we decide to employ these calculations as a tool for a first approximated dimensioning of our 
chips, whose architecture is then refined through the results of a systematic experimental char-
acterization (see further). 
Assuming Poiseuille flow conditions, the ratio between the flow rate through a chamber and the 
one through its bypass channel can be calculated as the inverse of the ratio between the hydraulic 
resistances of the two fluidic paths (Figure 4.4a). For a straight channel with rectangular cross-
sectional shape, the hydraulic resistance can be calculated using Equation (3.1). In our case, the 
resistance of the bypass channel, Rbypass, can be approximated using (3.1), while the fluidic path 
across the culture chamber is calculated as a series of 3 main resistances (Figure 4.4a): (i) Rincubator, 
including the resistances of a single-embryo trap and its drain connection to the chamber; (ii) the 
chamber resistance, Rchamber and (iii) Routlet, made up of two interconnected series of parallel re-
sistances. We estimated the trapping efficiency for 6 similar versions of our device and fabricated 
them to experimentally determine the hydraulic resistance ratio which maximizes the capture ef-
ficiency in our geometry. For these tests, we employ 30 μm polymeric beads as trapping objects 
and define the capture efficiency as the percentage of traps containing a single bead over the total 
number of available trapping sites, for a constant amount of beads injected into the microfluidic 
device. From our experimental analysis, we conclude that a ratio Rbypass / (Rincubator + Rchamber + Routlet) 
of ~2.6 maximizes the system trapping efficiency (Figure 4.4b). After ensuring similar results by 
 
Figure 4.4 | Engineering of the hydrodynamic trapping system. (a) Schematic representation of the design 
of the hydrodynamic embryo trapping system, with indication of the hydraulic resistances associated to the 
different parts of the microfluidic geometry. (b) Experimental characterization of the trapping efficiency of 
the system for 6 similar microfluidic designs (characterized by different hydraulic resistances in their main 
constitutive parts). The “single bead trapping efficiency” is measured as the percentage of traps capturing 
a single 30 μm bead over the total number of available trapping sites. (c) Video frames superposition show-
ing a single embryo trapping event in the device design with higher capture efficiency. Scale bar = 100 μm. 
4.3   Engineering of the chip functionalities 
83 
 
using C. elegans embryos, we hence selected the chip geometry associated to this hydraulic re-
sistance ratio as preferred choice for our successive chip designs. The selected geometry ensures 
in fact both correct embryo reorientation and positioning inside each micro-incubator (Figure 
4.4c) and reliable assembly of matrices of 16 embryos upon their transfer from the parents’ cham-
ber (Figure 4.5a). 
4.3.2 Parallel transfer of embryos from incubators to chambers 
Size and shape of the micro-incubators are designed to gently accommodate single C. elegans 
embryos in a horizontal position, aligned along their longitudinal direction. As reported in chapter 
3, elongated semicircular incubators (35 μm wide, 30 μm long) prove to be perfectly suitable for 
this purpose, each one associated to a 12 μm wide, 8 μm long drain connection for correct embryo 
trapping and stable positioning. In our chip, we now add a new functionality, since, upon its trap-
ping in a micro-incubator, each embryo need to be transferred to its dedicated culture chamber. 
We rely on PDMS elasticity to control a fast reversible deformation of micro-incubators and drains 
and trigger the delivery of the embryos inside the chambers. We optimize this protocol according 
to some key requirements: (i) perfect embryo viability after the transfer; (ii) fast simultaneous 
displacement of all the trapped embryos; (iii) simple operations, automatically handled via syringe 
pumps. We find that a 1 s flow pulse of 20 μL along the In5-Out2 direction ensures the reliable 
transfer of the whole embryo matrix from incubators to chambers, according to all the aforemen-
tioned requirements (Figure 4.5b). Because of the relatively high fluidic resistance of our chip ge-
ometry, this flow pulse induces in fact enough deformation of our structures, with no need of 
 
Figure 4.5 | Embryo isolation and parallel transfer to microfluidic chambers. (a) Pictures of a representa-
tive array of embryos, upon complete filling of the incubator array. The hydrodynamic trapping mechanism 
results in stable embryo positioning, with a single embryo associated to each culture chamber. Scale bars = 
50 μm. (b) Time-lapse pictures of a micro-incubator, during the injection of an embryo into the adjacent 
chamber. A 1 s flow pulse triggers a fast reversible enlargement of the drain, allowing the transfer of the 
embryos inside their dedicated chambers. The PDMS structures get back to their undeformed shape in 
about 5 s. 
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multiple PDMS layers fabricated at different “curing agent vs base” compositions to tune their 
stiffness [162].  4.4 Embryo-to-adulthood worm imaging at single-organism resolu-tion 4.4.1 Embryogenesis monitoring 
When embryos are transferred inside the progeny’s culture chambers, each of them is directed 
towards the central part of the outlet filter by the microchannel arrangement itself. The specific 
geometry of these filters is in fact designed to generate a flow focusing effect across the central 
portion of each chamber. Thanks to this feature, a relatively slow flow – typically 5-15 nL/s – along 
the In5-Out2 direction allows retaining the embryos at stable positions in each chamber, for their 
long-term imaging via high-magnification objectives (Figure 4.6a). If E. coli suspension is used, 
moreover, such a flow allows distributing bacteria across the chamber matrix, to provide the 
worms with their first food source upon egg hatching.  
In our device, embryos can be transferred to their dedicated chambers at any time during their 
development, prior to egg hatching. In our experiments, the transfer is either performed upon full 
array filling or after all the embryos have reached the twitching phase. Although the former option 
is readily compatible with full protocol automation, the latter is usually preferred for two main 
reasons: (i) higher imaging stability is ensured when embryos are observed inside the micro-incu-
bators; (ii) no mechanical stress is introduced on the embryos during early – and more delicate – 
phases of their development. Even when subjected to the transfer at very early developmental 
stages, embryos in our device proved to undergo normal development and perfect viability, in line 
with previously reported results [163], showing therefore no effect of any possible stress intro-
duced by the transfer process itself.     
As in the device presented in chapter 3, also in this chip, the different phases of the full embryonic 
development can be monitored and studied with extreme accuracy (Figure 4.6b). 4.4.2 Worm growth and development monitoring 
The gentle flow (5-15 nL/s) used to retain the embryos at stable positions, in combination with 
the narrow size of all the microfluidic connections around the chambers, prove to be suitable to 
ensure the confinement of each worm in its chamber at any developmental stage, therefore ena-
bling long-term studies at single-worm resolution. Only at the L1 larval stage, in fact, the worms’ 
section is still comparable in size with the one of the incubator drain, so that a flow is needed to 
ensure their permanence in the same chamber. Starting from the L2 larval stage, worms are in-
stead geometrically confined within the chambers by their own larger size and food delivery can 
be pursued via periodical flow activation at desired rate. In particular, about 5 µL E. coli suspension 
is injected into the chip every 10 minutes, at 1.4·109 bacteria/mL concentration. This feeding pro-
tocol proves to ensure quite reproducible worm development, in good agreement with results 
reported in literature [96] (Figure 4.6c). For worm growth monitoring, we usually take time-lapse 
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pictures of each chamber at 15 min intervals. Fully automated operations for this processs are 
allowed by a computer-controlled xyz-scanning microscope stage.  
The presence of a single worm per chamber allows easily identifying the molting time of each 
worm and therefore accurately defining every transition from/to a different larval stage, up to the 
worms’ adulthood. By analysing series of time-laspe pictures for each chamber, each molt can be 
found either attached to a worm tail during the molting itself or floating inside the worm culture 
chamber, if the picture was taken upon the molting (Figure 4.6c). These molting events represent 
a very accurate way to identify the actual biological transitions amongst the different larval stages 
 
Figure 4.6 | Embryo-to-adult worm monitoring at single-organism resolution. (a) Embryonic development 
within a worm culture chamber, from (ai) bean stage to (aii) 1.5-fold stage till (aiii) hatching, as observed in 
a sequence of brightfield microscopy images (40× NA 0.6 objective) taken from a movie with 12 frames per 
hour. (b) Average duration of main embryonic development phases – bean to 1.5-fold; 1.5-fold to hatching 
–, as observed for an array of 16 embryos for a N2 wild-type worm strain at 25°C. Bar graphs are expressed 
as mean+SD (c) Full development of the worm in (a), as observed in a sequence of brightfield microscopy 
images (4× NA 0.1 objective) taken from a movie with 4 frames per hour. Accurate identification of the onset 
of the different developmental stages – (ci) L2, (cii) L3, (ciii) L4, (civ) young adult – is achieved by observation 
of the molting events. Progeny analysis – (cv) first laid egg, (cvi) first progeny – is demonstrated as well. (d) 
Duration of the main development phases – L1, L2, L3, L4, young adult (YA) – as observed for an array of 14 
worms for a N2 wild-type worm strain at 25°C. The end of YA stage is defined by the appearance of fertilized 
eggs within the worm body. Variations of the time durations are commented in the main text; (e) average 
duration of development phases, as obtained from the data in (d). Bar graphs are expressed as mean+SD. 
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(L1-L4), up to the young adult (YA) stage. Other parameters could have been monitored to define 
these transitions – such as worm size or the apparition of specific features within the worms’ tis-
sues – but these alternative methods can be strongly affected by the variability of these parame-
ters among different worm strains or conditions. In our device, the whole on-chip larval develop-
ment can be hence monitored at an unprecedented combination of resolution and level of auto-
mation (Figure 4.6d-e). The duration of the YA stage is instead here defined as the time interval 
between the L4/YA molting and the appearance of the first fertilized eggs inside the worm.  
The results of the representative experiment reported in Figure 4.6d are chosen to highlight some 
remaining issues and future applications of our device. As previously mentioned, if the microfluidic 
flow across the chamber array is temporarily stopped during the L1 phase, worms are still capable 
of escaping from the chambers, as it happened in this case for worms 10 and 14 (missing bars in 
the graph of Figure 4.6d). A further optimization of the worm feeding protocol for this device is 
moreover desirable, since variations of the duration of the different development phases may 
likely be induced by some non-uniformities in the E. coli distribution across the chamber array. 
The extreme sensitivity of our measurements to the food delivery method suggests however novel 
interesting applications for our device, which could in fact be readily employed for accurate caloric 
restriction studies, combined with developmental analyses. This possibility is further confirmed 
by the observation of the time-lapse development of worm 9 of Figure 4.6d. This nematode got 
accidentally blocked at a fixed location of its chamber – and hence experienced food deprivation 
– for several hours during the L1 phase. This “accident” has a very clear impact on its whole de-
velopment, which is accurately detected by our device (see Figure 4.6d). 4.5 Materials and methods 4.5.1 Chemicals and Materials  
4-inch 550 µm thick Si wafers and DIW were obtained from the Center of Micro- and Nanotech-
nology of EPFL. GM 1070 SU-8 negative photoresist was purchased from Gersteltec (Pully, Swit-
zerland). PDMS Sylgard 184 was acquired from Dow Corning (Wiesbaden, Germany). 1 mL boro-
silicate H-TLL-PE syringes were purchased from Innovative Labor Systeme (Stutzerbach, Germany). 
Microline ethyl vinyl acetate tube with 0.51 mm inner and 1.52 mm outside diameters was bought 
from Fisher Scientific (Wohlen, Switzerland). Pluronic F-127 was purchased from BASF (Basel, Swit-
zerland). M9 buffer was obtained by adding 3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl, 1 mL 1 M MgSO4, 
H2O to 1 litre and sterilization by autoclaving. Pluronic F127 solution was prepared by diluting 
0.02% (weight/volume) Pluronic F127 in M9. 4.5.2 C. elegans strains and culture  
C. elegans strains were cultured at 20°C on nematode growth media agar plates seeded with Esch-
erichia coli strain OP50, unless stated otherwise. The wild-type Bristol N2 worm strain was pro-
vided by the Caenorhabditis Genetics Center (University of Minnesota). Worms were suspended 
in M9 solution prior to each microfluidic experiment.  
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4.5.3 Fabrication of the microfluidic chips  
Microfluidic devices were prepared by soft lithography [144] using 2-layer SU-8 molds. Briefly, 
conventional photolithography was used to pattern a 35 μm-thick layer of SU-8 photoresist on 4-
inch wafers. A 85 μm-thick layer of SU-8 was then patterned on top of the first one. A liquid PDMS 
mixture (10:1 base:cross-linker weight ratio) was poured onto the mold, degassed, and cured at 
100 °C for 1 h. Each PDMS chip was then cut along its sidewalls with a scalpel, gently detached 
from the SU-8 mold and bonded by plasma-activation to a glass microscope slide. The chip was 
then connected to syringes through external tubing. 4.5.4 Image acquisition and processing 
The microfluidic chip was integrated onto an inverted microscope (Axio Observer, Zeiss) equipped 
with a precisExcite High-Power LED Illumination system (Visitron, Puchheim, Germany) for bright-
field imaging. The microscope had a motorized xy-stage, equipped with an ASI piezo controller for 
z-displacement (Visitron, Puchheim, Germany) and the automated imaging process was controlled 
using VisiView Premier Image acquisition software (Visitron, Puchheim, Germany). To start the 
automated embryo imaging process, the position of the first egg in the array was set as initial 
point of the xy-stage scanning, while the locations of the other eggs were automatically deter-
mined by the interdistance between adjacent incubators. A 40× NA 0.6 objective, corrected for 1 
mm-thick glass slides (LD Plan-Neofluar 40x/0.6 Corr Ph2 M27), was typically used for this imaging. 
“Time-lapse” and “stage position” programs were set to automatically perform scanning and im-
aging over the full array at a desired rate, hence resulting in parallel time-lapse imaging of all the 
embryos. An analogous protocol was set for the automated worm monitoring, performed through 
a 4× NA 0.1 objective.  A simple Matlab script (MathWorks, Natick, MA, U.S.A) was used to reorder 
the large amount of data of each experiment according to the image xy-coordinates and time. 
Image processing was performed with Fiji software (http://imagej.nih.gov/ij; version 1.47b). 4.6 Conclusions 
The device presented in this chapter further extends the analytical possibilities enabled by the 
microfluidic platform presented in chapter 3. In this device, a well-defined and synchronized C. 
elegans population can be isolated from an on-chip worm culture and studied in a fully automated 
way, starting from worms’ early embryogenesis up to their adult stage. The device allows opera-
tion and analysis at the single-organism level, thus preserving the identity of each individual worm 
during its whole development, while at the same time providing statistics of the complete popu-
lation, thanks to the multi-chamber array format. We demonstrate the capability of our platform 
to accurately analyze the real-time dynamics of different phases of the embryonic development, 
as well as monitoring all the successive larval stages at unprecedented resolution and level of 
automation.   
To the best of our knowledge, this is the first microfluidic device in which worms are isolated 
directly upon egg laying and then longitudinally monitored, potentially for their complete lifespan 
– i.e. from early cellular divisions to death. This will allow not only setting new standards in terms 
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of on-chip C. elegans culture and long-term analysis, but will also open the new possibility of ac-
curately correlating developmental parameters, gene expression and any other phenotypic traits 
among all the different phases of worm growth, including the embyogenesis. Simultaneaous on-
chip culture of the “parent worms” of each experiment will instead pave the way for fully auto-
mated on-chip transgenerational studies. For full lifespan studies at single-worm resolution, 
worms can be treated on-chip with 5-FU (see chapter 3), to prevent the development of the “third 
generation progeny” in the chamber matrix and preserve the identity of the 16 worms under test. 
Alternatively, the “third generation progeny” could be washed out of the chambers at the L1 
stage, transported by relatively fast flow pulses through the microchannels at the otlet of each 
chamber (similarly to what will be presented in chapter 5). Eventually, to increase the throughput 
of each test, a new chip comprising more than 16 chambers could be easily designed and fabri-
cated, thanks to the modularity of the presented microfluidic geometry and its regular array for-
mat, which ensure high device scalability.    
All the further developments of this work have become subjects of a new PhD project at the LMIS2 
laboratory. 
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 Microfluidic platform for high-resolution imaging of C. elegans and longitudinal monitoring of neurodegener-ative disease  
Abstract While many biological studies can be performed on cell-based systems, the inves-
tigation of molecular pathways related to complex human dysfunctions – e.g. neurodegenerative 
diseases – often require long-term studies in animal models. The nematode C. elegans represents 
one of the best model organisms for many of these tests and, therefore, versatile and automated 
systems for accurate time-resolved analyses on C. elegans are becoming highly desirable tools in 
the field. Here we describe a new multi-functional platform for C. elegans analytical research, en-
abling automated worm isolation and culture, reversible worm immobilization and long-term 
high-resolution imaging, and this under active control of the main culture parameters, including 
temperature. We employ our platform for in vivo observation of biomolecules and analysis of pro-
tein aggregation in a C. elegans model for amyotrophic lateral sclerosis (ALS). Our device allows 
automatically monitoring the growth rate and development of individual worms within a matrix 
of microfluidic chambers. We demonstrate the progression of specific protein aggregates – mu-
tated human SOD1-YFP fusion proteins in the body wall muscles, in particular – for each worm 
over several days. Moreover, by combining reversible worm immobilization and on-chip high-res-
olution imaging, the device allows precisely localizing the expression of biomolecules within the 
worms’ tissues, as well as monitoring the evolution of single aggregates over consecutive days at 
the sub-cellular level. This chapter is an adapted version of the following publications: 
o M. Cornaglia, G. Krishnamani, L. Mouchiroud, T. Lehnert, J. Auwerx, and M.A.M. Gijs., Auto-
mated longitudinal monitoring of in vivo protein aggregation in a neurodegenerative disease 
C. elegans model, Mol Neurodegener, under revision 
o M. Cornaglia, G. Krishnamani, M. Meurville, L. Mouchiroud, T. Lehnert, J. Auwerx, and M.A.M. 
Gijs. A microfluidic device for longitudinal studies of C. elegans neurodegenerative models. 
Proc. of 19th International Conference on Miniaturized Systems for Chemistry and Life Sci-
ences (microTAS 2015), Gyeongju, Korea, October 2015. 
o M. Cornaglia, G. Krishnamani, M. Meurville, L. Mouchiroud, T. Lehnert, J. Auwerx, and M.A.M. 
Gijs. An automated microfluidic platform for long-term high-resolution imaging of C. elegans. 
Proc. of 18th International Conference on Miniaturized Systems for Chemistry and Life Sci-
ences (microTAS 2014), San Antonio, TX, USA, October 2014. 
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5.1 Introduction 5.1.1 Microfluidic tools for worm immobilization and high-resolution imaging 
Because of the small size of C. elegans nematodes (a few hundreds of microns), high-magnification 
imaging is usually needed to extract relevant biological information, while studies on transgenic 
animals often require the accurate observation of highly localized fluorescent signals inside the 
worms. Hence, during imaging, animals have usually to be fully immobilized to prevent any move-
ment, which otherwise would result in image distortion. Moreover, to observe the dynamics of 
biological processes, the same worm has to be immobilized repeatedly in a reversible manner. 
This should be done under normal physiological conditions in order to ensure minimal impact dur-
ing the imaging phase. For high-throughput analyses, automation of this process is highly prefer-
able. Some microfluidic-based worm immobilization methods have been recently proposed, based 
on worms’ confinement in microchannels [164], suction flows [111], mechanical compression 
[165], CO2 delivery [166], temperature decrease [112], electrotaxis [167], surface acoustic waves 
[168], and thermosensitive polymers [169]. 
More in detail, the first microfluidic solutions for in vivo C. elegans immobilization and imaging 
first appeared in the late years 2000s. Chronis et al. introduced the so-called “olfactory” and “be-
havior” devices, able to trap single worms and monitor their neuronal and behavioral activity (Fig-
ure 5.1a) [164]. These devices were fabricated in PDMS and their main constitutive part was rep-
resented by “worm-traps”, optimized in size for hosting young adult worms (approximately 1 mm 
long and 70 µm in diameter), and characterized by a tapered end to block the worm, while still 
permitting analysis of its locomotion patterns in the wider section of the microfluidic channel 
[170].  
Rohde et al. introduced then “high-speed microfluidic sorters”, to immobilize single C. elegans for 
screening phenotypic features at sub-cellular resolution in physiologically active animals [111]. 
These microfluidic devices were based on separated flow and control layers, made from flexible 
polymers. Microchannels were used as a flow layer, to deliver reagents and manipulate worms, 
while the control layer consisted of a second set of microchannels built above the flow layer. (Fig-
ure 5.1bi) When pressurized, the channels of the control layer provided a valving function by de-
flection of a membrane into the flow channel, used for blocking or redirecting the flow. In these 
devices, worm immobilization was based on suction flows (Figure 5.1bii). 
Krajniak et al. presented then a method for reversible immobilization of worms based on the use 
of a thermosensitive polymer [169]. Their PDMS microfluidic device consisted again of separate 
flow and control layers. The flow network featured culture chambers, isolated by inlet and outlet 
valves, for selectively retaining and culturing the worms inside the chip. The control layer of the 
device comprised instead the pneumatic circuitry for valve control and a second series of channels 
for flowing a pre-heated solution on top of the flow layer, to precisely control its temperature. 
Pluronic F127 block copolymer was injected into the culture chambers for selective immobilization 
of the worms by temperature-dependent gelation of the Pluronic solution (Figure 5.1c).  
5.1   Introduction 
91 
 
5.1.2 Challenges and opportunities for studies on C. elegans neurodegenerative models  
The growing incidence of neurodegenerative diseases (NDs) urges for a complete understanding 
of the molecular processes underlying neurodegeneration, as a first step towards the final prom-
ise of a new class of therapeutics for these diseases. Cellular models have been exploited for some 
of these studies [171, 172], but the high complexity of the molecular mechanisms implicated in 
NDs increasingly demands in vivo models for the investigation of complex phenotypes, which are 
determined by the interplay among different tissues and pathways [173]. The nematode C. ele-
gans represents a perfect model organism for such in vivo tests, mainly because of its very fast life 
cycle, combined with the ease of its genetic manipulation and the relatively high level of conserved 
mechanisms between C. elegans and humans [174]. In the last two decades, several protein-mis-
folding disorders, including age-related NDs, have been successfully modeled in C. elegans indeed 
[175]; libraries of transgenic worms are currently available for the research of the molecular mech-
anisms underlying Alzheimer’s, Parkinson’s and Huntington’s diseases, as well as ALS [173]. Trans-
genic expression of disease genes in C. elegans is typically visualized via fluorescently tagged pro-
teins within its transparent tissues. In most of the NDs, specific proteins self-assemble into aggre-
gated species and cellular toxicity can be induced by the protein misfolding and aggregation pro-
cess itself [173]. Therefore, the spatio-temporal-resolved observation of protein expression and 
aggregation, associated with the quantification and localization of these aggregates is a key ana-
lytical method for the in vivo monitoring of disease evolution. Unfortunately, conventional C. ele-
gans handling and imaging techniques do not allow accurate monitoring of aggregate progression 
in individual worms over time, since nematodes are typically cultured in large populations on agar 
plates and irreversibly immobilized by means of anesthetics for high-resolution imaging.   
Nevertheless, several miniaturized devices already proved their potential in neurobiology studies, 
such as the investigation of C. elegans oxygen sensation [176], olfactory [177] and chemosensory 
[112] neuronal activity, exploratory and learning behavior [178], neurotoxin-induced responses 
 
Figure 5.1 | Examples of microfluidic chips for C. elegans immobilization and imaging. (a) Pictures of (ai) 
the “behavior” and (aii) the “olfactory” chips proposed by Chronis et al. (reproduced from [164]). Worms 
are here confined in narrowing microfluidic channels. (bi) Picture of the microfluidic worm sorter proposed 
by Rohde et al., with (bii) a zoom of a worm immobilized on suction channels (reproduced from [111]). (c) 
Pictures of the chip-gel hybrid microfluidic device proposed by Krajniak et al., during (ci) worm culture, (cii) 
PF127 solution injection, (ciii) worm imaging, and (civ) worm release. (reproduced from [169]).  
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[179], neuromuscular function [180], and nerve regeneration [181, 182]. In the neurodegenera-
tion research field, Càceres et al. [183] recently proposed a microscale system for high-throughput 
visual screens on worms. This system exploited a curved microchannel geometry to trigger the 
positioning of nematodes into lateral orientations and facilitate the inspection of D-type motor 
neurons. Although this device allowed efficiently screening mutants carrying neurodegenerative 
defects, it did not permit longitudinal monitoring of the worms. Other microfluidic platforms have 
instead demonstrated the feasibility of continuous worm culture and observation. For example, 
Krajniak et al. [169] showed the microfluidic culture of L1-L3 larvae over periods of 12 to 36 h. 
However, protein aggregation monitoring within ND disease models typically requires worm cul-
ture and repeated high-resolution imaging of the same worm over significantly longer time peri-
ods (e.g. > 3 days). This imposes severe requirements in terms of system robustness and automa-
tion, related to the simultaneous and strict control of environmental conditions, like worm feed-
ing, fluidic exchanges, temperature of the microfluidic environment, etc.. In this perspective, 
Rohde et al. [184] demonstrated an elegant automated system for in vivo time-lapse imaging and 
high-throughput screening of C. elegans in standard multiwell plates, which employed an in-well 
cooling apparatus for reversible worm immobilization. However, the use of this device for protein 
aggregation monitoring at single animal resolution is less trivial, as it did not have microfluidics 
on-board and could not exploit brightfield transmission microscopy as analytical tool.  
Here we introduce a microfluidic platform for long-term and high-resolution monitoring of protein 
aggregation and automated analysis of C. elegans ND models. Specifically, we demonstrate the 
feasibility of in vivo observation over 4 days at single-animal resolution of superoxide dismutase 
1 (SOD1) aggregation in the AM725 C. elegans transgenic strain, which we use as a biological 
model system for the investigation of the human ALS disease. This is enabled by our microfluidic 
platform, which co-integrates the following features and functionalities: (i) a method for fast con-
finement of worms of desired age in microfluidic chambers, by means of pure passive hydrody-
namics with no need of any active components, such as integrated valves; (ii) a technique for con-
tinuous worm feeding and progeny removal, to preserve the on-chip worm identity over long-
term studies; (iii) a method for reversible C. elegans immobilization using a hydrogel, enabling 
high-resolution imaging at arbitrarily selected moments of their whole lifespan; (iv) an integrated 
active temperature control system, both to set precise environmental conditions for C. elegans 
maintenance and to automatically steer the worm immobilization/release process; (v) a compact 
device assembly, readily adaptable to host different microfluidic designs and suitable for auto-
mated multi-dimensional imaging on any upright or inverted microscope. 5.2 Worm culture and imaging platform overview  
Our worm culture and imaging platform features different components (Figure 5.2a). Worms are 
manipulated inside a monolithic PDMS microfluidic chip, conceived as a simple 1-layer device and 
operating via pure passive hydrodynamics, with no need of any active valving system. The chip is 
bonded to a standard 150 µm-thick glass coverslip for accurate worm imaging through high-mag-
nification oil immersion objectives. An aluminum frame is specifically designed to host the chip 
and set a well-defined temperature distribution over its 3D geometry. Both the frame and the top 
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of the PDMS chip are positioned in contact with a thermoelectric module used to set the temper-
ature of the assembly. A central hole in the Peltier module allows light transmission through the 
PDMS chip, therefore enabling worm imaging via transmission microscopy. A well-dimensioned 
heat sink ensures the dissipation of excess heat produced by the thermoelectric module; a ther-
mally insulating holder allows positioning the device on the microscope stage while preventing 
thermal dissipation. The entire structure is held together by screws and springs at the four corners, 
in order to ensure good thermal contacts throughout the stack. A resistive temperature detector 
(RTD), in contact with the glass substrate, is employed to sense the temperature of the microflu-
idic device. The signal measured by the sensor is exploited to set the power provided to the ther-
moelectric module in a closed-loop configuration, for active control and constant monitoring of 
the temperature experienced by the worms inside the chip. The feedback loop management is 
committed to a portable proportional-integral-derivative (PID) controller (Figure 5.2b), provided 
with a software interface. The microfluidic flow inside the device is regulated by computer-con-
trolled syringe pumps.  
The tubings connecting the chip to the external syringes are directly plugged to the sidewalls of 
the PDMS device. To get this peculiar configuration, we casted PDMS inside a specifically designed 
mold, allowing to shape its whole 3D structure (see subsection 5.6.3). Lateral tubing connections 
are employed to partially embed the tubes in the aluminum thermalization frame, therefore put-
ting them in contact with the Peltier module as well (Figure 5.2c). This allows pre-thermalizing the 
liquids prior to their injection inside the PDMS chip and opens the possibility of tuning the chip 
temperature through the injected liquid as well, as will be clarified further. Moreover, the lateral 
positioning of the microfluidic tubing makes our device readily suitable for imaging on both up-
right and inverted microscopes. Size and shape of the device holder allow perfect fit with any 
microscope stage or equipment compatible with standard 60 mm Petri dishes. The imaging area 
 
Figure 5.2 | Overview of the microfluidic device. (a) Schematic representation of the main constitutive 
components of the microfluidic platform. (b) Photograph of the device, with schematic picture of the closed-
loop temperature control system. (c) Section view of the device assembly, with a zoom on a microfluidic 
design within the imaging area. Scale bar = 2 mm. (d) Representative microfluidic geometries for use with 
the platform, featuring matrices of worm culture chambers, tailored for the isolation of either (i) L4, (ii) L2 
or (iii) L1 C. elegans larvae. Scale bars = 200 µm. 
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available for transmission microscopy has about 15 mm in diameter, corresponding to the central 
hole of the thermoelectric module (Figure 5.2c). This represents the only geometrical constrain in 
the design of the PDMS chip, thus offering full versatility in using multiple microfluidic layouts. In 
particular, for our studies, we use three different microfluidic architectures, featuring matrices of 
worm culture chambers of different shapes and sizes (Figure 5.2d). 5.3 Engineering of the device temperature control system  5.3.1 Theoretical considerations 
We investigate the performance of our temperature control system both theoretically and exper-
imentally. The setup can be operated either in “closed-loop configuration” – by means of the PID 
controller – or in “open-loop mode”, i.e. by providing the Peltier module with a constant electrical 
power. The former configuration results in fully automated control of the setup temperature, the 
latter option has the advantage of allowing device operation with no need of a feedback sensing 
system. When electrical power is supplied to the thermoelectric module, heat exchange is induced 
through the assembly, resulting in the heating or cooling of the chip, for positive and negative 
electrical powers, respectively. The temperature distribution achieved in the device satisfies the 
following equation in time: 
𝜌𝜌𝐶𝐶𝑑𝑑
𝜕𝜕𝜕𝜕
𝜕𝜕𝑡𝑡
+ ∇(−𝑘𝑘∇𝜕𝜕) = 𝑄𝑄 (5.1) 
with density ρ, heat capacity Cp, and thermal conductivity k, varying according to the material (a 
scalar or a tensor for an isotropic or anisotropic material, respectively). In our case the tempera-
ture T is modulated by the heat source Q (unit: W/m3), represented by the Peltier module. Further 
heat exchange occurs then via convective heat transfer at the boundaries of the assembly through 
the surrounding air, according to: 
𝑞𝑞 = ℎ(𝜕𝜕𝑐𝑐𝑚𝑚𝑡𝑡 − 𝜕𝜕) (5.2) 
where q is the convective heat flux through a boundary (unit: W/m2), h is the heat transfer coeffi-
cient and Text the temperature of the ambient air, far from the boundary. Because of the compo-
site geometry of our device, including different materials with complex 3D shapes, Equations (5.1) 
and (5.2) are best solved via 3D FEM modeling, as will be detailed further. 5.3.2 Steady state temperatures in “open-loop” mode 
To extract the “open-loop” calibration curve of our device, we first characterize its response for 
different constant cooling electrical powers (Figure 5.3a). In this study, the temperature is meas-
ured by means of a 1.6 × 2.5 mm2 Pt1000 sensor positioned on the bottom face of the glass co-
verslip, aligned with the center of the microfluidic chip (at x=y=0 in the insert of Figure 5.3b). 
Because of the reduced thickness of the glass substrate, negligible temperature variations are ex-
pected between top and bottom face of the coverslip. As expected, for different cooling power in 
the “open-loop” configuration, the system is cooled down to specific steady-state temperatures, 
set by the equilibrium between thermoelectric cooling and heat convection in the surrounding air. 
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Starting from an ambient temperature of 24°C, stable temperatures down to 10 °C can be reached 
at the chip center, with a clear linear dependence on the electrical power that is applied to the 
Peltier module (Figure 5.3b). Because of the specific geometry of the device, the spatial tempera-
ture distribution is not constant throughout the chip area, as observed via measurements at dif-
ferent locations from the coverslip center (Figure 5.3c). By fitting these data with the correspond-
ing simulated results, we empirically extract the heat transfer coefficient h, which models heat 
convection in our system (Equation (5.2)). A slight deviation in the fit between measured and sim-
ulated data is observed only close to the PDMS chip edge (y = ± 10 mm). This is attributed to 
imperfections of the contact surfaces between the chip and the metallic frame. We moreover 
simulate the spatial temperature distribution for different cooling powers, showing again good 
agreement between theoretical and experimental results (Figure 5.3c).  
5.3.3 Heat exchange dynamics 
The dynamics of heat exchange in our system can be efficiently studied by normalizing the curves 
of Figure 5.3a with respect to the external temperature Text and the steady-state temperature Teq 
for each applied power. Normalized data prove to be independent from the electrical power and 
allow defining the calibration curve that describes the temperature evolution of the device in the 
“open-loop” configuration (Figure 5.3d). The same result can be obtained via FEM by plotting the 
temperature at the chip center using a time-dependent simulation. In this analysis, the coefficient 
 
Figure 5.3 | Temperature control system characterization. (a) Experimental characterization of the device 
cooling performance in “open-loop” configuration, for different cooling power applied to the thermoelectric 
module starting from t=0  and an external temperature of 24 °C (temperature sensor positioned at the chip 
center). (b) Measured equilibrium temperature Teq at the chip center (x=y=0) for different constant cooling 
power and starting from an external temperature Text = 24 °C. N=3, errors are SD. (c) Spatial temperature 
distribution across the chip area, both measured experimentally and simulated via FEM. (d) Temporal evo-
lution of the “normalized chip temperature”. Experimental data are obtained by plotting the curves of (a) 
normalized in the form of (T –Teq)/(Text–Teq);  each experimental point represents the average of all normal-
ized data points for a specific time. (e) Measured equilibrium temperature Teq, and (f) time to reach T = 15 
°C during liquid injection at different flow rates at constant cooling power (P = 0.6 × Pmax ~ 24 W). 
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of performance (COP) of the thermoelectric module needs to be carefully taken into account, with 
COP typically defined as the ratio between the effective cooling power and the supplied electrical 
power. In our case, when the maximum allowed electrical power is provided to the thermoelectric 
module (Pmax ~ 40 W), its COP is inversely proportional to the temperature difference created be-
tween its two plates (information extracted from the datasheet of the thermoelectric module). By 
including this specific dependence in our simulation, we obtain a theoretical calibration curve in 
very good agreement with the experimental data Figure 5.3d). The measured temperature de-
crease in our device is fitted by an exponential decay with time-constant τ = 2.23 min, with the 
temperature at the chip center reaching 80% of its steady-state value in ~4 min and 90% in ~6 
min. The slight difference between the measured decay and the simulated one is mainly attributed 
to imperfections of the thermal contact among the different parts of the assembly, which are not 
included in the FEM calculations. Much faster cooling is obviously observed at the metallic frame, 
where the temperature reaches 90% of its final value within 2 min.  5.3.4 Inflow pre-thermalization 
As previously described, the fluid entering the microfluidic chip is pre-thermalized during its pas-
sage through the metallic frame in which both PDMS chip and tubing are inserted. First, this allows 
achieving lower on-chip temperatures than without fluid flow, thereby improving the cooling ef-
ficiency of the device. Second, fluid pre-thermalization reduces the time constants of the system, 
thus making temperature changes faster and reducing the overall stabilization time of each ex-
periment. Finally, the speed of the pre-thermalized inflow can be exploited as an additional pa-
rameter for temperature control, allowing the fine-tuning of the temperature of the actual micro-
fluidic environment. We experimentally characterize the influence of the pre-thermalized inflow 
by measuring the steady-state temperature at the chip center for constant electrical power and 
different flow rates of the liquid entering the chip (Figure 5.3e). For this study, we work at constant 
power P ~ 24 W, since this results in setting the on-chip temperature around 15 °C, which is a 
critical value for our applications, as will be shown later. In this case, fast inflows (> 1000 nL/s) 
allow a 25% further reduction of the chip temperature, down to about 11 °C. In certain experi-
ments, such additional cooling by pre-thermalization may, however, be undesirable and can be 
rendered minimal by working at relatively low flow rates (e.g. 100-200 nL/s) or finely-tuned via 
proper combinations of thermoelectric and liquid cooling parameters. Finally, we characterize the 
dynamics of heat exchange during liquid injection at different flow rates: liquid pre-thermalization 
allows much faster chip cooling, e.g. resulting in a 44% to 87% reduction of the time needed to 
reach 15 °C at P ~ 24 W, for flow rates from 250 to 2000 nL/s, respectively (Figure 5.3f).  5.4 Automated device operation  5.4.1 Worm arraying via passive valves 
Passive hydrodynamics allows avoiding the need of additional fluidic control layers or active 
valving systems, which would complicate use and design of the chip and would reduce its ease of 
automation. The first critical protocol steps are typically represented by synchronization, loading 
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and distribution of the worms inside the device. In our platform, all these operations are simulta-
neously accomplished by simply injecting a mixed worm suspension into the microfluidic chip at a 
proper flow rate, along the In1-Out1 direction (Figure 5.4a). We mainly worked with three differ-
ent chip designs (Figure 5.2d) for selecting either L1, L2/L3 or L4 larvae, as these are commonly 
employed stages for worm synchronization and successive analyses. Size and shape of the micro-
fluidic channels connecting adjacent chambers along the In1-Out1 direction are designed to en-
sure uniform flow distribution across the chambers and allow access to the chip only to worms 
which are younger than the desired age – and thus smaller than a certain size. More specifically, 
we exploit the flexible nature of PDMS to trigger a passive valving mechanism [162] in the channels 
(zoom of Figure 5.4a).  
In the “L1 design” (Figure 5.2diii), only L1 worms can access the culture chambers because of their 
smaller size, which is compatible with the passage through microfluidic channels sizing 8 × 14 μm2 
in section. When a 1 s pulse of 2 µL inflow is injected into the device, a slight overpressure instan-
taneously builds up inside the channels, causing a fast temporary increase of their section. This 
triggers the passage of L1 larvae through the channels (Figure 5.4b). The end of the pulse results 
then in worm confinement inside the chambers, since each channel immediately returns to its 
initial shape, preventing any spontaneous passage of worms. A few subsequent inflow pulses al-
low distributing L1 larvae over the whole matrix of 32 chambers in a few seconds. The same prin-
ciple is employed in the L2 and L4 chip designs (Figure 5.2di-dii), for the automated dispensing of 
larvae in a single culture chamber or in the 4 chamber array. In this case microchannels (30 × 14 
μm2 and 60 × 14 μm2 in section for the L2 and L4 designs, respectively) are sized as such to block 
the passage of adult worms, confine larvae of desired size inside the chambers by the passive 
valving effect, while directly washing all the smaller larvae out of the chip. 
Our passive valve-based worm loading method allows moreover tuning the distribution of worms 
throughout the microfluidic chamber matrices in very a simple and versatile way. Two main worm 
 
Figure 5.4 | Worm arraying via passive valves. (a) Schematic representation of the worm loading process. 
A pressure pulse triggers the fast deformation of the PDMS valving channels and allows the injection of 
worms of desired size into the culture chamber. (b) Time-lapse pictures of a valving channel, during the 
injection of a L1 worm in the chip of Figure 5.2diii. Scale bars = 10 µm. 
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distribution approaches can be implemented in our chips. First, when large data statistics are 
needed, concentrated worm samples are injected into the microfluidic device and/or chamber 
matrices of small dimensions are chosen (e.g. 1-4 chambers, Figure 5.2di-dii). Passive valves allow 
automatically distributing the worms over the different chambers in a quite uniform way, resulting 
in small groups of worms – e.g. 2 to 5 worms – per each chamber. Second, if a reduced number of 
isolated worms is needed, diluted samples are injected in large chamber matrixes (e.g. 32 cham-
bers, like in Figure 5.2diii). In this case, Poisson statistics ensures the presence of single worms in 
each of the occupied chambers, at the price, however, of having many empty chambers in the 
matrix. Eventually, direct user control and iteration of the worm loading protocol can be used to 
adjust the worm distribution until a desired number of worms per chamber is obtained.   5.4.2 Worm culture and imaging protocol 
The cross-shape of our chips, with in- and outflows along two orthogonal directions, is designed 
to decouple the worms’ dispensing operation (in the In1-Out1 direction) from the worm culture 
and imaging protocol. Instead, along the In2-Out2 direction, adjacent chambers are connected by 
narrow filters – 5 × 14 µm2 in section – allowing perfusion of liquids across the whole chamber 
matrix, while preventing any inter-chamber exchange of worms, even under over-pressure condi-
tions. Also, after worm dispensing, the In1-Out1 flow direction can be employed during the culture 
experiments for evacuating the progeny of the adult worms under analysis. Each switching be-
tween the two flow directions is simply controlled by two external valves at the two chip outlets. 
We develop a fully automated protocol for worm culture and high-resolution imaging inside the 
device (Figure 5.5a). Worms are cultured on-chip at a desired temperature (typically in the 20-25 
°C range) by operating the temperature controller in a closed-loop configuration. E. coli suspen-
sion is perfused at desired rate along the In2-Out2 direction for worm feeding (Figure 5.5ai). For 
the accurate and repeatable observation of the worms through high-magnification objectives, C. 
elegans need to be temporarily immobilized in a reversible manner. To fulfill this requirement, we 
employ the thermoreversible gelation of a PF127 solution around the worms, as a minimally inva-
sive C. elegans immobilization technique [169]. Prior to imaging, the chip temperature is set at 15 
°C and a liquid solution of 25% w/v PF127 is injected into the culture chambers (Figure 5.5aii). The 
chip temperature is then raised to 25 °C, to trigger the gelation of the Pluronic solution. This sig-
nificant increases the viscosity ensuring stable worm immobilization (Figure 5.5aiii). Upon imag-
ing, the chip temperature is brought back to 15 °C, to release the worms and wash the PF127 
solution out of the chambers, by replacing it with E. coli suspension to restart worm culture and 
feeding (Figure 5.5aiv). The whole protocol can be iterated many times per experiment and 
strongly relies on accurate temperature control, especially to trigger the worm immobilization/re-
lease process [169]. The closed-loop temperature management system plays therefore a crucial 
role for the system automation. The spatial distribution of temperature over the whole chip ge-
ometry is carefully considered, to minimize inter-chamber variations and expose all the worms to 
the same experimental conditions. We demonstrate via FEM simulations that our device ensures 
temperature uniformity within 1 °C difference, even when using the largest chamber matrix, and 
this both during worm culture (at 20 °C) and PF127 injection and washing (at 15 °C) (Figure 5.5b). 
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PID parameters are chosen to minimize any overshoots outside of the standard temperature range 
for worm culture (15-25 °C) (Figure 5.5c). Active temperature control allows moreover fast and 
accurate steering of the sol-gel transition of the PF127 solution. In our device, such a transition 
occurs about 1 min after the temperature setpoint shift from 15 °C to 25 °C – i.e. worms are ready 
for high-resolution imaging in about 2 to 3 min, when the viscosity of the PF127 gel reaches its 
highest value and guarantees worm immobilization (Figure 5.5d).  
We experimentally determine the viscosity at different temperatures by dispensing a ∼2 mL PF127 
solution over the bottom plate of a cone-plate viscometer (Bohlin Gemini Malvern, UK) and meas-
uring using a shear rate of 10 s-1. This value is chosen to be comparable with typical shear rates 
associated to the C. elegans swimming motion (1 to 20 s-1) [185]. Finally, we attribute a crucial 
role to the liquid inflow pre-thermalization as far as the PF127 injection process is concerned. Even 
in liquid phase, the PF127 solution behaves in fact as a very viscous non-newtonian fluid, and, as 
such, it is challenging to manipulate through syringes, tubes and microchannels. Pre-thermalizing 
the PF127 inflow in the metallic frame to temperatures even lower than 15 °C allows further re-
ducing the solution viscosity at the chip inlet and improving the control over its injection. 
 
Figure 5.5 | Worm culture, immobilization and imaging. (a) Schematic representation of the iterative worm 
culture and imaging protocol. (b) FEM simulations of the spatial temperature distribution over the chip area 
(temperature contour plots) for temperature setpoints (i) at 20 °C for culture and (ii) at 15 °C for imaging. 
(c) Experimental temperature at the chip center during a worm culture-to-imaging transition, as managed 
by the active temperature control system, indicating the periods of PF127 injection and chip temperature 
changes. (d) Temperature rise in the 15-19 min period in more detail. The axis on the right shows the vari-
ation of PF127 solution viscosity (25% w/v in water) during the transition from 15 °C to 25 °C in the device. 
The PF127 sol-gel transition occurs abruptly at about 17 °C, in a time window of ∼1 min. Values of PF127 
viscosity at the different temperatures are measured through a cone-plate viscometer. 
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5.5 Automated longitudinal studies on C. elegans  5.5.1 Worm viability and culture tests 
Before using our device for answering specific biological questions, we test its capability of auto-
matically running worm cultures over several days and optimize the worm feeding protocol for 
good worm viability and healthy growth. For this preliminary validation, we employ wild-type C. 
elegans and feed them with HT115 E. coli bacteria. Different feeding protocols are tested to es-
tablish optimal conditions for worm growth. A delicate balance has to be found between two main 
competing factors. On the one hand, too strongly diluted E. coli suspensions (and/or less frequent 
injections) might cause worm starvation. On the other hand, too concentrated E. coli suspensions 
(and/or too frequent injections) usually result in the uncontrolled clogging of narrow microfluidic 
connections, which has then to be eliminated via user-controlled washing steps. A good compro-
mise between these factors is found by injecting in the device ~1.5 μL E. coli suspension per mi-
crofluidic chamber (e.g. ~6 μL for the 4-chamber matrix) at 1.4·109 bacteria mL-1 concentration, 
every 10 minutes. This protocol is automatically handled by the syringe pump software interface 
and allows attaining reliable worm growth inside the chip over several days, with no significant 
channel clogging or extra washing steps. Moreover, worm immobilization via thermoreversible 
PF127 gelation proves neither to affect worms’ viability nor to alter their physiological functions, 
as already reported in previous works [156, 169]. 5.5.2 Long-term protein aggregation analysis in amyotrophic lateral sclerosis (ALS) 
C. elegans models 
Upon full validation of the capabilities and performance of our device, we employ it to monitor 
the dynamics of protein aggregation in amyotrophic lateral sclerosis (ALS) disease C. elegans mod-
els. ALS is a neurodegenerative human disease causing selective death of motor neurons. In Eu-
rope and the United States, this disease affects about 2 people per 100,000 per year [186], with 
average survival form onset to death of only 3 to 5 years and no cure currently available [187]. In 
ALS, such as in many other neurodegenerative diseases, cellular toxicity could be mediated by the 
misfolding and aggregation of specific mutant proteins [188-190]. Time-resolved imaging and 
quantification of these aggregates is hence a key phenotyping method to monitor disease pro-
gression. In our study, we employ an ALS C. elegans model expressing mutated human SOD1-YFP 
fusion proteins in the body wall muscle cells (AM725 transgenic worms) [191]. Worms are loaded 
at the L2 stage into a 4-chamber microfluidic chip (Figure 5.2dii), where their distribution is ad-
justed to isolate a single worm in each chamber. Automated on-chip culture of these worms is 
then conducted according to the previously described protocols. Correct worm feeding, develop-
ment and reproduction are constantly monitored via brigthfield time-lapse imaging (Figure 5.6a). 
Automated image processing algorithms on these time-lapse pictures allow moreover extracting 
detailed information about the worms’ growth rate, not only at a population level, but also at 
single-worm resolution (Figure 5.6b-c). Specifically, the area occupied by each worm is here used 
as a quantitative indicator of growth. Data about the growth rate of individual worms allow pre-
serving detailed information on the development of each nematode (Figure 5.6b), while the aver-
age growth trend is found to follow a well-defined sigmoidal dependence on time (Figure 5.6c). 
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At desired moments during worms’ development (e.g., in our study, 43 h, 60 h and 91 h upon 
worm injection), the reversible worm immobilization protocol for high-resolution imaging (see 
Figure 5.5a) is employed. At each observation and in a matter of a few minutes, all the worms are 
perfectly immobilized in a PF127 gel matrix and SOD1-YFP expression can be monitored within 
their tissues via fluorescent microscopy through high-magnification objectives. A first analysis at 
10× magnification allows observing protein aggregates within the whole body of each worm (Fig-
ure 5.7a). It is worth noticing that, because of the relatively high exposure times used for the 
 
Figure 5.6 | Worm growth monitoring and quantification. (a) Time-lapse brightfield pictures of four AM725 
transgenic worms, isolated at t = 0 at the L2 larval stage in the 4 different culture chambers. Scale bars = 
100 μm. (b) On-chip growth rate of the four worms over 87 hours, as estimated by measuring the worm 
area from time-lapse pictures. (c) Average on-chip worm growth, featuring a sigmoidal time-dependence. 
 
 
Figure 5.7 | Protein aggregation monitoring and quantification. (a) Time-lapse fluorescent pictures of four 
AM725 transgenic worms, immobilized in a PF127 gel matrix within the culture chambers. Scale bars = 100 
μm. (b) Growth rate of SOD1-YFP aggregates in the body wall muscle cells of each worm, as estimated by 
measuring YFP expression area across each worm’s body during their immobilization in the gel matrix. (c) 
Average protein aggregate area per worm, normalized by the average worm area. A linear time-dependence 
of this parameter is observed over the period from 43 to 91 hours upon loading on chip (day 1 to day 3 of 
worm adulthood). (d) Brightfield and fluorescent images of an immobilized worm (worm 1), as taken 
through a 63× NA 1.4 oil immersion objective 91 hours upon worm loading into the device. These pictures 
allow mapping the aggregate morphology at high spatio-temporal resolution. (e) Superimposed brightfield 
and fluorescent images of an immobilized worm (worm 4), as taken through a 63× NA 1.4 oil immersion 
objective 43 and 60 hours upon worm loading into the device. Arrows point at specific SOD1-YFP aggregates, 
which can be re-identified in subsequent images and tracked over time. Scale bars = 20 μm. 
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imaging (120 ms), this analysis would have been impossible to perform on freely moving worms. 
Perfect image stability is in fact needed for non-distorted observation and accurate estimation of 
the aggregate size. Interestingly, we find that the temporal evolution of SOD1-YFP aggregation 
features some observable worm-to-worm variability (Figure 5.7b), and follows an overall linear 
trend in the considered temporal window (43 to 91 hours after on-chip loading at the L2 stage) 
(Figure 5.7c).  
A second set of studies is then conducted by imaging the immobilized worms through a 63× oil 
immersion objective (NA 1.4). Many aggregates in AM725 worms, unlike in other analogous SOD1-
transgenic strains, appear as irregular, elongated foci. This feature could be observed before by 
confocal imaging of paralyzed worms [191]. We are now able to confirm this observation in alive 
immobilized worms and provide a precise sub-cellular mapping of their protein aggregation pat-
tern at high spatio-temporal resolution by using a standard fluorescent microscope (Figure 5.7d). 
Moreover, the possibility to take quasi-instantaneous brightfield and fluorescent pictures in our 
chip allows accurately locating each fluorescent signal inside the C. elegans body. In combination 
with reversible worm immobilization, this opens the possibility of following the temporal evolu-
tion of protein aggregation at precise locations within the worm tissues and monitoring aggregate 
progression in vivo, not only at single-worm, but even at the single-cell level (Figure 5.7e).    5.6 Materials and methods 5.6.1 Chemicals and Materials  
4-inch 550 µm thick Si wafers and DIW were obtained from the Center of Micro- and Nanotech-
nology of EPFL. GM 1070 SU-8 negative photoresist was purchased from Gersteltec (Pully, Swit-
zerland). PDMS Sylgard 184 was acquired from Dow Corning (Wiesbaden, Germany). 1 mL boro-
silicate H-TLL-PE syringes were purchased from Innovative Laborsysteme GmbH (Stutzerbach, Ger-
many). Microline ethyl vinyl acetate tube with 0.51 mm inner and 1.52 mm outer diameters was 
bought from Fisher Scientific (Wohlen, Switzerland). Pluronic F-127 was purchased from Sigma-
Aldrich (Buchs, Switzerland). M9 buffer was obtained by adding 3 g KH2PO4, 6 g Na2HPO4, 5 g 
NaCl, 1 mL 1 M MgSO4, H2O to 1 litre and sterilization by autoclaving. S-medium buffer was ob-
tained by adding 10 mL 1 M potassium citrate pH 6, 10 mL trace metals solution (1.86 g disodium 
EDTA, 0.69 g FeSO4·7H2O, 0.2 g MnCl2·4H2O, 0.29 g ZnSO4·7H2O and 0.025 g CuSO4·5H2O, H2O to 1 
litre) 3 mL 1 M CaCl2, 3 mL 1M MgSO4, 1 mL [50 mg/mL] carbenicillin, 0.5 mL tween 20 to 1 litre S 
Basal (5.85 g NaCl, 1 g K2HPO4, 6 g KH2PO4, 1 mL [5 mg/mL] cholesterol, H2O to 1 litre) and sterili-
zation by autoclaving. Pluronic F127 solution was prepared by diluting 25% (weight/volume) Plu-
ronic F127 in water. Aluminum and PMMA assembly parts were fabricated at the engineering 
workshop of EPFL. Thermoelectric modules were bought from TE Technology, Inc. (Traverse City, 
MI, USA), heat sinks from Advanced Thermal Solutions, Inc. (Norwood, MA, USA) and RTD sensors 
from Innovative Sensor Technology AG (Ebnat-Kappel, Switzerland), while a PID temperature con-
troller was purchased from BelektroniG GmbH (Freital, Germany).  
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5.6.2 C. elegans strains and culture 
C. elegans strains were cultured at 20°C on nematode growth media agar plates seeded with the 
Escherichia coli strain OP50. Strains used were wild-type Bristol N2 and AM725 (rmIs290[unc-
54p::Hsa-sod-1(127X)::YFP]). Strains were provided by the Caenorhabditis Genetics Center (Uni-
versity of Minnesota). Worms were suspended in S-medium solution prior to each microfluidic 
experiment. For microfluidic experiments, the E. coli strain HT115 was suspended in S-medium at 
a concentration of 1.4 x 109 cells/mL. 5.6.3 Fabrication of the microfluidic chips 
Microfluidic devices were prepared by soft lithography [144] using 2-layer SU-8 molds. Briefly, 
conventional photolithography was used to pattern a 14 μm-thick layer of SU-8 photoresist on 4-
inch wafers. A ~110 μm-thick layer of SU-8 was then patterned on top of the first one. Layer thick-
nesses were confirmed by mechanical profilometer measurements. The silicon mold was then 
diced in 20 mm × 20 mm microchips, which were inserted at the bottom of an aluminum/PMMA 
mold for PDMS casting (Figure 5.8). 1.5 mm diameter steel pins were used to define the lateral 
connections of the device for the external tubing insertion. A liquid PDMS mixture (10:1 
base:cross-linker weight ratio) was degassed, injected into the mold and cured at 100 °C for 1 h. 
Upon extraction from the mold, each PDMS chip was bonded by plasma-activation to a 150 μm-
thick, 32 × 24 mm2 glass coverslip. The chip was then connected to external tubing and enclosed 
in the device assembly as reported in Figure 5.2a.  
 
Figure 5.8 | PDMS injection molding technique. Schematic representation of the casting mold designed to 
shape the whole 3D geometry of our PDMS microfluidic chips. The SU-8/silicon master corresponding to 
the desired microfluidic design is positioned inside an aluminum base, which is then sealed to a PMMA 
frame using 4 M3 screws. 1.5 mm diameter steel pins are inserted into the PMMA frame through dedicated 
holes, machined at 45° angle with respect to the master mold. The flat base of each pin contacts the SU-8 
structures at the position of each inlet (or outlet). This specific configuration is conceived to achieve lateral 
microfluidic connections entering the sidewalls of the chip, leaving hence free access for observation and 
manipulation both from the top and the bottom faces of the chip. PDMS is injected inside the casting mold 
through the “PDMS injection hole” using a syringe. The whole assembly is then positioned between two 
parallel hot plates at 100 °C for PDMS curing, using the aluminum base part to ensure good thermal ex-
change with the hot plates, so that the liquid PDMS correctly polymerizes.  
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5.6.4 Image acquisition and processing 
The microfluidic platform was placed within an inverted microscope (Axio Observer, Zeiss) 
equipped with two illumination systems: (i) a precisExcite High-Power LED illumination system 
(Visitron, Puchheim, Germany) for brightfield imaging and (ii) a Lambda DG4 illumination system 
(Sutter instruments, Novato, CA, USA) for fluorescence imaging. The microscope had a motorized 
xy-stage and the automated imaging process was controlled using VisiView Premier Image acqui-
sition software (Visitron, Puchheim, Germany). Images were acquired through a Hamamatsu Orca-
ER CCD camera (Hamamatsu, Solothurn, Switzerland). Image processing was performed with Fiji 
software (http://imagej.nih.gov/ij; version 1.47b).  5.7 Conclusions 
We introduce a new device for automated high-resolution imaging and studies on C. elegans nem-
atodes down to single-cell resolution. Our platform is based on a multi-functional approach, where 
several functionalities are integrated in a single miniaturized device, to allow fully automated 
worm analyses. The device is moreover designed to be compatible with different microfluidic de-
signs and readily suitable for different sets of studies.  
In our platform, C. elegans nematodes are loaded into a microfluidic chip, where they are directly 
distributed among a set of culture chambers via a “passive valving” method. Geometrical con-
straints on the chip allow retaining only worms of desired size inside the device, whereas an au-
tomated on-chip culture protocol is established to ensure their correct feeding and development. 
Active control of the chip temperature ensures moreover running worm cultures at desired tem-
peratures, with minimal variation throughout long-term analyses. To allow longitudinal high-res-
olution imaging of the worms, we optimize an automated procedure for reversible worm immo-
bilization on-chip. This protocol is based on the thermoreversible gelation of PF127 polymer inside 
the device, managed by the closed-loop temperature control system as well. Any worms’ progeny 
is periodically washed out of the chip, with no risk of mixing the identities of the worms under 
analysis. Therefore, tests at single-worm resolution can be easily performed on our platform. Fi-
nally, all the microfluidic designs used in our studies are conceived in a “chamber-matrix” format, 
which allows easy automation of the imaging process as well. 
We fully characterize the different functionalities of our platform, both theoretically and experi-
mentally. We demonstrate fast and precise temperature management on the device and provide 
calibration curves for its use both in open-loop mode and in closed-loop configuration. We char-
acterize the different integrated worm handling protocols – i.e. on-chip worm loading, feeding, 
immobilization, imaging – and provide details for their use on the platform. We then employ our 
device to tackle the challenging task of monitoring the dynamics of protein aggregation in ALS 
worm models over long-term experiments. Our results show that the device ensures reliable cul-
ture and reproducible growth rate of the worms over several days. The possibility of isolating sin-
gle worms in separated chambers allows collecting population statistics, while preserving at the 
same time all the information related to the single nematodes under test.  
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We employ the on-chip immobilization protocol to temporarily immobilize the worms in a reversi-
ble way and periodically collect data about protein aggregation in their tissues via high-resolution 
fluorescent imaging. Our results show that the amount of SOD1-YFP aggregates in ALS C. elegans 
models (AM725 transgenic worms) linearly increases over the whole analysed period (i.e. day 1 to 
day 4 of adult life). Combined brightfield and fluorescent imaging at high magnification allows 
moreover mapping the geometry of the aggregates, precisely locate them within the tissues of 
each worm and following their progression over consecutive days. The relatively short period 
needed for the quantification of a significant increase in SOD1-YFP aggregates opens the possibil-
ity for future studies of rapid identification of ALS modifiers [192]. Because of its unprecedented 
performance in terms of automation and versatility, we envision that our device could be em-
ployed to address many other challenging biological questions on C. elegans, related in particular 
to the study of neurodegenerative diseases – such as Huntington’s, Parkinson’s, and Alzheimer’s 
disease – which are all modelled in worms [173]. Our platform could moreover be used for studies 
of movement disorders, for quantifying other phenotypes such as pharyngeal pumping rates, mo-
tility, etc., or more generally could be used in non-C. elegans biology laboratories. The active tem-
perature control, together with the described on-chip  protocols, allow in fact easy and reliable 
organism culture and analysis, without need of any calibration and no influence of external tem-
perature or other environmental and human factors. 
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 Conclusions and Outlook 6.1 Results overview 
Micro- and nano-science allows nowadays good control and study of the basic building blocks of 
biological matter, being micro-organisms, cells or even single molecules. Moreover, microfluidics 
– the technology for manipulating small volumes of fluids – largely demonstrated its potential to 
miniaturize whole complex laboratory protocols onto single micro-chips, with substantial ad-
vantages over standard laboratory procedures. The technological options provided by these so-
called “lab-on-a-chip” (LOC) devices are however still far from being standardized solutions, so 
that even the most groundbreaking LOC components proposed in the last years proved to be less 
suitable for commercialization, usually because of their fundamental incompatibility with batch-
type techniques. In the light of these considerations, we focused our research efforts on the de-
velopment of versatile, fully automated LOC tools, answering to the urgent need for future com-
mercial solutions. We typically demonstrated the capabilities of our devices to address specific 
biomedical questions, while always carefully designing them to be mutually compatible and easily 
readaptable for a manifold of applications. A common feature of all our developed LOC devices is 
represented by the combination of both microfluidics and “micro-arraying” approaches, which we 
envision to be key elements towards standardization, full automation and easy scalability of the 
LOC technology.  
We first proposed a new LOC-based method for ultra-sensitive protein detection in serum. Meas-
uring biomarkers at very low concentration in blood or serum samples can allow early disease 
diagnosis and can thus be crucial for proposing life-saving medical treatments to the patients. 
Moreover, disease detection via measurement of specific antigens in a serum matrix is often the 
preferred minimally invasive solution. Very sensitive nucleic acid detection is enabled by polymer-
ase chain reaction (PCR) techniques, but there is no comparable method that can be used to “am-
plify” proteins, which hence necessitates the development of very sensitive types of assays. With 
our on-chip assay method, we demonstrated detection down to only 200 molecules of the clini-
cally relevant biomarker TNF- α, in serum sample volumes of 5 µL – the size of a small blood drop-
let – corresponding to a concentration of 60 attomolar. This result proved that our solution allows 
attaining unprecedented limits of detection, 10 to 100 times lower than the most sensitive avail-
able techniques and only comparable with complex and expensive PCR-based methods. Moreo-
ver, we designed our technique to be easily standardizable, by employing micro-arrays of com-
mercially available superparamagnetic beads, as a key technological feature of the assay. In this 
same framework, we took care of providing the research community with a comprehensive mod-
eling and a deep understanding of our detection method. By combining FEM simulations with 
analytical calculations, we first built a predictive model for our technique, to be employed as a 
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guide for its further use, optimization and development. In this study, we elucidated the key role 
of magnetic bead dipole–dipole interactions, combined with microfluidic viscous forces, to dra-
matically enhance the selectivity of specific antigen-antibody immunocomplex formation in the 
so-called “sandwich immunoassays”. In a second study, we included considerations on the prob-
ability of the single immunocomplex formation in our assay. This led to a careful investigation of 
the assay kinetics and ultimately to the full understanding of the peculiar behavior of the assay’s 
dose-response curves, which remained unexplained, until then. Finally, we introduced the concept 
of “magnetic particle-scanning”, which we proved to be, both theoretically and experimentally, a 
new powerful method for building immunoassays with extremely low limit of detection, down to 
the single-molecule level.  
As a further proof of the versatility of our technology, we modified our bead-micro-arraying tech-
nique, to make it suitable for the immobilization of particles of various sizes, materials and prop-
erties – and even of cells – to be readily applicable in a manifold of research fields. In a first study, 
we developed a method for the electrostatic self-assembly of dielectric microspheres in well tem-
plates, which we employed as a tool for rapid, cost-effective fabrication of microlens arrays. We 
demonstrated that our method ensured extremely fast and reliable lens array formation (> 99% 
lens loading efficiency, in a few seconds), while moreover offering the possibility to reversibly as-
semble and disassemble the array by simply tuning the pH of the microsphere patterning and 
washing solutions. Different particle sizes and materials could be directly used with our technique, 
to fabricate microlens arrays with specific light focusing properties. By combining microsphere 
arrays with microfluidics, we demonstrated single-nanoparticle detection in flowing media via 
conventional brightfield and fluorescence microscopes – which we made therefore indirectly op-
erate far below their physical diffraction limit. Our microsphere arrays permit in fact enhancing 
the light scattering and fluorescence intensity of the nanoparticles by up to a factor ~40, over a 
very wide field of view. This resulted in the possibility of detecting gold nanoparticles down to 50 
nm in size, as well as fluorescent nanoparticles down to 20 nm in size, through a common low 
magnification/low numerical aperture microscope objective. Finally, in the framework of a re-
search collaboration with the biosensors group at KU Leuven, Belgium, we further re-adapted this 
“microparticle arraying” concept, to be suitable for seeding single non-adherent cells in isolated 
micro-compartments. This new method was combined with the use of a DMF platform, for the 
implementation of high-throughput cytotoxicity assays on yeast cells, at significantly enhanced 
spatio-temporal resolution. 
In parallel with the described work, we tackled the challenging task of conceiving technological 
solutions which allow creating micro-arrays of small living organisms, for their automated study 
in a high-throughput format. The nematode Caenorhabditis elegans is definitely one of the most 
employed model organisms in biomedical research.  In C. elegans, many events occurring during 
larval stages are known to have a strong impact on the animal’s lifespan. Whether conditions in 
the embryonic phase of life have an influence on the later development is instead a much more 
challenging question to answer, mainly because systematic C. elegans embryonic morphogenesis 
studies are extremely difficult from a technical viewpoint. C. elegans embryos are in fact only a 
few tens of micrometers in size and almost impossible to handle manually. To solve this issue, we 
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developed a microfluidic platform for automated on-chip worm culture, creation of synchronized 
embryo micro-arrays, and for long-term parallel live imaging at the single embryo level. Our device 
features two main components: a “worm chamber”, where C. elegans nematodes are loaded and 
cultured, and an “embryo-incubator array", where the worms’ progeny is transferred upon natural 
egg laying in the chamber. The microfluidic device relies on a passive hydrodynamic trapping ap-
proach to gently position each embryo in a dedicated micro-incubator. The whole embryo popu-
lation can then be studied over several hours via fully automated multi-dimensional imaging, cov-
ering six independent dimensions: the 3 spatial coordinates, the development time, the exposure 
(brightfield, fluorescent) duration, and the embryo number in the array. We successfully em-
ployed our platform to investigate relevant biological phenomena occurring during the embryonic 
development, with a particular focus on mitochondrial biogenesis and stress. The incubator array 
format of our platform provided a unique opportunity to study the intra-embryo variability in 
terms of viability, development and gene expression. By means of our device, we were able to 
discriminate variations in terms of embryonic development with unprecedented resolution and 
describe how perturbations of the mitochondrial functions can profoundly impact the embryo-
genesis. Our analyses revealed in fact that such perturbations can trigger the mitochondrial un-
folded protein response (UPRmt) pathway in the embryos. These observations were the first proof 
that UPRmt is functional during C. elegans embryogenesis.  
A very interesting feature of our platform is represented by the fact that worms are directly cul-
tured on-chip and embryos analyzed upon spontaneous egg-laying, so that the whole information 
related to the natural reproduction process is preserved and the link between parents and prog-
eny is maintained. Starting from these considerations, we designed a “second generation proto-
type” of our device, with the specific aim of investigating trans-generational properties on worms’ 
progeny and epigenetic imprints in successive worm generations. In our new device, each micro-
incubator is now coupled with an additional worm chamber, where each larva is transferred prior 
to egg hatching. Also this system automatically operates via pure passive hydrodynamics and al-
lows not only potentially observing on-chip, for the first time, the entire lifespan of C. elegans from 
embryogenesis to death – and at single-worm resolution –, but also relating it to conditions or 
events occurred to the previous generation. When arrays of living organisms need to be studied, 
the fact that the animal can freely move typically complicates observation and analysis. Our mi-
crofluidic devices allow confining single worms in culture chambers of desired size, thus ensuring 
that worms can always be found within a well-defined field of view. However, high-magnification 
imaging is usually needed to extract relevant biological information, while studies on transgenic 
animals often require the accurate observation of highly localized fluorescent signals inside the 
worms. During imaging, hence, animals have usually to be fully immobilized to prevent their move-
ment, which would result in image distortion. Moreover, to observe the dynamics of biological 
processes, while ensuring minimal impact during the imaging phase, the same worm has to be 
immobilized repeatedly in a reversible manner, and under normal physiological conditions. Based 
on these needs, we developed our “third generation prototype”, which features: (i) a new micro-
fluidic design tailored for the isolation of L1 or L4 larvae from a mixed larval population and for 
their successive culture and treatment; (ii) a worm immobilization method, based on the ther-
moreversible gelation of a biocompatible polymer inside the microfluidic chip, thereby enabling 
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high-resolution imaging; (iii) an integrated temperature control system, both to ensure viable en-
vironmental conditions for C. elegans culture and to steer the worm immobilization/release pro-
cess. The chip geometry is again conceived in an array-format, and parallel multi-dimensional im-
aging over the device allows gathering plenty of information on the whole worm population in an 
automated way. We successfully employed this device to pursue challenging time-resolved stud-
ies, in particular the long-term in vivo observation at single-animal resolution of SOD1 aggregation 
in the AM725 C. elegans transgenic strain, which we use as a biological model system for the in-
vestigation of the human ALS disease. In particular, we exploited the on-chip immobilization pro-
tocol to temporarily immobilize the worms in a reversible way and periodically collect data about 
protein aggregation in their tissues via high-resolution fluorescent imaging. Our results showed 
that the amount of SOD1-YFP aggregates in ALS C. elegans models (AM725 transgenic worms) 
linearly increases over the whole analysed period (i.e. day 1 to day 4 of adult life). Combined 
brightfield and fluorescent imaging at high magnification allowed moreover mapping the geome-
try of single aggregates, precisely locate them within the tissues of each worm and following their 
progression over consecutive days. 6.2 Future opportunities 
The combination of passive microfluidics and micro-arraying approaches will likely represent one 
of the answers to the need of versatile, commercializable LOC systems. The use of pure passive 
hydrodynamics, rather than complex microfluidic architectures with active components, could sig-
nificantly help evolving towards the industrialization phase, in which key requirements are typi-
cally represented by the ease of integration and control of the device itself. The micro-array for-
mat provides then any microfluidic geometry with even more precious features for commerciali-
zation purposes, which are modularity, scalability and versatility of the design. At the same time, 
these characteristics are particularly convenient in the research environment as well, where they 
allow the same devices and techniques being rapidly re-adapted for different applications.  6.2.1 New research directions for micro-arrays of beads, lenses and single-cells 
Our “magnetic bead-scanning” immunoassay method (see chapter 1) could be readily used for the 
detection of any biomarker in serum, provided that their capture antigen is available in a biotinyl-
ated form. The behavior of the system for any modification of the microfluidic or magnetic proto-
col can be easily predicted through our modeling tools, while the use of parallel detection chan-
nels would directly allow the simultaneous detection of a whole set of different molecules. Mi-
crowell array templates (see chapter 2) of different materials, size and geometries will be fabri-
cated for the creation of microlens arrays with tailored optical properties. Moreover, our tech-
nique recently proved to be useful not only for NPs detection, but also for immunodetection of 
biomolecules immobilized on gold NPs (data not shown). In future, it may develop into a versatile 
tool to detect other nanoscale objects of environmental or biological relevance – such as cancer-
ous nanomaterial or viruses – or even to directly observe the nanoscale dynamics of biological 
phenomena within living cells. Eventually, multiple single-cell arrays could be employed on a single 
microfluidic device for multiplexed testing of compound libraries on the same cell type or even on 
different cell strains or mutants. 
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6.2.2 New research directions for micro-arrays of C. elegans embryos 
The live imaging capabilities of the device presented in chapter 3 can be extended to include other 
types of microscopies, like differential interference contrast microscopy, for high-contrast bright-
field live imaging, and confocal microscopy to achieve extreme spatial resolution. Computer-en-
hanced image processing can be used to further extend the analytical possibilities of the platform 
for real-time embryonic screening and phenotyping, or even automated cell lineage and expres-
sion profiling in the developing embryos. In our device embryos are isolated immediately after 
they are naturally laid, thus their monitoring typically starts at the 26 to 44-cell stage. However, 
with our system, earlier cell division events may be optionally observed by directly injecting em-
bryo suspensions prepared via standard manual bleaching protocols into the device. However, as 
in our platform worms are directly cultured on-chip and embryos analyzed upon spontaneous egg-
laying, the whole information related to the natural reproduction process is preserved, maintain-
ing the link between parents and progeny. Therefore, the platform is directly suitable for investi-
gating trans-generational properties on the embryos and, with the adaptation of the microfluidic 
design proposed in chapter 4, even studying the progeny and epigenetic imprints in successive 
worm generations. Devices for related parasitic nematodes can be readily designed by re-adapting 
the incubator size, for example to study the effects of anti-parasitic drugs. Finally, we expect that 
similar microfluidic devices will be used to perform live imaging of a multitude of development 
events, like gastrulation and tissue morphogenesis during embryogenesis in other species of nem-
atodes or other model organisms.  6.2.3 New research directions for micro-arrays of C. elegans nematodes 
C. elegans recently gained a lot of attention as a model organism for the investigation of neuro-
degenerative diseases, such as ALS, Alzheimer’s, Parkinson’s, and Huntington’s disease (see chap-
ter 5). Studies on C. elegans are increasingly leading towards high-throughput screens for the iden-
tification of new genes and novel pharmaceuticals which could modify the course of different 
neurodegenerative diseases. These kind of studies would enormously benefit from microfabri-
cated solutions in which different compounds and conditions can be tested at the same time, 
under accurate control of all the other long-term culture conditions. Moreover, extremely pre-
cious tools in this field will be represented by software interfaces for “worm tracking” and motility 
assessment, as well as other image processing tools which allow automatically extracting multi-
phenotypic profiles of the worms, including data such as body volume, growth rate, reproduction 
rate and – by means of transgenic strains – gene and protein expression. Moreover, we are cur-
rently employing our “worm-chips” to address some crucial biological questions: (i) what is the 
progression of the different neurodegenerative diseases in C. elegans and how protein aggrega-
tion phenomena relate to other phenotypes over long-term analyses?  (ii) Which are the effects 
of specific antibiotic treatments on the worms’ mitochondrial activity and how is this reflected on 
different worms’ phenotypes? (iii) Can we reliably identify new anti-parasitic drugs by screening 
compound libraries through our device? Keeping in mind that more than 80% of the C. ele-
gans proteome has human homologous genes, by answering to these biological questions, we 
expect to get precious insights about human neurodegenerative and metabolic diseases as well 
as possibly discover new cures to parasitic infections in humans.  The versatility and automation 
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levels that we could reach with our worm-chip designs will hopefully set a new standard in the C. 
elegans research community. The proposed devices might have large impact in the drug discovery 
field, with a future potential as new platforms for high-content drug-screening.   
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